-DOCSTART- -X- -X- O

Identification NN NN O
of NN NN O
APC2 NN NN O
, NN NN O
a NN NN O
homologue NN NN O
of NN NN O
the NN NN O
adenomatous NN NN B-Modifier
polyposis NN NN I-Modifier
coli NN NN I-Modifier
tumour NN NN I-Modifier
suppressor NN NN O
. NN NN O

A NN NN O
common NN NN O
MSH2 NN NN O
mutation NN NN O
in NN NN O
English NN NN O
and NN NN O
North NN NN O
American NN NN O
HNPCC NN NN B-Modifier
families NN NN O
: NN NN O
origin NN NN O
, NN NN O
phenotypic NN NN O
expression NN NN O
, NN NN O
and NN NN O
sex NN NN O
specific NN NN O
differences NN NN O
in NN NN O
colorectal NN NN B-SpecificDisease
cancer NN NN I-SpecificDisease
. NN NN O

Age NN NN O
of NN NN O
onset NN NN O
in NN NN O
Huntington NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
: NN NN O
sex NN NN O
specific NN NN O
influence NN NN O
of NN NN O
apolipoprotein NN NN O
E NN NN O
genotype NN NN O
and NN NN O
normal NN NN O
CAG NN NN O
repeat NN NN O
length NN NN O
. NN NN O

Familial NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
seventh NN NN I-SpecificDisease
component NN NN I-SpecificDisease
of NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
associated NN NN O
with NN NN O
recurrent NN NN O
bacteremic NN NN B-DiseaseClass
infections NN NN I-DiseaseClass
due NN NN I-DiseaseClass
to NN NN I-DiseaseClass
Neisseria NN NN I-DiseaseClass
. NN NN O

Increased NN NN O
incidence NN NN O
of NN NN O
cancer NN NN B-DiseaseClass
in NN NN O
patients NN NN O
with NN NN O
cartilage-hair NN NN B-SpecificDisease
hypoplasia NN NN I-SpecificDisease
. NN NN O

Genotype NN NN O
and NN NN O
phenotype NN NN O
in NN NN O
patients NN NN O
with NN NN O
dihydropyrimidine NN NN B-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
. NN NN O

Fibroblast NN NN O
growth NN NN O
factor NN NN O
homologous NN NN O
factor NN NN O
2 NN NN O
( NN NN O
FHF2 NN NN O
): NN NN O
gene NN NN O
structure NN NN O
, NN NN O
expression NN NN O
and NN NN O
mapping NN NN O
to NN NN O
the NN NN O
Borjeson-Forssman-Lehmann NN NN B-Modifier
syndrome NN NN I-Modifier
region NN NN O
in NN NN O
Xq26 NN NN O
delineated NN NN O
by NN NN O
a NN NN O
duplication NN NN O
breakpoint NN NN O
in NN NN O
a NN NN O
BFLS NN NN B-Modifier
- NN NN O
like NN NN O
patient NN NN O
. NN NN O

Germline NN NN O
E-cadherin NN NN O
gene NN NN O
( NN NN O
CDH1 NN NN O
) NN NN O
mutations NN NN O
predispose NN NN O
to NN NN O
familial NN NN B-SpecificDisease
gastric NN NN I-SpecificDisease
cancer NN NN I-SpecificDisease
and NN NN O
colorectal NN NN B-SpecificDisease
cancer NN NN I-SpecificDisease
. NN NN O

A NN NN O
zinc NN NN O
finger NN NN O
truncation NN NN O
of NN NN O
murine NN NN O
WT1 NN NN O
results NN NN O
in NN NN O
the NN NN O
characteristic NN NN O
urogenital NN NN B-DiseaseClass
abnormalities NN NN I-DiseaseClass
of NN NN O
Denys-Drash NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Mechanism NN NN O
of NN NN O
increased NN NN O
iron NN NN O
absorption NN NN O
in NN NN O
murine NN NN O
model NN NN O
of NN NN O
hereditary NN NN B-SpecificDisease
hemochromatosis NN NN I-SpecificDisease
: NN NN O
increased NN NN O
duodenal NN NN O
expression NN NN O
of NN NN O
the NN NN O
iron NN NN O
transporter NN NN O
DMT1 NN NN O
. NN NN O

Neurophysiologic NN NN O
follow-up NN NN O
of NN NN O
long-term NN NN O
dietary NN NN O
treatment NN NN O
in NN NN O
adult-onset NN NN O
adrenoleukodystrophy NN NN B-SpecificDisease
. NN NN O

GCH1 NN NN O
mutation NN NN O
in NN NN O
a NN NN O
patient NN NN O
with NN NN O
adult-onset NN NN O
oromandibular NN NN B-SpecificDisease
dystonia NN NN I-SpecificDisease
. NN NN O

Germline NN NN O
mutations NN NN O
of NN NN O
the NN NN O
APC NN NN B-Modifier
gene NN NN O
in NN NN O
Korean NN NN O
familial NN NN B-Modifier
adenomatous NN NN I-Modifier
polyposis NN NN I-Modifier
patients NN NN O
. NN NN O

Molecular NN NN O
epidemiology NN NN O
of NN NN O
C9 NN NN B-Modifier
deficiency NN NN I-Modifier
heterozygotes NN NN O
with NN NN O
an NN NN O
Arg95Stop NN NN O
mutation NN NN O
of NN NN O
the NN NN O
C9 NN NN O
gene NN NN O
in NN NN O
Japan NN NN O
. NN NN O

The NN NN O
hereditary NN NN B-Modifier
hemochromatosis NN NN I-Modifier
protein NN NN O
, NN NN O
HFE NN NN O
, NN NN O
specifically NN NN O
regulates NN NN O
transferrin-mediated NN NN O
iron NN NN O
uptake NN NN O
in NN NN O
HeLa NN NN O
cells NN NN O
. NN NN O

Mutation NN NN O
and NN NN O
haplotype NN NN O
studies NN NN O
of NN NN O
familial NN NN B-SpecificDisease
Mediterranean NN NN I-SpecificDisease
fever NN NN I-SpecificDisease
reveal NN NN O
new NN NN O
ancestral NN NN O
relationships NN NN O
and NN NN O
evidence NN NN O
for NN NN O
a NN NN O
high NN NN O
carrier NN NN O
frequency NN NN O
with NN NN O
reduced NN NN O
penetrance NN NN O
in NN NN O
the NN NN O
Ashkenazi NN NN O
Jewish NN NN O
population NN NN O
. NN NN O

Autoimmune NN NN B-SpecificDisease
lymphoproliferative NN NN I-SpecificDisease
syndrome NN NN I-SpecificDisease
with NN NN O
defective NN NN O
Fas NN NN O
: NN NN O
genotype NN NN O
influences NN NN O
penetrance NN NN O
. NN NN O

Multicentric NN NN O
origin NN NN O
of NN NN O
hemochromatosis NN NN B-Modifier
gene NN NN O
( NN NN O
HFE NN NN O
) NN NN O
mutations NN NN O
. NN NN O

A NN NN O
retrospective NN NN O
anonymous NN NN O
pilot NN NN O
study NN NN O
in NN NN O
screening NN NN O
newborns NN NN O
for NN NN O
HFE NN NN O
mutations NN NN O
in NN NN O
Scandinavian NN NN O
populations NN NN O
. NN NN O

Identification NN NN O
of NN NN O
the NN NN O
mutation NN NN O
in NN NN O
the NN NN O
alkaptonuria NN NN B-Modifier
mouse NN NN O
model NN NN O
. NN NN O

Non-syndromic NN NN B-SpecificDisease
hearing NN NN I-SpecificDisease
loss NN NN I-SpecificDisease
associated NN NN O
with NN NN O
enlarged NN NN B-SpecificDisease
vestibular NN NN I-SpecificDisease
aqueduct NN NN I-SpecificDisease
is NN NN O
caused NN NN O
by NN NN O
PDS NN NN B-Modifier
mutations NN NN O
. NN NN O

Mutational NN NN O
analysis NN NN O
and NN NN O
genotype-phenotype NN NN O
correlation NN NN O
of NN NN O
29 NN NN O
unrelated NN NN O
Japanese NN NN O
patients NN NN O
with NN NN O
X-linked NN NN B-SpecificDisease
adrenoleukodystrophy NN NN I-SpecificDisease
. NN NN O

A NN NN O
common NN NN O
human NN NN O
skin NN NN B-DiseaseClass
tumour NN NN I-DiseaseClass
is NN NN O
caused NN NN O
by NN NN O
activating NN NN O
mutations NN NN O
in NN NN O
beta-catenin NN NN O
. NN NN O

The NN NN O
Pendred NN NN B-Modifier
syndrome NN NN I-Modifier
gene NN NN O
encodes NN NN O
a NN NN O
chloride-iodide NN NN O
transport NN NN O
protein NN NN O
. NN NN O

HFE NN NN O
mutations NN NN O
analysis NN NN O
in NN NN O
711 NN NN O
hemochromatosis NN NN B-Modifier
probands NN NN O
: NN NN O
evidence NN NN O
for NN NN O
S65C NN NN O
implication NN NN O
in NN NN O
mild NN NN O
form NN NN O
of NN NN O
hemochromatosis NN NN B-SpecificDisease
. NN NN O

Germline NN NN O
BRCA1 NN NN O
alterations NN NN O
in NN NN O
a NN NN O
population-based NN NN O
series NN NN O
of NN NN O
ovarian NN NN B-Modifier
cancer NN NN I-Modifier
cases NN NN O
. NN NN O

Adrenoleukodystrophy-related NN NN O
protein NN NN O
can NN NN O
compensate NN NN O
functionally NN NN O
for NN NN O
adrenoleukodystrophy NN NN B-SpecificDisease
protein NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
( NN NN O
X-ALD NN NN B-SpecificDisease
): NN NN O
implications NN NN O
for NN NN O
therapy NN NN O
. NN NN O

Centrosome NN NN O
amplification NN NN O
and NN NN O
a NN NN O
defective NN NN O
G2-M NN NN O
cell NN NN O
cycle NN NN O
checkpoint NN NN O
induce NN NN O
genetic NN NN O
instability NN NN O
in NN NN O
BRCA1 NN NN O
exon NN NN O
11 NN NN O
isoform-deficient NN NN O
cells NN NN O
. NN NN O

Defective NN NN O
CD95/APO-1/Fas NN NN O
signal NN NN O
complex NN NN O
formation NN NN O
in NN NN O
the NN NN O
human NN NN O
autoimmune NN NN B-SpecificDisease
lymphoproliferative NN NN I-SpecificDisease
syndrome NN NN I-SpecificDisease
, NN NN I-SpecificDisease
type NN NN I-SpecificDisease
Ia NN NN I-SpecificDisease
. NN NN O

Analysis NN NN O
of NN NN O
alkaptonuria NN NN B-Modifier
( NN NN O
AKU NN NN B-Modifier
) NN NN O
mutations NN NN O
and NN NN O
polymorphisms NN NN O
reveals NN NN O
that NN NN O
the NN NN O
CCC NN NN O
sequence NN NN O
motif NN NN O
is NN NN O
a NN NN O
mutational NN NN O
hot NN NN O
spot NN NN O
in NN NN O
the NN NN O
homogentisate NN NN O
1,2 NN NN O
dioxygenase NN NN O
gene NN NN O
( NN NN O
HGO NN NN O
). NN NN O

Pharmacokinetics NN NN O
of NN NN O
chlorpheniramine NN NN O
, NN NN O
phenytoin NN NN O
, NN NN O
glipizide NN NN O
and NN NN O
nifedipine NN NN O
in NN NN O
an NN NN O
individual NN NN O
homozygous NN NN O
for NN NN O
the NN NN O
CYP2C9*3 NN NN O
allele NN NN O
. NN NN O

Fabry NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
: NN NN O
identification NN NN O
of NN NN O
novel NN NN O
alpha-galactosidase NN NN O
A NN NN O
mutations NN NN O
and NN NN O
molecular NN NN O
carrier NN NN O
detection NN NN O
by NN NN O
use NN NN O
of NN NN O
fluorescent NN NN O
chemical NN NN O
cleavage NN NN O
of NN NN O
mismatches NN NN O
. NN NN O

Prenatal NN NN O
diagnosis NN NN O
by NN NN O
FISH NN NN O
in NN NN O
a NN NN O
family NN NN O
with NN NN O
Pelizaeus-Merzbacher NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
caused NN NN O
by NN NN O
duplication NN NN O
of NN NN O
PLP NN NN O
gene NN NN O
. NN NN O

Dominant NN NN O
negative NN NN O
effect NN NN O
of NN NN O
the NN NN O
APC1309 NN NN O
mutation NN NN O
: NN NN O
a NN NN O
possible NN NN O
explanation NN NN O
for NN NN O
genotype-phenotype NN NN O
correlations NN NN O
in NN NN O
familial NN NN B-SpecificDisease
adenomatous NN NN I-SpecificDisease
polyposis NN NN I-SpecificDisease
. NN NN O

BRCA1 NN NN O
interacts NN NN O
with NN NN O
components NN NN O
of NN NN O
the NN NN O
histone NN NN O
deacetylase NN NN O
complex NN NN O
. NN NN O

Combined NN NN B-CompositeMention
genetic NN NN I-CompositeMention
deficiency NN NN I-CompositeMention
of NN NN I-CompositeMention
C6 NN NN I-CompositeMention
and NN NN I-CompositeMention
C7 NN NN I-CompositeMention
in NN NN O
man NN NN O
. NN NN O

Changes NN NN O
at NN NN O
P183 NN NN O
of NN NN O
emerin NN NN O
weaken NN NN O
its NN NN O
protein-protein NN NN O
interactions NN NN O
resulting NN NN O
in NN NN O
X-linked NN NN B-SpecificDisease
Emery-Dreifuss NN NN I-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

Microdeletions NN NN O
at NN NN O
chromosome NN NN O
bands NN NN O
1q32-q41 NN NN O
as NN NN O
a NN NN O
cause NN NN O
of NN NN O
Van NN NN B-SpecificDisease
der NN NN I-SpecificDisease
Woude NN NN I-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Splicing NN NN O
defects NN NN O
in NN NN O
the NN NN O
ataxia-telangiectasia NN NN B-Modifier
gene NN NN O
, NN NN O
ATM NN NN O
: NN NN O
underlying NN NN O
mutations NN NN O
and NN NN O
consequences NN NN O
. NN NN O

Alpha-cardiac NN NN O
actin NN NN O
is NN NN O
a NN NN O
novel NN NN O
disease NN NN O
gene NN NN O
in NN NN O
familial NN NN B-SpecificDisease
hypertrophic NN NN I-SpecificDisease
cardiomyopathy NN NN I-SpecificDisease
. NN NN O

Overgrowth NN NN B-CompositeMention
of NN NN I-CompositeMention
oral NN NN I-CompositeMention
mucosa NN NN I-CompositeMention
and NN NN I-CompositeMention
facial NN NN I-CompositeMention
skin NN NN I-CompositeMention
, NN NN O
a NN NN O
novel NN NN O
feature NN NN O
of NN NN O
aspartylglucosaminuria NN NN B-SpecificDisease
. NN NN O

Characterization NN NN O
of NN NN O
a NN NN O
germline NN NN O
mosaicism NN NN O
in NN NN O
families NN NN O
with NN NN O
Lowe NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
, NN NN O
and NN NN O
identification NN NN O
of NN NN O
seven NN NN O
novel NN NN O
mutations NN NN O
in NN NN O
the NN NN O
OCRL1 NN NN O
gene NN NN O
. NN NN O

MEFV-Gene NN NN O
analysis NN NN O
in NN NN O
armenian NN NN O
patients NN NN O
with NN NN O
Familial NN NN B-SpecificDisease
Mediterranean NN NN I-SpecificDisease
fever NN NN I-SpecificDisease
: NN NN O
diagnostic NN NN O
value NN NN O
and NN NN O
unfavorable NN NN O
renal NN NN O
prognosis NN NN O
of NN NN O
the NN NN O
M694V NN NN O
homozygous NN NN O
genotype-genetic NN NN O
and NN NN O
therapeutic NN NN O
implications NN NN O
. NN NN O

Noninvasive NN NN O
test NN NN O
for NN NN O
fragile NN NN B-SpecificDisease
X NN NN I-SpecificDisease
syndrome NN NN I-SpecificDisease
, NN NN O
using NN NN O
hair NN NN O
root NN NN O
analysis NN NN O
. NN NN O

In NN NN O
Swedish NN NN O
families NN NN O
with NN NN O
hereditary NN NN B-SpecificDisease
prostate NN NN I-SpecificDisease
cancer NN NN I-SpecificDisease
, NN NN O
linkage NN NN O
to NN NN O
the NN NN O
HPC1 NN NN O
locus NN NN O
on NN NN O
chromosome NN NN O
1q24-25 NN NN O
is NN NN O
restricted NN NN O
to NN NN O
families NN NN O
with NN NN O
early-onset NN NN O
prostate NN NN B-SpecificDisease
cancer NN NN I-SpecificDisease
. NN NN O

Molecular NN NN O
basis NN NN O
of NN NN O
feline NN NN O
beta-glucuronidase NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
: NN NN O
an NN NN O
animal NN NN O
model NN NN O
of NN NN O
mucopolysaccharidosis NN NN B-SpecificDisease
VII NN NN I-SpecificDisease
. NN NN O

A NN NN O
common NN NN O
molecular NN NN O
basis NN NN O
for NN NN O
rearrangement NN NN B-DiseaseClass
disorders NN NN I-DiseaseClass
on NN NN O
chromosome NN NN O
22q11 NN NN O
. NN NN O

Functional NN NN O
consequences NN NN O
of NN NN O
mutations NN NN O
in NN NN O
the NN NN O
early NN NN O
growth NN NN O
response NN NN O
2 NN NN O
gene NN NN O
( NN NN O
EGR2 NN NN O
) NN NN O
correlate NN NN O
with NN NN O
severity NN NN O
of NN NN O
human NN NN O
myelinopathies NN NN B-DiseaseClass
. NN NN O

Autosomal NN NN B-SpecificDisease
recessive NN NN I-SpecificDisease
familial NN NN I-SpecificDisease
neurohypophyseal NN NN I-SpecificDisease
diabetes NN NN I-SpecificDisease
insipidus NN NN I-SpecificDisease
with NN NN O
continued NN NN O
secretion NN NN O
of NN NN O
mutant NN NN O
weakly NN NN O
active NN NN O
vasopressin NN NN O
. NN NN O

X NN NN O
inactivation NN NN O
and NN NN O
somatic NN NN O
cell NN NN O
selection NN NN O
rescue NN NN O
female NN NN O
mice NN NN O
carrying NN NN O
a NN NN O
Piga-null NN NN O
mutation NN NN O
. NN NN O

The NN NN O
C282Y NN NN O
mutation NN NN O
causing NN NN O
hereditary NN NN B-SpecificDisease
hemochromatosis NN NN I-SpecificDisease
does NN NN O
not NN NN O
produce NN NN O
a NN NN O
null NN NN O
allele NN NN O
. NN NN O

Genotype-phenotype NN NN O
analysis NN NN O
in NN NN O
X-linked NN NN B-SpecificDisease
Emery-Dreifuss NN NN I-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
and NN NN O
identification NN NN O
of NN NN O
a NN NN O
missense NN NN O
mutation NN NN O
associated NN NN O
with NN NN O
a NN NN O
milder NN NN O
phenotype NN NN O
. NN NN O

Severe NN NN O
clinical NN NN O
expression NN NN O
in NN NN O
X-linked NN NN B-SpecificDisease
Emery-Dreifuss NN NN I-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

Common NN NN O
mutations NN NN O
in NN NN O
BRCA1 NN NN O
and NN NN O
BRCA2 NN NN O
do NN NN O
not NN NN O
contribute NN NN O
to NN NN O
early NN NN O
prostate NN NN B-SpecificDisease
cancer NN NN I-SpecificDisease
in NN NN O
Jewish NN NN O
men NN NN O
. NN NN O

Beta-catenin NN NN O
accumulation NN NN O
and NN NN O
mutation NN NN O
of NN NN O
the NN NN O
CTNNB1 NN NN O
gene NN NN O
in NN NN O
hepatoblastoma NN NN B-SpecificDisease
. NN NN O

Decrease NN NN O
in NN NN O
GTP NN NN O
cyclohydrolase NN NN O
I NN NN O
gene NN NN O
expression NN NN O
caused NN NN O
by NN NN O
inactivation NN NN O
of NN NN O
one NN NN O
allele NN NN O
in NN NN O
hereditary NN NN B-SpecificDisease
progressive NN NN I-SpecificDisease
dystonia NN NN I-SpecificDisease
with NN NN O
marked NN NN O
diurnal NN NN O
fluctuation NN NN O
. NN NN O

Sulfate NN NN O
transport NN NN O
is NN NN O
not NN NN O
impaired NN NN O
in NN NN O
pendred NN NN B-Modifier
syndrome NN NN I-Modifier
thyrocytes NN NN O
. NN NN O

Small NN NN O
deletions NN NN O
in NN NN O
the NN NN O
type NN NN O
II NN NN O
collagen NN NN O
triple NN NN O
helix NN NN O
produce NN NN O
kniest NN NN B-SpecificDisease
dysplasia NN NN I-SpecificDisease
. NN NN O

Classical NN NN B-SpecificDisease
galactosemia NN NN I-SpecificDisease
and NN NN O
mutations NN NN O
at NN NN O
the NN NN O
galactose-1-phosphate NN NN O
uridyl NN NN O
transferase NN NN O
( NN NN O
GALT NN NN O
) NN NN O
gene NN NN O
. NN NN O

Mutations NN NN O
of NN NN O
the NN NN O
VHL NN NN B-Modifier
gene NN NN O
in NN NN O
sporadic NN NN B-SpecificDisease
renal NN NN I-SpecificDisease
cell NN NN I-SpecificDisease
carcinoma NN NN I-SpecificDisease
: NN NN O
definition NN NN O
of NN NN O
a NN NN O
risk NN NN O
factor NN NN O
for NN NN O
VHL NN NN B-Modifier
patients NN NN O
to NN NN O
develop NN NN O
an NN NN O
RCC NN NN B-SpecificDisease
. NN NN O

Defective NN NN O
CTLA-4 NN NN O
cycling NN NN O
pathway NN NN O
in NN NN O
Chediak-Higashi NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
: NN NN O
a NN NN O
possible NN NN O
mechanism NN NN O
for NN NN O
deregulation NN NN O
of NN NN O
T NN NN O
lymphocyte NN NN O
activation NN NN O
. NN NN O

Proteolipoprotein NN NN O
gene NN NN O
analysis NN NN O
in NN NN O
82 NN NN O
patients NN NN O
with NN NN O
sporadic NN NN O
Pelizaeus-Merzbacher NN NN B-SpecificDisease
Disease NN NN I-SpecificDisease
: NN NN O
duplications NN NN O
, NN NN O
the NN NN O
major NN NN O
cause NN NN O
of NN NN O
the NN NN O
disease NN NN O
, NN NN O
originate NN NN O
more NN NN O
frequently NN NN O
in NN NN O
male NN NN O
germ NN NN O
cells NN NN O
, NN NN O
but NN NN O
point NN NN O
mutations NN NN O
do NN NN O
not NN NN O
. NN NN O

The NN NN O
Clinical NN NN O
European NN NN O
Network NN NN O
on NN NN O
Brain NN NN B-DiseaseClass
Dysmyelinating NN NN I-DiseaseClass
Disease NN NN I-DiseaseClass
. NN NN O

Chromosome NN NN O
breakage NN NN O
in NN NN O
the NN NN O
Prader-Willi NN NN B-CompositeMention
and NN NN I-CompositeMention
Angelman NN NN I-CompositeMention
syndromes NN NN I-CompositeMention
involves NN NN O
recombination NN NN O
between NN NN O
large NN NN O
, NN NN O
transcribed NN NN O
repeats NN NN O
at NN NN O
proximal NN NN O
and NN NN O
distal NN NN O
breakpoints NN NN O
. NN NN O

Linkage NN NN O
analysis NN NN O
in NN NN O
a NN NN O
large NN NN O
Brazilian NN NN O
family NN NN O
with NN NN O
van NN NN B-SpecificDisease
der NN NN I-SpecificDisease
Woude NN NN I-SpecificDisease
syndrome NN NN I-SpecificDisease
suggests NN NN O
the NN NN O
existence NN NN O
of NN NN O
a NN NN O
susceptibility NN NN O
locus NN NN O
for NN NN O
cleft NN NN B-SpecificDisease
palate NN NN I-SpecificDisease
at NN NN O
17p11.2-11.1 NN NN O
. NN NN O

New NN NN O
mutations NN NN O
, NN NN O
polymorphisms NN NN O
, NN NN O
and NN NN O
rare NN NN O
variants NN NN O
in NN NN O
the NN NN O
ATM NN NN O
gene NN NN O
detected NN NN O
by NN NN O
a NN NN O
novel NN NN O
SSCP NN NN O
strategy NN NN O
. NN NN O

A NN NN O
novel NN NN O
frameshift NN NN O
mutation NN NN O
in NN NN O
the NN NN O
McLeod NN NN B-Modifier
syndrome NN NN I-Modifier
gene NN NN O
in NN NN O
a NN NN O
Japanese NN NN O
family NN NN O
. NN NN O

Association NN NN O
of NN NN O
BRCA1 NN NN O
with NN NN O
the NN NN O
hRad50-hMre11-p95 NN NN O
complex NN NN O
and NN NN O
the NN NN O
DNA NN NN O
damage NN NN O
response NN NN O
. NN NN O

Relationship NN NN O
among NN NN O
genotype NN NN O
, NN NN O
biochemical NN NN O
phenotype NN NN O
, NN NN O
and NN NN O
cognitive NN NN O
performance NN NN O
in NN NN O
females NN NN O
with NN NN O
phenylalanine NN NN B-SpecificDisease
hydroxylase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
: NN NN O
report NN NN O
from NN NN O
the NN NN O
Maternal NN NN B-Modifier
Phenylketonuria NN NN I-Modifier
Collaborative NN NN O
Study NN NN O
. NN NN O

Spinal NN NN B-SpecificDisease
xanthomatosis NN NN I-SpecificDisease
: NN NN O
a NN NN O
variant NN NN O
of NN NN O
cerebrotendinous NN NN B-DiseaseClass
xanthomatosis NN NN I-DiseaseClass
. NN NN O

A NN NN O
transgene NN NN O
insertion NN NN O
creating NN NN O
a NN NN O
heritable NN NN O
chromosome NN NN O
deletion NN NN O
mouse NN NN O
model NN NN O
of NN NN O
Prader-Willi NN NN B-CompositeMention
and NN NN I-CompositeMention
angelman NN NN I-CompositeMention
syndromes NN NN I-CompositeMention
. NN NN O

Linkage NN NN O
analysis NN NN O
of NN NN O
5 NN NN O
novel NN NN O
van NN NN B-Modifier
der NN NN I-Modifier
Woude NN NN I-Modifier
syndrome NN NN I-Modifier
kindreds NN NN O
to NN NN O
1q32-q41 NN NN O
markers NN NN O
further NN NN O
supports NN NN O
locus NN NN O
homogeneity NN NN O
of NN NN O
the NN NN O
disease NN NN O
trait NN NN O
. NN NN O

Null NN NN O
mutation NN NN O
of NN NN O
the NN NN O
murine NN NN O
ATP7B NN NN O
( NN NN O
Wilson NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
) NN NN O
gene NN NN O
results NN NN O
in NN NN O
intracellular NN NN B-DiseaseClass
copper NN NN I-DiseaseClass
accumulation NN NN I-DiseaseClass
and NN NN O
late-onset NN NN B-DiseaseClass
hepatic NN NN I-DiseaseClass
nodular NN NN I-DiseaseClass
transformation NN NN I-DiseaseClass
. NN NN O

French NN NN O
Machado-Joseph NN NN B-Modifier
disease NN NN I-Modifier
patients NN NN O
do NN NN O
not NN NN O
exhibit NN NN O
gametic NN NN O
segregation NN NN O
distortion NN NN O
: NN NN O
a NN NN O
sperm NN NN O
typing NN NN O
analysis NN NN O
. NN NN O

Missense NN NN O
mutation NN NN O
in NN NN O
the NN NN O
alternative NN NN O
splice NN NN O
region NN NN O
of NN NN O
the NN NN O
PAX6 NN NN O
gene NN NN O
in NN NN O
eye NN NN B-DiseaseClass
anomalies NN NN I-DiseaseClass
. NN NN O

Penetrances NN NN O
of NN NN O
BRCA1 NN NN O
1675delA NN NN O
and NN NN O
1135insA NN NN O
with NN NN O
respect NN NN O
to NN NN O
breast NN NN B-SpecificDisease
cancer NN NN I-SpecificDisease
and NN NN O
ovarian NN NN B-SpecificDisease
cancer NN NN I-SpecificDisease
. NN NN O

The NN NN O
dermatofibrosarcoma NN NN B-Modifier
protuberans NN NN I-Modifier
- NN NN O
associated NN NN O
collagen NN NN O
type NN NN O
Ialpha1/platelet-derived NN NN O
growth NN NN O
factor NN NN O
( NN NN O
PDGF NN NN O
) NN NN O
B-chain NN NN O
fusion NN NN O
gene NN NN O
generates NN NN O
a NN NN O
transforming NN NN O
protein NN NN O
that NN NN O
is NN NN O
processed NN NN O
to NN NN O
functional NN NN O
PDGF-BB NN NN O
. NN NN O

Identification NN NN O
of NN NN O
a NN NN O
common NN NN O
PEX1 NN NN O
mutation NN NN O
in NN NN O
Zellweger NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Novel NN NN O
mutations NN NN O
in NN NN O
the NN NN O
Wiskott-Aldrich NN NN B-Modifier
syndrome NN NN I-Modifier
protein NN NN O
gene NN NN O
and NN NN O
their NN NN O
effects NN NN O
on NN NN O
transcriptional NN NN O
, NN NN O
translational NN NN O
, NN NN O
and NN NN O
clinical NN NN O
phenotypes NN NN O
. NN NN O

Aminoglycoside NN NN O
antibiotics NN NN O
restore NN NN O
dystrophin NN NN O
function NN NN O
to NN NN O
skeletal NN NN O
muscles NN NN O
of NN NN O
mdx NN NN O
mice NN NN O
. NN NN O

Loss NN NN O
of NN NN O
the NN NN O
ataxia-telangiectasia NN NN B-Modifier
gene NN NN O
product NN NN O
causes NN NN O
oxidative NN NN O
damage NN NN O
in NN NN O
target NN NN O
organs NN NN O
. NN NN O

Recessively NN NN O
inherited NN NN O
multiple NN NN B-SpecificDisease
epiphyseal NN NN I-SpecificDisease
dysplasia NN NN I-SpecificDisease
with NN NN O
normal NN NN O
stature NN NN O
, NN NN O
club NN NN B-SpecificDisease
foot NN NN I-SpecificDisease
, NN NN O
and NN NN O
double NN NN B-DiseaseClass
layered NN NN I-DiseaseClass
patella NN NN I-DiseaseClass
caused NN NN O
by NN NN O
a NN NN O
DTDST NN NN O
mutation NN NN O
. NN NN O

Homozygosity NN NN O
for NN NN O
a NN NN O
novel NN NN O
DTDST NN NN O
mutation NN NN O
in NN NN O
a NN NN O
child NN NN O
with NN NN O
a NN NN O
' NN NN O
broad NN NN O
bone-platyspondylic NN NN O
' NN NN O
variant NN NN O
of NN NN O
diastrophic NN NN B-SpecificDisease
dysplasia NN NN I-SpecificDisease
. NN NN O

The NN NN O
type NN NN O
of NN NN O
somatic NN NN O
mutation NN NN O
at NN NN O
APC NN NN O
in NN NN O
familial NN NN B-SpecificDisease
adenomatous NN NN I-SpecificDisease
polyposis NN NN I-SpecificDisease
is NN NN O
determined NN NN O
by NN NN O
the NN NN O
site NN NN O
of NN NN O
the NN NN O
germline NN NN O
mutation NN NN O
: NN NN O
a NN NN O
new NN NN O
facet NN NN O
to NN NN O
Knudson's NN NN O
' NN NN O
two-hit NN NN O
' NN NN O
hypothesis NN NN O
. NN NN O

Mxi1 NN NN O
mutations NN NN O
in NN NN O
human NN NN O
neurofibrosarcomas NN NN B-SpecificDisease
. NN NN O

A NN NN O
population-based NN NN O
study NN NN O
of NN NN O
the NN NN O
clinical NN NN O
expression NN NN O
of NN NN O
the NN NN O
hemochromatosis NN NN B-Modifier
gene NN NN O
. NN NN O

Large NN NN O
heterozygous NN NN O
deletion NN NN O
masquerading NN NN O
as NN NN O
homozygous NN NN O
missense NN NN O
mutation NN NN O
: NN NN O
a NN NN O
pitfall NN NN O
in NN NN O
diagnostic NN NN O
mutation NN NN O
analysis NN NN O
. NN NN O

Early NN NN O
onset NN NN O
of NN NN O
X-linked NN NN B-SpecificDisease
Emery-Dreifuss NN NN I-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
in NN NN O
a NN NN O
boy NN NN O
with NN NN O
emerin NN NN O
gene NN NN O
deletion NN NN O
. NN NN O

Duchenne/Becker NN NN B-CompositeMention
muscular NN NN I-CompositeMention
dystrophy NN NN I-CompositeMention
: NN NN O
correlation NN NN O
of NN NN O
phenotype NN NN O
by NN NN O
electroretinography NN NN O
with NN NN O
sites NN NN O
of NN NN O
dystrophin NN NN O
mutations NN NN O
. NN NN O

Cis NN NN O
and NN NN O
trans NN NN O
effects NN NN O
of NN NN O
the NN NN O
myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
( NN NN O
DM NN NN B-Modifier
) NN NN O
mutation NN NN O
in NN NN O
a NN NN O
cell NN NN O
culture NN NN O
model NN NN O
. NN NN O

Coats NN NN B-SpecificDisease
' NN NN I-SpecificDisease
disease NN NN I-SpecificDisease
of NN NN O
the NN NN O
retina NN NN O
( NN NN O
unilateral NN NN B-SpecificDisease
retinal NN NN I-SpecificDisease
telangiectasis NN NN I-SpecificDisease
) NN NN O
caused NN NN O
by NN NN O
somatic NN NN O
mutation NN NN O
in NN NN O
the NN NN O
NDP NN NN O
gene NN NN O
: NN NN O
a NN NN O
role NN NN O
for NN NN O
norrin NN NN O
in NN NN O
retinal NN NN O
angiogenesis NN NN O
. NN NN O

Hereditary NN NN O
TP53 NN NN O
codon NN NN O
292 NN NN O
and NN NN O
somatic NN NN O
P16INK4A NN NN O
codon NN NN O
94 NN NN O
mutations NN NN O
in NN NN O
a NN NN O
Li-Fraumeni NN NN B-Modifier
syndrome NN NN I-Modifier
family NN NN O
. NN NN O

A NN NN O
novel NN NN O
mutation NN NN O
in NN NN O
the NN NN O
sodium/iodide NN NN O
symporter NN NN O
gene NN NN O
in NN NN O
the NN NN O
largest NN NN O
family NN NN O
with NN NN O
iodide NN NN B-DiseaseClass
transport NN NN I-DiseaseClass
defect NN NN I-DiseaseClass
. NN NN O

Molecular NN NN O
analysis NN NN O
in NN NN O
familial NN NN B-SpecificDisease
neurohypophyseal NN NN I-SpecificDisease
diabetes NN NN I-SpecificDisease
insipidus NN NN I-SpecificDisease
: NN NN O
early NN NN O
diagnosis NN NN O
of NN NN O
an NN NN O
asymptomatic NN NN O
carrier NN NN O
. NN NN O

Deficit NN NN O
of NN NN O
in NN NN O
vivo NN NN O
mitochondrial NN NN O
ATP NN NN O
production NN NN O
in NN NN O
patients NN NN O
with NN NN O
Friedreich NN NN B-SpecificDisease
ataxia NN NN I-SpecificDisease
. NN NN O

Identification NN NN O
of NN NN O
a NN NN O
novel NN NN O
R21X NN NN O
mutation NN NN O
in NN NN O
the NN NN O
liver-type NN NN O
arginase NN NN O
gene NN NN O
( NN NN O
ARG1 NN NN O
) NN NN O
in NN NN O
four NN NN O
Portuguese NN NN O
patients NN NN O
with NN NN O
argininemia NN NN B-SpecificDisease
. NN NN O

Mutation NN NN O
of NN NN O
the NN NN O
sterol NN NN O
27-hydroxylase NN NN O
gene NN NN O
( NN NN O
CYP27 NN NN O
) NN NN O
results NN NN O
in NN NN O
truncation NN NN O
of NN NN O
mRNA NN NN O
expressed NN NN O
in NN NN O
leucocytes NN NN O
in NN NN O
a NN NN O
Japanese NN NN O
family NN NN O
with NN NN O
cerebrotendinous NN NN B-SpecificDisease
xanthomatosis NN NN I-SpecificDisease
. NN NN O

Clinical NN NN O
and NN NN O
molecular NN NN O
genetic NN NN O
analysis NN NN O
of NN NN O
19 NN NN O
Wolfram NN NN B-Modifier
syndrome NN NN I-Modifier
kindreds NN NN O
demonstrating NN NN O
a NN NN O
wide NN NN O
spectrum NN NN O
of NN NN O
mutations NN NN O
in NN NN O
WFS1 NN NN O
. NN NN O

Late-onset NN NN O
familial NN NN B-SpecificDisease
Mediterranean NN NN I-SpecificDisease
fever NN NN I-SpecificDisease
( NN NN O
FMF NN NN B-SpecificDisease
): NN NN O
a NN NN O
subset NN NN O
with NN NN O
distinct NN NN O
clinical NN NN O
, NN NN O
demographic NN NN O
, NN NN O
and NN NN O
molecular NN NN O
genetic NN NN O
characteristics NN NN O
. NN NN O

A NN NN O
highly NN NN O
accurate NN NN O
, NN NN O
low NN NN O
cost NN NN O
test NN NN O
for NN NN O
BRCA1 NN NN O
mutations NN NN O
. NN NN O

Maternal NN NN B-SpecificDisease
uniparental NN NN I-SpecificDisease
disomy NN NN I-SpecificDisease
for NN NN I-SpecificDisease
chromosome NN NN I-SpecificDisease
14 NN NN I-SpecificDisease
in NN NN O
a NN NN O
boy NN NN O
with NN NN O
a NN NN O
normal NN NN O
karyotype NN NN O
. NN NN O

Clinical NN NN O
and NN NN O
genetic NN NN O
study NN NN O
of NN NN O
Friedreich NN NN B-SpecificDisease
ataxia NN NN I-SpecificDisease
in NN NN O
an NN NN O
Australian NN NN O
population NN NN O
. NN NN O

Novel NN NN O
mutations NN NN O
in NN NN O
XLRS1 NN NN O
causing NN NN O
retinoschisis NN NN B-SpecificDisease
, NN NN O
including NN NN O
first NN NN O
evidence NN NN O
of NN NN O
putative NN NN O
leader NN NN O
sequence NN NN O
change NN NN O
. NN NN O

Growth NN NN O
hormone NN NN O
treatment NN NN O
increases NN NN O
CO(2 NN NN O
) NN NN O
response NN NN O
, NN NN O
ventilation NN NN O
and NN NN O
central NN NN O
inspiratory NN NN O
drive NN NN O
in NN NN O
children NN NN O
with NN NN O
Prader-Willi NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

G130V NN NN O
, NN NN O
a NN NN O
common NN NN O
FRDA NN NN B-Modifier
point NN NN O
mutation NN NN O
, NN NN O
appears NN NN O
to NN NN O
have NN NN O
arisen NN NN O
from NN NN O
a NN NN O
common NN NN O
founder NN NN O
. NN NN O

Synergistic NN NN O
effect NN NN O
of NN NN O
histone NN NN O
hyperacetylation NN NN O
and NN NN O
DNA NN NN O
demethylation NN NN O
in NN NN O
the NN NN O
reactivation NN NN O
of NN NN O
the NN NN O
FMR1 NN NN O
gene NN NN O
. NN NN O

Constitutional NN NN O
von NN NN B-Modifier
Hippel-Lindau NN NN I-Modifier
( NN NN O
VHL NN NN B-Modifier
) NN NN O
gene NN NN O
deletions NN NN O
detected NN NN O
in NN NN O
VHL NN NN B-Modifier
families NN NN O
by NN NN O
fluorescence NN NN O
in NN NN O
situ NN NN O
hybridization NN NN O
. NN NN O

Spectrum NN NN O
of NN NN O
hSNF5/INI1 NN NN O
somatic NN NN O
mutations NN NN O
in NN NN O
human NN NN O
cancer NN NN B-DiseaseClass
and NN NN O
genotype-phenotype NN NN O
correlations NN NN O
. NN NN O

Ataxin-3 NN NN O
with NN NN O
an NN NN O
altered NN NN O
conformation NN NN O
that NN NN O
exposes NN NN O
the NN NN O
polyglutamine NN NN O
domain NN NN O
is NN NN O
associated NN NN O
with NN NN O
the NN NN O
nuclear NN NN O
matrix NN NN O
. NN NN O

The NN NN O
human NN NN O
MAGEL2 NN NN O
gene NN NN O
and NN NN O
its NN NN O
mouse NN NN O
homologue NN NN O
are NN NN O
paternally NN NN O
expressed NN NN O
and NN NN O
mapped NN NN O
to NN NN O
the NN NN O
Prader-Willi NN NN B-Modifier
region NN NN O
. NN NN O

cDNA NN NN O
microarrays NN NN O
detect NN NN O
activation NN NN O
of NN NN O
a NN NN O
myogenic NN NN O
transcription NN NN O
program NN NN O
by NN NN O
the NN NN O
PAX3-FKHR NN NN O
fusion NN NN O
oncogene NN NN O
. NN NN O

Experimental NN NN O
hemochromatosis NN NN B-SpecificDisease
due NN NN O
to NN NN O
MHC NN NN O
class NN NN O
I NN NN O
HFE NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
: NN NN O
immune NN NN O
status NN NN O
and NN NN O
iron NN NN O
metabolism NN NN O
. NN NN O

Somatic NN NN O
rearrangement NN NN O
of NN NN O
chromosome NN NN O
14 NN NN O
in NN NN O
human NN NN O
lymphocytes NN NN O
. NN NN O

Exon NN NN O
9 NN NN O
mutations NN NN O
in NN NN O
the NN NN O
WT1 NN NN O
gene NN NN O
, NN NN O
without NN NN O
influencing NN NN O
KTS NN NN O
splice NN NN O
isoforms NN NN O
, NN NN O
are NN NN O
also NN NN O
responsible NN NN O
for NN NN O
Frasier NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Splice-site NN NN O
mutation NN NN O
in NN NN O
the NN NN O
PDS NN NN B-Modifier
gene NN NN O
may NN NN O
result NN NN O
in NN NN O
intrafamilial NN NN O
variability NN NN O
for NN NN O
deafness NN NN B-SpecificDisease
in NN NN O
Pendred NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

The NN NN O
molecular NN NN O
basis NN NN O
of NN NN O
Sjogren-Larsson NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
: NN NN O
mutation NN NN O
analysis NN NN O
of NN NN O
the NN NN O
fatty NN NN O
aldehyde NN NN O
dehydrogenase NN NN O
gene NN NN O
. NN NN O

Loss-of-function NN NN O
mutations NN NN O
in NN NN O
the NN NN O
cathepsin NN NN O
C NN NN O
gene NN NN O
result NN NN O
in NN NN O
periodontal NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
and NN NN O
palmoplantar NN NN B-DiseaseClass
keratosis NN NN I-DiseaseClass
. NN NN O

Confirmation NN NN O
of NN NN O
linkage NN NN O
of NN NN O
Van NN NN B-SpecificDisease
der NN NN I-SpecificDisease
Woude NN NN I-SpecificDisease
syndrome NN NN I-SpecificDisease
to NN NN O
chromosome NN NN O
1q32 NN NN O
: NN NN O
evidence NN NN O
of NN NN O
association NN NN O
with NN NN O
STR NN NN O
alleles NN NN O
suggests NN NN O
possible NN NN O
unique NN NN O
origin NN NN O
of NN NN O
the NN NN O
disease NN NN O
mutation NN NN O
. NN NN O

A NN NN O
point NN NN O
mutation NN NN O
Thr(799)Met NN NN O
on NN NN O
the NN NN O
alpha(2 NN NN O
) NN NN O
integrin NN NN O
leads NN NN O
to NN NN O
the NN NN O
formation NN NN O
of NN NN O
new NN NN O
human NN NN O
platelet NN NN O
alloantigen NN NN O
Sit NN NN O

( NN NN O
a NN NN O
) NN NN O
and NN NN O
affects NN NN O
collagen-induced NN NN O
aggregation NN NN O
. NN NN O

Mutations NN NN O
of NN NN O
the NN NN O
cathepsin NN NN O
C NN NN O
gene NN NN O
are NN NN O
responsible NN NN O
for NN NN O
Papillon-Lefevre NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Mutational NN NN O
analysis NN NN O
of NN NN O
the NN NN O
HGO NN NN O
gene NN NN O
in NN NN O
Finnish NN NN O
alkaptonuria NN NN B-Modifier
patients NN NN O
. NN NN O

The NN NN O
identical NN NN O
5 NN NN O
' NN NN O
splice-site NN NN O
acceptor NN NN O
mutation NN NN O
in NN NN O
five NN NN O
attenuated NN NN B-Modifier
APC NN NN I-Modifier
families NN NN O
from NN NN O
Newfoundland NN NN O
demonstrates NN NN O
a NN NN O
founder NN NN O
effect NN NN O
. NN NN O

Alstrom NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
: NN NN O
further NN NN O
evidence NN NN O
for NN NN O
linkage NN NN O
to NN NN O
human NN NN O
chromosome NN NN O
2p13 NN NN O
. NN NN O

Pendred NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
: NN NN O
phenotypic NN NN O
variability NN NN O
in NN NN O
two NN NN O
families NN NN O
carrying NN NN O
the NN NN O
same NN NN O
PDS NN NN B-Modifier
missense NN NN O
mutation NN NN O
. NN NN O

Knobloch NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
involving NN NN O
midline NN NN B-DiseaseClass
scalp NN NN I-DiseaseClass
defect NN NN I-DiseaseClass
of NN NN I-DiseaseClass
the NN NN I-DiseaseClass
frontal NN NN I-DiseaseClass
region NN NN I-DiseaseClass
. NN NN O

The NN NN O
DNA NN NN O
double-strand NN NN O
break NN NN O
repair NN NN O
gene NN NN O
hMRE11 NN NN O
is NN NN O
mutated NN NN O
in NN NN O
individuals NN NN O
with NN NN O
an NN NN O
ataxia-telangiectasia-like NN NN B-SpecificDisease
disorder NN NN I-SpecificDisease
. NN NN O

Mutations NN NN O
in NN NN O
TNFRSF11A NN NN O
, NN NN O
affecting NN NN O
the NN NN O
signal NN NN O
peptide NN NN O
of NN NN O
RANK NN NN O
, NN NN O
cause NN NN O
familial NN NN B-SpecificDisease
expansile NN NN I-SpecificDisease
osteolysis NN NN I-SpecificDisease
. NN NN O

Cardiac NN NN O
Na(+ NN NN O
) NN NN O
channel NN NN O
dysfunction NN NN O
in NN NN O
Brugada NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
is NN NN O
aggravated NN NN O
by NN NN O
beta(1)-subunit NN NN O
. NN NN O

Meiotic NN NN O
segregation NN NN O
analysis NN NN O
of NN NN O
RB1 NN NN O
alleles NN NN O
in NN NN O
retinoblastoma NN NN B-Modifier
pedigrees NN NN O
by NN NN O
use NN NN O
of NN NN O
single-sperm NN NN O
typing NN NN O
. NN NN O

Friedreich NN NN B-SpecificDisease
ataxia NN NN I-SpecificDisease
: NN NN O
an NN NN O
overview NN NN O
. NN NN O

X-linked NN NN B-SpecificDisease
retinoschisis NN NN I-SpecificDisease
with NN NN O
point NN NN O
mutations NN NN O
in NN NN O
the NN NN O
XLRS1 NN NN O
gene NN NN O
. NN NN O

Atm NN NN O
and NN NN O
Bax NN NN O
cooperate NN NN O
in NN NN O
ionizing NN NN O
radiation-induced NN NN O
apoptosis NN NN O
in NN NN O
the NN NN O
central NN NN O
nervous NN NN O
system NN NN O
. NN NN O

Haim-Munk NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
and NN NN O
Papillon-Lefevre NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
are NN NN O
allelic NN NN O
mutations NN NN O
in NN NN O
cathepsin NN NN O
C NN NN O
. NN NN O

ATM-heterozygous NN NN O
germline NN NN O
mutations NN NN O
contribute NN NN O
to NN NN O
breast NN NN B-Modifier
cancer NN NN I-Modifier
- NN NN O
susceptibility NN NN O
. NN NN O

Human NN NN O
mutations NN NN O
in NN NN O
glucose NN NN O
6-phosphate NN NN O
dehydrogenase NN NN O
reflect NN NN O
evolutionary NN NN O
history NN NN O
. NN NN O

Constitutive NN NN O
and NN NN O
regulated NN NN O
modes NN NN O
of NN NN O
splicing NN NN O
produce NN NN O
six NN NN O
major NN NN O
myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
protein NN NN O
kinase NN NN O
( NN NN O
DMPK NN NN O
) NN NN O
isoforms NN NN O
with NN NN O
distinct NN NN O
properties NN NN O
. NN NN O

Genetic NN NN O
analysis NN NN O
, NN NN O
phenotypic NN NN O
diagnosis NN NN O
, NN NN O
and NN NN O
risk NN NN O
of NN NN O
venous NN NN B-SpecificDisease
thrombosis NN NN I-SpecificDisease
in NN NN O
families NN NN O
with NN NN O
inherited NN NN O
deficiencies NN NN B-SpecificDisease
of NN NN I-SpecificDisease
protein NN NN I-SpecificDisease
S NN NN I-SpecificDisease
. NN NN O

Autoimmune NN NN B-SpecificDisease
lymphoproliferative NN NN I-SpecificDisease
syndrome NN NN I-SpecificDisease
( NN NN O
ALPS NN NN B-SpecificDisease
) NN NN O
in NN NN O
a NN NN O
child NN NN O
from NN NN O
consanguineous NN NN O
parents NN NN O
: NN NN O
a NN NN O
dominant NN NN O
or NN NN O
recessive NN NN O
disease NN NN O
? NN NN O

Identification NN NN O
of NN NN O
novel NN NN O
imprinted NN NN O
transcripts NN NN O
in NN NN O
the NN NN O
Prader-Willi NN NN B-Modifier
syndrome NN NN I-Modifier
and NN NN O
Angelman NN NN B-Modifier
syndrome NN NN I-Modifier
deletion NN NN O
region NN NN O
: NN NN O
further NN NN O
evidence NN NN O
for NN NN O
regional NN NN O
imprinting NN NN O
control NN NN O
. NN NN O

Combined NN NN O
analysis NN NN O
of NN NN O
hereditary NN NN B-Modifier
prostate NN NN I-Modifier
cancer NN NN I-Modifier
linkage NN NN O
to NN NN O
1q24-25 NN NN O
: NN NN O
results NN NN O
from NN NN O
772 NN NN O
hereditary NN NN B-Modifier
prostate NN NN I-Modifier
cancer NN NN I-Modifier
families NN NN O
from NN NN O
the NN NN O
International NN NN O
Consortium NN NN O
for NN NN O
Prostate NN NN B-Modifier
Cancer NN NN I-Modifier
Genetics NN NN O
. NN NN O

A NN NN O
recurrent NN NN O
expansion NN NN O
of NN NN O
a NN NN O
maternal NN NN O
allele NN NN O
with NN NN O
36 NN NN O
CAG NN NN O
repeats NN NN O
causes NN NN O
Huntington NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
in NN NN O
two NN NN O
sisters NN NN O
. NN NN O

Abnormal NN NN O
development NN NN O
of NN NN O
Purkinje NN NN O
cells NN NN O
and NN NN O
lymphocytes NN NN O
in NN NN O
Atm NN NN O
mutant NN NN O
mice NN NN O
. NN NN O

Novel NN NN O
mutations NN NN O
of NN NN O
the NN NN O
ATP7B NN NN O
gene NN NN O
in NN NN O
Japanese NN NN O
patients NN NN O
with NN NN O
Wilson NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
. NN NN O

Autoinhibition NN NN O
and NN NN O
activation NN NN O
mechanisms NN NN O
of NN NN O
the NN NN O
Wiskott-Aldrich NN NN B-Modifier
syndrome NN NN I-Modifier
protein NN NN O
. NN NN O

hCds1-mediated NN NN O
phosphorylation NN NN O
of NN NN O
BRCA1 NN NN O
regulates NN NN O
the NN NN O
DNA NN NN O
damage NN NN O
response NN NN O
. NN NN O

Characterization NN NN O
of NN NN O
the NN NN O
rat NN NN O
spinocerebellar NN NN O
ataxia NN NN O
type NN NN O
3 NN NN O
gene NN NN O
. NN NN O

Emerin NN NN B-SpecificDisease
, NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
of NN NN O
which NN NN O
causes NN NN O
Emery-Dreifuss NN NN B-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
, NN NN O
is NN NN O
localized NN NN O
at NN NN O
the NN NN O
inner NN NN O
nuclear NN NN O
membrane NN NN O
. NN NN O

Locus NN NN O
heterogeneity NN NN O
in NN NN O
Friedreich NN NN B-SpecificDisease
ataxia NN NN I-SpecificDisease
. NN NN O

Glycerol NN NN O
as NN NN O
a NN NN O
correlate NN NN O
of NN NN O
impaired NN NN B-SpecificDisease
glucose NN NN I-SpecificDisease
tolerance NN NN I-SpecificDisease
: NN NN O
dissection NN NN O
of NN NN O
a NN NN O
complex NN NN O
system NN NN O
by NN NN O
use NN NN O
of NN NN O
a NN NN O
simple NN NN O
genetic NN NN O
trait NN NN O
. NN NN O

Clinical NN NN O
and NN NN O
molecular NN NN O
genetics NN NN O
of NN NN O
primary NN NN B-DiseaseClass
dystonias NN NN I-DiseaseClass
. NN NN O

Determination NN NN O
of NN NN O
30 NN NN O
X-linked NN NN B-Modifier
adrenoleukodystrophy NN NN I-Modifier
mutations NN NN O
, NN NN O
including NN NN O
15 NN NN O
not NN NN O
previously NN NN O
described NN NN O
. NN NN O

beta-galactosidase NN NN O
gene NN NN O
mutations NN NN O
affecting NN NN O
the NN NN O
lysosomal NN NN O
enzyme NN NN O
and NN NN O
the NN NN O
elastin-binding NN NN O
protein NN NN O
in NN NN O
GM1-gangliosidosis NN NN B-Modifier
patients NN NN O
with NN NN O
cardiac NN NN B-SpecificDisease
involvement NN NN I-SpecificDisease
. NN NN O

In NN NN O
vivo NN NN O
modulation NN NN O
of NN NN O
Hmgic NN NN O
reduces NN NN O
obesity NN NN B-SpecificDisease
. NN NN O

Molecular NN NN O
analysis NN NN O
of NN NN O
the NN NN O
genotype-phenotype NN NN O
relationship NN NN O
in NN NN O
factor NN NN B-SpecificDisease
X NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
. NN NN O

Transgenic NN NN O
mice NN NN O
expressing NN NN O
a NN NN O
truncated NN NN O
form NN NN O
of NN NN O
the NN NN O
high NN NN O
mobility NN NN O
group NN NN O
I-C NN NN O
protein NN NN O
develop NN NN O
adiposity NN NN O
and NN NN O
an NN NN O
abnormally NN NN O
high NN NN O
prevalence NN NN O
of NN NN O
lipomas NN NN B-DiseaseClass
. NN NN O

ATM NN NN O
phosphorylates NN NN O
p95/nbs1 NN NN O
in NN NN O
an NN NN O
S-phase NN NN O
checkpoint NN NN O
pathway NN NN O
. NN NN O

Understanding NN NN O
the NN NN O
molecular NN NN O
basis NN NN O
of NN NN O
fragile NN NN B-SpecificDisease
X NN NN I-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Haploinsufficiency NN NN B-CompositeMention
of NN NN I-CompositeMention
the NN NN I-CompositeMention
transcription NN NN I-CompositeMention
factors NN NN I-CompositeMention
FOXC1 NN NN I-CompositeMention
and NN NN I-CompositeMention
FOXC2 NN NN I-CompositeMention
results NN NN O
in NN NN O
aberrant NN NN O
ocular NN NN O
development NN NN O
. NN NN O

( NN NN O
Over)correction NN NN O
of NN NN O
FMR1 NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
with NN NN O
YAC NN NN O
transgenics NN NN O
: NN NN O
behavioral NN NN O
and NN NN O
physical NN NN O
features NN NN O
. NN NN O

Transgenic NN NN O
mice NN NN O
carrying NN NN O
large NN NN O
human NN NN O
genomic NN NN O
sequences NN NN O
with NN NN O
expanded NN NN O
CTG NN NN O
repeat NN NN O
mimic NN NN O
closely NN NN O
the NN NN O
DM NN NN B-Modifier
CTG NN NN O
repeat NN NN O
intergenerational NN NN O
and NN NN O
somatic NN NN O
instability NN NN O
. NN NN O

Inactivation NN NN O
of NN NN O
the NN NN O
Friedreich NN NN B-Modifier
ataxia NN NN I-Modifier
mouse NN NN O
gene NN NN O
leads NN NN O
to NN NN O
early NN NN O
embryonic NN NN B-SpecificDisease
lethality NN NN I-SpecificDisease
without NN NN O
iron NN NN O
accumulation NN NN O
. NN NN O

Gaucher NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
: NN NN O
the NN NN O
origins NN NN O
of NN NN O
the NN NN O
Ashkenazi NN NN O
Jewish NN NN O
N370S NN NN O
and NN NN O
84GG NN NN O
acid NN NN O
beta-glucosidase NN NN O
mutations NN NN O
. NN NN O

HLA NN NN O
B27 NN NN O
and NN NN O
the NN NN O
genetics NN NN O
of NN NN O
ankylosing NN NN B-SpecificDisease
spondylitis NN NN I-SpecificDisease
. NN NN O

Founder NN NN O
mutations NN NN O
in NN NN O
the NN NN O
BRCA1 NN NN O
gene NN NN O
in NN NN O
Polish NN NN O
families NN NN O
with NN NN O
breast-ovarian NN NN B-CompositeMention
cancer NN NN I-CompositeMention
. NN NN O

Molecular NN NN O
basis NN NN O
of NN NN O
very NN NN B-SpecificDisease
long NN NN I-SpecificDisease
chain NN NN I-SpecificDisease
acyl-CoA NN NN I-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
in NN NN O
three NN NN O
Israeli NN NN O
patients NN NN O
: NN NN O
identification NN NN O
of NN NN O
a NN NN O
complex NN NN O
mutant NN NN O
allele NN NN O
with NN NN O
P65L NN NN O
and NN NN O
K247Q NN NN O
mutations NN NN O
, NN NN O
the NN NN O
former NN NN O
being NN NN O
an NN NN O
exonic NN NN O
mutation NN NN O
causing NN NN O
exon NN NN O
3 NN NN O
skipping NN NN O
. NN NN O

Submicroscopic NN NN O
deletion NN NN O
in NN NN O
cousins NN NN O
with NN NN O
Prader-Willi NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
causes NN NN O
a NN NN O
grandmatrilineal NN NN O
inheritance NN NN O
pattern NN NN O
: NN NN O
effects NN NN O
of NN NN O
imprinting NN NN O
. NN NN O

Human NN NN O
glycine NN NN O
decarboxylase NN NN O
gene NN NN O
( NN NN O
GLDC NN NN O
) NN NN O
and NN NN O
its NN NN O
highly NN NN O
conserved NN NN O
processed NN NN O
pseudogene NN NN O
( NN NN O
psiGLDC NN NN O
): NN NN O
their NN NN O
structure NN NN O
and NN NN O
expression NN NN O
, NN NN O
and NN NN O
the NN NN O
identification NN NN O
of NN NN O
a NN NN O
large NN NN O
deletion NN NN O
in NN NN O
a NN NN O
family NN NN O
with NN NN O
nonketotic NN NN B-SpecificDisease
hyperglycinemia NN NN I-SpecificDisease
. NN NN O

De NN NN O
novo NN NN O
deletions NN NN O
of NN NN O
SNRPN NN NN O
exon NN NN O
1 NN NN O
in NN NN O
early NN NN O
human NN NN O
and NN NN O
mouse NN NN O
embryos NN NN O
result NN NN O
in NN NN O
a NN NN O
paternal NN NN O
to NN NN O
maternal NN NN O
imprint NN NN O
switch NN NN O
. NN NN O

Mice NN NN O
deficient NN NN B-SpecificDisease
in NN NN I-SpecificDisease
Six5 NN NN I-SpecificDisease
develop NN NN O
cataracts NN NN B-SpecificDisease
: NN NN O
implications NN NN O
for NN NN O
myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

Heterozygous NN NN O
loss NN NN O
of NN NN O
Six5 NN NN O
in NN NN O
mice NN NN O
is NN NN O
sufficient NN NN O
to NN NN O
cause NN NN O
ocular NN NN O
cataracts NN NN B-SpecificDisease
. NN NN O

ATM-dependent NN NN O
phosphorylation NN NN O
of NN NN O
nibrin NN NN O
in NN NN O
response NN NN O
to NN NN O
radiation NN NN O
exposure NN NN O
. NN NN O

Clinicopathologic NN NN O
features NN NN O
of NN NN O
BRCA-linked NN NN B-CompositeMention
and NN NN I-CompositeMention
sporadic NN NN I-CompositeMention
ovarian NN NN I-CompositeMention
cancer NN NN I-CompositeMention
. NN NN O

The NN NN O
gene NN NN O
for NN NN O
familial NN NN B-SpecificDisease
Mediterranean NN NN I-SpecificDisease
fever NN NN I-SpecificDisease
, NN NN O
MEFV NN NN O
, NN NN O
is NN NN O
expressed NN NN O
in NN NN O
early NN NN O
leukocyte NN NN O
development NN NN O
and NN NN O
is NN NN O
regulated NN NN O
in NN NN O
response NN NN O
to NN NN O
inflammatory NN NN O
mediators NN NN O
. NN NN O

Biochemical NN NN O
and NN NN O
structural NN NN O
analysis NN NN O
of NN NN O
missense NN NN O
mutations NN NN O
in NN NN O
N-acetylgalactosamine-6-sulfate NN NN O
sulfatase NN NN O
causing NN NN O
mucopolysaccharidosis NN NN B-Modifier
IVA NN NN I-Modifier
phenotypes NN NN O
. NN NN O

Mutations NN NN O
at NN NN O
the NN NN O
ataxia-telangiectasia NN NN B-Modifier
locus NN NN O
and NN NN O
clinical NN NN O
phenotypes NN NN O
of NN NN O
A-T NN NN B-Modifier
patients NN NN O
. NN NN O

Isolation NN NN O
, NN NN O
genomic NN NN O
organization NN NN O
, NN NN O
and NN NN O
expression NN NN O
analysis NN NN O
of NN NN O
the NN NN O
mouse NN NN O
and NN NN O
rat NN NN O
homologs NN NN O
of NN NN O
MEFV NN NN O
, NN NN O
the NN NN O
gene NN NN O
for NN NN O
familial NN NN B-SpecificDisease
mediterranean NN NN I-SpecificDisease
fever NN NN I-SpecificDisease
. NN NN O

Additional NN NN O
copies NN NN O
of NN NN O
the NN NN O
proteolipid NN NN O
protein NN NN O
gene NN NN O
causing NN NN O
Pelizaeus-Merzbacher NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
arise NN NN O
by NN NN O
separate NN NN O
integration NN NN O
into NN NN O
the NN NN O
X NN NN O
chromosome NN NN O
. NN NN O

The NN NN O
exon NN NN O
13 NN NN O
duplication NN NN O
in NN NN O
the NN NN O
BRCA1 NN NN O
gene NN NN O
is NN NN O
a NN NN O
founder NN NN O
mutation NN NN O
present NN NN O
in NN NN O
geographically NN NN O
diverse NN NN O
populations NN NN O
. NN NN O

The NN NN O
BRCA1 NN NN O
Exon NN NN O
13 NN NN O
Duplication NN NN O
Screening NN NN O
Group NN NN O
. NN NN O

Genotype-phenotype NN NN O
correlations NN NN O
in NN NN O
families NN NN O
with NN NN O
deletions NN NN O
in NN NN O
the NN NN O
von NN NN B-Modifier
Hippel-Lindau NN NN I-Modifier
( NN NN O
VHL NN NN B-Modifier
) NN NN O
gene NN NN O
. NN NN O

Age NN NN O
of NN NN O
the NN NN O
intronic NN NN O
GAA NN NN O
triplet NN NN O
repeat NN NN O
expansion NN NN O
mutation NN NN O
in NN NN O
Friedreich NN NN B-SpecificDisease
ataxia NN NN I-SpecificDisease
. NN NN O

Functional NN NN O
link NN NN O
between NN NN O
ataxia-telangiectasia NN NN B-Modifier
and NN NN O
Nijmegen NN NN B-Modifier
breakage NN NN I-Modifier
syndrome NN NN I-Modifier
gene NN NN O
products NN NN O
. NN NN O

Homozygosity NN NN O
mapping NN NN O
in NN NN O
a NN NN O
family NN NN O
with NN NN O
microcephaly NN NN B-DiseaseClass
, NN NN O
mental NN NN B-DiseaseClass
retardation NN NN I-DiseaseClass
, NN NN O
and NN NN O
short NN NN B-DiseaseClass
stature NN NN I-DiseaseClass
to NN NN O
a NN NN O
Cohen NN NN B-Modifier
syndrome NN NN I-Modifier
region NN NN O
on NN NN O
8q21.3-8q22.1 NN NN O
: NN NN O
redefining NN NN O
a NN NN O
clinical NN NN O
entity NN NN O
. NN NN O

Polymorphisms NN NN O
of NN NN O
the NN NN O
CYP2D6 NN NN O
gene NN NN O
increase NN NN O
susceptibility NN NN O
to NN NN O
ankylosing NN NN B-SpecificDisease
spondylitis NN NN I-SpecificDisease
. NN NN O

Functional NN NN O
differences NN NN O
of NN NN O
the NN NN O
PDS NN NN B-Modifier
gene NN NN O
product NN NN O
are NN NN O
associated NN NN O
with NN NN O
phenotypic NN NN O
variation NN NN O
in NN NN O
patients NN NN O
with NN NN O
Pendred NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
and NN NN O
non-syndromic NN NN B-SpecificDisease
hearing NN NN I-SpecificDisease
loss NN NN I-SpecificDisease
( NN NN O
DFNB4 NN NN B-SpecificDisease
). NN NN O

The NN NN O
human NN NN O
factor NN NN O
IX NN NN O
gene NN NN O
as NN NN O
germline NN NN O
mutagen NN NN O
test NN NN O
: NN NN O
samples NN NN O
from NN NN O
Mainland NN NN O
China NN NN O
have NN NN O
the NN NN O
putatively NN NN O
endogenous NN NN O
pattern NN NN O
of NN NN O
mutation NN NN O
. NN NN O

Fas NN NN O
preassociation NN NN O
required NN NN O
for NN NN O
apoptosis NN NN O
signaling NN NN O
and NN NN O
dominant NN NN O
inhibition NN NN O
by NN NN O
pathogenic NN NN O
mutations NN NN O
. NN NN O

Determination NN NN O
of NN NN O
carrier NN NN O
status NN NN O
for NN NN O
the NN NN O
Wiskott-Aldrich NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
by NN NN O
flow NN NN O
cytometric NN NN O
analysis NN NN O
of NN NN O
Wiskott-Aldrich NN NN B-Modifier
syndrome NN NN I-Modifier
protein NN NN O
expression NN NN O
in NN NN O
peripheral NN NN O
blood NN NN O
mononuclear NN NN O
cells NN NN O
. NN NN O

Restoration NN NN O
of NN NN O
photoreceptor NN NN O
ultrastructure NN NN O
and NN NN O
function NN NN O
in NN NN O
retinal NN NN B-Modifier
degeneration NN NN I-Modifier
slow NN NN O
mice NN NN O
by NN NN O
gene NN NN O
therapy NN NN O
. NN NN O

Mutations NN NN O
in NN NN O
the NN NN O
fibrinogen NN NN O
aalpha NN NN O
gene NN NN O
account NN NN O
for NN NN O
the NN NN O
majority NN NN O
of NN NN O
cases NN NN O
of NN NN O
congenital NN NN B-SpecificDisease
afibrinogenemia NN NN I-SpecificDisease
. NN NN O

Myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
: NN NN O
the NN NN O
role NN NN O
of NN NN O
the NN NN O
CUG NN NN O
triplet NN NN O
repeats NN NN O
in NN NN O
splicing NN NN O
of NN NN O
a NN NN O
novel NN NN O
DMPK NN NN O
exon NN NN O
and NN NN O
altered NN NN O
cytoplasmic NN NN O
DMPK NN NN O
mRNA NN NN O
isoform NN NN O
ratios NN NN O
. NN NN O

Expression NN NN O
and NN NN O
imprinting NN NN O
of NN NN O
MAGEL2 NN NN O
suggest NN NN O
a NN NN O
role NN NN O
in NN NN O
Prader-willi NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
and NN NN O
the NN NN O
homologous NN NN O
murine NN NN O
imprinting NN NN O
phenotype NN NN O
. NN NN O

Retinoschisin NN NN O
, NN NN O
the NN NN O
X-linked NN NN B-Modifier
retinoschisis NN NN I-Modifier
protein NN NN O
, NN NN O
is NN NN O
a NN NN O
secreted NN NN O
photoreceptor NN NN O
protein NN NN O
, NN NN O
and NN NN O
is NN NN O
expressed NN NN O
and NN NN O
released NN NN O
by NN NN O
Weri-Rb1 NN NN O
cells NN NN O
. NN NN O

Study NN NN O
of NN NN O
the NN NN O
voltage-gated NN NN O
sodium NN NN O
channel NN NN O
beta NN NN O
1 NN NN O
subunit NN NN O
gene NN NN O
( NN NN O
SCN1B NN NN O
) NN NN O
in NN NN O
the NN NN O
benign NN NN B-SpecificDisease
familial NN NN I-SpecificDisease
infantile NN NN I-SpecificDisease
convulsions NN NN I-SpecificDisease
syndrome NN NN I-SpecificDisease
( NN NN O
BFIC NN NN B-SpecificDisease
). NN NN O

Inactivation NN NN O
of NN NN O
germline NN NN O
mutant NN NN O
APC NN NN B-Modifier
alleles NN NN O
by NN NN O
attenuated NN NN O
somatic NN NN O
mutations NN NN O
: NN NN O
a NN NN O
molecular NN NN O
genetic NN NN O
mechanism NN NN O
for NN NN O
attenuated NN NN B-SpecificDisease
familial NN NN I-SpecificDisease
adenomatous NN NN I-SpecificDisease
polyposis NN NN I-SpecificDisease
. NN NN O

Iron-dependent NN NN O
self-assembly NN NN O
of NN NN O
recombinant NN NN O
yeast NN NN O
frataxin NN NN O
: NN NN O
implications NN NN O
for NN NN O
Friedreich NN NN B-SpecificDisease
ataxia NN NN I-SpecificDisease
. NN NN O

A NN NN O
mutation NN NN O
in NN NN O
the NN NN O
pleckstrin NN NN O
homology NN NN O
( NN NN O
PH NN NN O
) NN NN O
domain NN NN O
of NN NN O
the NN NN O
FGD1 NN NN O
gene NN NN O
in NN NN O
an NN NN O
Italian NN NN O
family NN NN O
with NN NN O
faciogenital NN NN B-SpecificDisease
dysplasia NN NN I-SpecificDisease
( NN NN O
Aarskog-Scott NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
). NN NN O

Amino-terminal NN NN O
fragments NN NN O
of NN NN O
mutant NN NN O
huntingtin NN NN O
show NN NN O
selective NN NN O
accumulation NN NN O
in NN NN O
striatal NN NN O
neurons NN NN O
and NN NN O
synaptic NN NN O
toxicity NN NN O
. NN NN O

BRCA1 NN NN O
is NN NN O
associated NN NN O
with NN NN O
a NN NN O
human NN NN O
SWI/SNF-related NN NN O
complex NN NN O
: NN NN O
linking NN NN O
chromatin NN NN O
remodeling NN NN O
to NN NN O
breast NN NN B-SpecificDisease
cancer NN NN I-SpecificDisease
. NN NN O

Asef NN NN O
, NN NN O
a NN NN O
link NN NN O
between NN NN O
the NN NN O
tumor NN NN B-Modifier
suppressor NN NN O
APC NN NN O
and NN NN O
G-protein NN NN O
signaling NN NN O
. NN NN O

Function NN NN O
of NN NN O
an NN NN O
axonal NN NN O
chemoattractant NN NN O
modulated NN NN O
by NN NN O
metalloprotease NN NN O
activity NN NN O
. NN NN O

Myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
in NN NN O
transgenic NN NN O
mice NN NN O
expressing NN NN O
an NN NN O
expanded NN NN O
CUG NN NN O
repeat NN NN O
. NN NN O

Genomic NN NN O
rearrangements NN NN O
of NN NN O
the NN NN O
APC NN NN B-Modifier
tumor NN NN I-Modifier
- NN NN O
suppressor NN NN O
gene NN NN O
in NN NN O
familial NN NN B-SpecificDisease
adenomatous NN NN I-SpecificDisease
polyposis NN NN I-SpecificDisease
. NN NN O

Detection NN NN O
of NN NN O
a NN NN O
novel NN NN O
missense NN NN O
mutation NN NN O
and NN NN O
second NN NN O
recurrent NN NN O
mutation NN NN O
in NN NN O
the NN NN O
CACNA1A NN NN O
gene NN NN O
in NN NN O
individuals NN NN O
with NN NN O
EA-2 NN NN B-SpecificDisease
and NN NN O
FHM NN NN B-SpecificDisease
. NN NN O

Analbuminemia NN NN B-SpecificDisease
in NN NN O
a NN NN O
neonate NN NN O
. NN NN O

Histidinemia NN NN B-SpecificDisease
. NN NN O

Classical NN NN O
and NN NN O
atypical NN NN O
form NN NN O
in NN NN O
siblings NN NN O
. NN NN O

Carrier NN NN O
detection NN NN O
of NN NN O
pyruvate NN NN B-SpecificDisease
carboxylase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
in NN NN O
fibroblasts NN NN O
and NN NN O
lymphocytes NN NN O
. NN NN O

Glucose-6-phosphate NN NN O
dehydrogenase NN NN O
variants NN NN O
from NN NN O
Italian NN NN O
subjects NN NN O
associated NN NN O
with NN NN O
severe NN NN B-SpecificDisease
neonatal NN NN I-SpecificDisease
jaundice NN NN I-SpecificDisease
. NN NN O

Cytogenetic NN NN O
investigations NN NN O
in NN NN O
families NN NN O
with NN NN O
ataxia-telangiectasia NN NN B-SpecificDisease
. NN NN O

Prenatal NN NN O
diagnosis NN NN O
of NN NN O
Wolman NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
. NN NN O

Malignant NN NN B-DiseaseClass
neoplasms NN NN I-DiseaseClass
in NN NN O
the NN NN O
families NN NN O
of NN NN O
patients NN NN O
with NN NN O
ataxia-telangiectasia NN NN B-SpecificDisease
. NN NN O

Striking NN NN O
prevalence NN NN O
of NN NN O
ankylosing NN NN B-SpecificDisease
spondylitis NN NN I-SpecificDisease
in NN NN O
" NN NN O
healthy NN NN O
" NN NN O
w27 NN NN O
positive NN NN O
males NN NN O
and NN NN O
females NN NN O
. NN NN O

Analbuminemia NN NN B-SpecificDisease
in NN NN O
an NN NN O
American NN NN O
Indian NN NN O
girl NN NN O
. NN NN O

Deletion NN NN O
of NN NN O
the NN NN O
KIT NN NN O
and NN NN O
PDGFRA NN NN O
genes NN NN O
in NN NN O
a NN NN O
patient NN NN O
with NN NN O
piebaldism NN NN B-SpecificDisease
. NN NN O

A NN NN O
germ NN NN O
line NN NN O
mutation NN NN O
within NN NN O
the NN NN O
coding NN NN O
sequence NN NN O
for NN NN O
the NN NN O
putative NN NN O
5-phosphoribosyl-1-pyrophosphate NN NN O
binding NN NN O
site NN NN O
of NN NN O
hypoxanthine-guanine NN NN O
phosphoribosyltransferase NN NN O
( NN NN O
HPRT NN NN O
) NN NN O
in NN NN O
a NN NN O
Lesch-Nyhan NN NN B-Modifier
patient NN NN O
: NN NN O
missense NN NN O
mutations NN NN O
within NN NN O
a NN NN O
functionally NN NN O
important NN NN O
region NN NN O
probably NN NN O
cause NN NN O
disease NN NN O
. NN NN O

Characterisation NN NN O
of NN NN O
a NN NN O
new NN NN O
rare NN NN O
fragile NN NN O
site NN NN O
easily NN NN O
confused NN NN O
with NN NN O
the NN NN O
fragile NN NN B-SpecificDisease
X NN NN I-SpecificDisease
. NN NN O

The NN NN O
Norrie NN NN B-Modifier
disease NN NN I-Modifier
gene NN NN O
maps NN NN O
to NN NN O
a NN NN O
150 NN NN O
kb NN NN O
region NN NN O
on NN NN O
chromosome NN NN O
Xp11.3 NN NN O
. NN NN O

Molecular NN NN O
basis NN NN O
of NN NN O
phenylketonuria NN NN B-SpecificDisease
and NN NN O
related NN NN O
hyperphenylalaninemias NN NN B-DiseaseClass
: NN NN O
mutations NN NN O
and NN NN O
polymorphisms NN NN O
in NN NN O
the NN NN O
human NN NN O
phenylalanine NN NN O
hydroxylase NN NN O
gene NN NN O
. NN NN O

A NN NN O
glycine250--> NN NN O
aspartate NN NN O
substitution NN NN O
in NN NN O
the NN NN O
alpha-subunit NN NN O
of NN NN O
hexosaminidase NN NN O
A NN NN O
causes NN NN O
juvenile-onset NN NN O
Tay-Sachs NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
in NN NN O
a NN NN O
Lebanese-Canadian NN NN O
family NN NN O
. NN NN O

Novel NN NN O
Tay-Sachs NN NN B-Modifier
disease NN NN I-Modifier
mutations NN NN O
from NN NN O
China NN NN O
. NN NN O

Two NN NN O
missense NN NN O
mutations NN NN O
causing NN NN O
mild NN NN O
hyperphenylalaninemia NN NN B-DiseaseClass
associated NN NN O
with NN NN O
DNA NN NN O
haplotype NN NN O
12 NN NN O
. NN NN O

In NN NN O
vitro NN NN O
and NN NN O
in NN NN O
vivo NN NN O
correlations NN NN O
for NN NN O
I65T NN NN O
and NN NN O
M1V NN NN O
mutations NN NN O
at NN NN O
the NN NN O
phenylalanine NN NN O
hydroxylase NN NN O
locus NN NN O
. NN NN O

Molecular NN NN O
basis NN NN O
of NN NN O
hexosaminidase NN NN B-SpecificDisease
A NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
and NN NN O
pseudodeficiency NN NN O
in NN NN O
the NN NN O
Berks NN NN O
County NN NN O
Pennsylvania NN NN O
Dutch NN NN O
. NN NN O

A NN NN O
mutation NN NN O
common NN NN O
in NN NN O
non-Jewish NN NN O
Tay-Sachs NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
: NN NN O
frequency NN NN O
and NN NN O
RNA NN NN O
studies NN NN O
. NN NN O

Aberrant NN NN O
splicing NN NN O
of NN NN O
the NN NN O
CHM NN NN B-Modifier
gene NN NN O
is NN NN O
a NN NN O
significant NN NN O
cause NN NN O
of NN NN O
choroideremia NN NN B-SpecificDisease
. NN NN O

Germline NN NN O
intronic NN NN O
and NN NN O
exonic NN NN O
mutations NN NN O
in NN NN O
the NN NN O
Wilms NN NN B-Modifier
' NN NN I-Modifier
tumour NN NN I-Modifier
gene NN NN O
( NN NN O
WT1 NN NN O
) NN NN O
affecting NN NN O
urogenital NN NN O
development NN NN O
. NN NN O

Characterization NN NN O
of NN NN O
the NN NN O
myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
region NN NN O
predicts NN NN O
multiple NN NN O
protein NN NN O
isoform-encoding NN NN O
mRNAs NN NN O
. NN NN O

Fragile NN NN B-SpecificDisease
X NN NN I-SpecificDisease
syndrome NN NN I-SpecificDisease
without NN NN O
CCG NN NN O
amplification NN NN O
has NN NN O
an NN NN O
FMR1 NN NN O
deletion NN NN O
. NN NN O

Cloning NN NN O
of NN NN O
the NN NN O
Huntington NN NN B-Modifier
disease NN NN I-Modifier
region NN NN O
in NN NN O
yeast NN NN O
artificial NN NN O
chromosomes NN NN O
. NN NN O

Characterization NN NN O
of NN NN O
a NN NN O
YAC NN NN O
containing NN NN O
part NN NN O
or NN NN O
all NN NN O
of NN NN O
the NN NN O
Norrie NN NN B-Modifier
disease NN NN I-Modifier
locus NN NN O
. NN NN O

Both NN NN O
mutations NN NN O
in NN NN O
G6PD NN NN O
A NN NN O
- NN NN O
are NN NN O
necessary NN NN O
to NN NN O
produce NN NN O
the NN NN O
G6PD NN NN B-Modifier
deficient NN NN I-Modifier
phenotype NN NN O
. NN NN O

Small NN NN O
nuclear NN NN O
ribonucleoprotein NN NN O
polypeptide NN NN O
N NN NN O
( NN NN O
SNRPN NN NN O
), NN NN O
an NN NN O
expressed NN NN O
gene NN NN O
in NN NN O
the NN NN O
Prader-Willi NN NN B-Modifier
syndrome NN NN I-Modifier
critical NN NN O
region NN NN O
. NN NN O

The NN NN O
presence NN NN O
of NN NN O
two NN NN O
different NN NN O
infantile NN NN O
Tay-Sachs NN NN B-Modifier
disease NN NN I-Modifier
mutations NN NN O
in NN NN O
a NN NN O
Cajun NN NN O
population NN NN O
. NN NN O

Mutations NN NN O
in NN NN O
the NN NN O
candidate NN NN O
gene NN NN O
for NN NN O
Norrie NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
. NN NN O

Detection NN NN O
of NN NN O
a NN NN O
nonsense NN NN O
mutation NN NN O
in NN NN O
the NN NN O
dystrophin NN NN O
gene NN NN O
by NN NN O
multiple NN NN O
SSCP NN NN O
. NN NN O

Proliferation-related NN NN O
expression NN NN O
of NN NN O
p19/nm23 NN NN O
nucleoside NN NN O
diphosphate NN NN O
kinase NN NN O
. NN NN O

An NN NN O
intrachromosomal NN NN O
insertion NN NN O
causing NN NN O
5q22 NN NN O
deletion NN NN O
and NN NN O
familial NN NN B-SpecificDisease
adenomatous NN NN I-SpecificDisease
polyposis NN NN I-SpecificDisease
coli NN NN I-SpecificDisease
in NN NN O
two NN NN O
generations NN NN O
. NN NN O

Chromosome NN NN O
mapping NN NN O
of NN NN O
the NN NN O
rod NN NN O
photoreceptor NN NN O
cGMP NN NN O
phosphodiesterase NN NN O
beta-subunit NN NN O
gene NN NN O
in NN NN O
mouse NN NN O
and NN NN O
human NN NN O
: NN NN O
tight NN NN O
linkage NN NN O
to NN NN O
the NN NN O
Huntington NN NN B-Modifier
disease NN NN I-Modifier
region NN NN O
( NN NN O
4p16.3 NN NN O
). NN NN O

Coincident NN NN O
Kaposi NN NN B-SpecificDisease
sarcoma NN NN I-SpecificDisease
and NN NN O
T-cell NN NN B-SpecificDisease
lymphoma NN NN I-SpecificDisease
in NN NN O
a NN NN O
patient NN NN O
with NN NN O
the NN NN O
Wiskott-Aldrich NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

The NN NN O
APC NN NN B-Modifier
gene NN NN O
, NN NN O
responsible NN NN O
for NN NN O
familial NN NN B-SpecificDisease
adenomatous NN NN I-SpecificDisease
polyposis NN NN I-SpecificDisease
, NN NN O
is NN NN O
mutated NN NN O
in NN NN O
human NN NN O
gastric NN NN B-SpecificDisease
cancer NN NN I-SpecificDisease
. NN NN O

A NN NN O
71-kilodalton NN NN O
protein NN NN O
is NN NN O
a NN NN O
major NN NN O
product NN NN O
of NN NN O
the NN NN O
Duchenne NN NN B-Modifier
muscular NN NN I-Modifier
dystrophy NN NN I-Modifier
gene NN NN O
in NN NN O
brain NN NN O
and NN NN O
other NN NN O
nonmuscle NN NN O
tissues NN NN O
. NN NN O

Correlation NN NN O
between NN NN O
the NN NN O
location NN NN O
of NN NN O
germ-line NN NN O
mutations NN NN O
in NN NN O
the NN NN O
APC NN NN B-Modifier
gene NN NN O
and NN NN O
the NN NN O
number NN NN O
of NN NN O
colorectal NN NN B-SpecificDisease
polyps NN NN I-SpecificDisease
in NN NN O
familial NN NN B-Modifier
adenomatous NN NN I-Modifier
polyposis NN NN I-Modifier
patients NN NN O
. NN NN O

Identification NN NN O
and NN NN O
rapid NN NN O
detection NN NN O
of NN NN O
three NN NN O
Tay-Sachs NN NN B-Modifier
mutations NN NN O
in NN NN O
the NN NN O
Moroccan NN NN O
Jewish NN NN O
population NN NN O
. NN NN O

Molecular NN NN O
characterization NN NN O
of NN NN O
glucose-6-phosphate NN NN B-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
( NN NN I-SpecificDisease
G6PD NN NN I-SpecificDisease
) NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
by NN NN O
natural NN NN O
and NN NN O
amplification NN NN O
created NN NN O
restriction NN NN O
sites NN NN O
: NN NN O
five NN NN O
mutations NN NN O
account NN NN O
for NN NN O
most NN NN O
G6PD NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
cases NN NN O
in NN NN O
Taiwan NN NN O
. NN NN O

Eight NN NN O
novel NN NN O
inactivating NN NN O
germ NN NN O
line NN NN O
mutations NN NN O
at NN NN O
the NN NN O
APC NN NN B-Modifier
gene NN NN O
identified NN NN O
by NN NN O
denaturing NN NN O
gradient NN NN O
gel NN NN O
electrophoresis NN NN O
. NN NN O

Yeast NN NN O
artificial NN NN O
chromosomes NN NN O
for NN NN O
the NN NN O
molecular NN NN O
analysis NN NN O
of NN NN O
the NN NN O
familial NN NN B-Modifier
polyposis NN NN I-Modifier
APC NN NN I-Modifier
gene NN NN O
region NN NN O
. NN NN O

Inherited NN NN O
WT1 NN NN O
mutation NN NN O
in NN NN O
Denys-Drash NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Submicroscopic NN NN O
deletions NN NN O
at NN NN O
the NN NN O
WAGR NN NN B-Modifier
locus NN NN O
, NN NN O
revealed NN NN O
by NN NN O
nonradioactive NN NN O
in NN NN O
situ NN NN O
hybridization NN NN O
. NN NN O

Linkage NN NN O
of NN NN O
gene NN NN O
for NN NN O
C2 NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
and NN NN O
the NN NN O
major NN NN O
histocompatibility NN NN O
complex NN NN O
MHC NN NN O
in NN NN O
man NN NN O
. NN NN O

Family NN NN O
study NN NN O
of NN NN O
a NN NN O
further NN NN O
case NN NN O
. NN NN O

Screening NN NN O
for NN NN O
germ-line NN NN O
mutations NN NN O
in NN NN O
familial NN NN B-Modifier
adenomatous NN NN I-Modifier
polyposis NN NN I-Modifier
patients NN NN O
: NN NN O
61 NN NN O
new NN NN O
patients NN NN O
and NN NN O
a NN NN O
summary NN NN O
of NN NN O
150 NN NN O
unrelated NN NN O
patients NN NN O
. NN NN O

Somatic NN NN O
mutations NN NN O
of NN NN O
the NN NN O
APC NN NN B-Modifier
gene NN NN O
in NN NN O
colorectal NN NN B-DiseaseClass
tumors NN NN I-DiseaseClass
: NN NN O
mutation NN NN O
cluster NN NN O
region NN NN O
in NN NN O
the NN NN O
APC NN NN B-Modifier
gene NN NN O
. NN NN O

Constitutional NN NN O
mutations NN NN O
in NN NN O
the NN NN O
WT1 NN NN O
gene NN NN O
in NN NN O
patients NN NN O
with NN NN O
Denys-Drash NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Linkage NN NN O
disequilibrium NN NN O
mapping NN NN O
in NN NN O
isolated NN NN O
founder NN NN O
populations NN NN O
: NN NN O
diastrophic NN NN B-SpecificDisease
dysplasia NN NN I-SpecificDisease
in NN NN O
Finland NN NN O
. NN NN O

The NN NN O
Wiskott-Aldrich NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
: NN NN O
refinement NN NN O
of NN NN O
the NN NN O
localization NN NN O
on NN NN O
Xp NN NN O
and NN NN O
identification NN NN O
of NN NN O
another NN NN O
closely NN NN O
linked NN NN O
marker NN NN O
locus NN NN O
, NN NN O
OATL1 NN NN O
. NN NN O

Detection NN NN O
of NN NN O
an NN NN O
unstable NN NN O
fragment NN NN O
of NN NN O
DNA NN NN O
specific NN NN O
to NN NN O
individuals NN NN O
with NN NN O
myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

Common NN NN O
sequence NN NN O
motifs NN NN O
at NN NN O
the NN NN O
rearrangement NN NN O
sites NN NN O
of NN NN O
a NN NN O
constitutional NN NN O
X/autosome NN NN O
translocation NN NN O
and NN NN O
associated NN NN O
deletion NN NN O
. NN NN O

A NN NN O
genetic NN NN O
etiology NN NN O
for NN NN O
DiGeorge NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
: NN NN O
consistent NN NN O
deletions NN NN O
and NN NN O
microdeletions NN NN O
of NN NN O
22q11 NN NN O
. NN NN O

Loss NN NN O
of NN NN O
normal NN NN O
allele NN NN O
of NN NN O
the NN NN O
APC NN NN B-Modifier
gene NN NN O
in NN NN O
an NN NN O
adrenocortical NN NN B-SpecificDisease
carcinoma NN NN I-SpecificDisease
from NN NN O
a NN NN O
patient NN NN O
with NN NN O
familial NN NN B-SpecificDisease
adenomatous NN NN I-SpecificDisease
polyposis NN NN I-SpecificDisease
. NN NN O

Oncogenic NN NN O
point NN NN O
mutations NN NN O
in NN NN O
exon NN NN O
20 NN NN O
of NN NN O
the NN NN O
RB1 NN NN O
gene NN NN O
in NN NN O
families NN NN O
showing NN NN O
incomplete NN NN O
penetrance NN NN O
and NN NN O
mild NN NN O
expression NN NN O
of NN NN O
the NN NN O
retinoblastoma NN NN B-Modifier
phenotype NN NN O
. NN NN O

Late-onset NN NN O
metachromatic NN NN B-SpecificDisease
leukodystrophy NN NN I-SpecificDisease
: NN NN O
molecular NN NN O
pathology NN NN O
in NN NN O
two NN NN O
siblings NN NN O
. NN NN O

Trisomy NN NN B-SpecificDisease
15 NN NN I-SpecificDisease
with NN NN O
loss NN NN O
of NN NN O
the NN NN O
paternal NN NN O
15 NN NN O
as NN NN O
a NN NN O
cause NN NN O
of NN NN O
Prader-Willi NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
due NN NN O
to NN NN O
maternal NN NN B-SpecificDisease
disomy NN NN I-SpecificDisease
. NN NN O

Genetic NN NN O
heterogeneity NN NN O
in NN NN O
X-linked NN NN B-SpecificDisease
amelogenesis NN NN I-SpecificDisease
imperfecta NN NN I-SpecificDisease
. NN NN O

Multiple NN NN O
origins NN NN O
for NN NN O
phenylketonuria NN NN B-SpecificDisease
in NN NN O
Europe NN NN O
. NN NN O

Complement NN NN B-SpecificDisease
factor NN NN I-SpecificDisease
2 NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
: NN NN O
a NN NN O
clinical NN NN O
and NN NN O
serological NN NN O
family NN NN O
study NN NN O
. NN NN O

New NN NN O
variant NN NN O
in NN NN O
exon NN NN O
3 NN NN O
of NN NN O
the NN NN O
proteolipid NN NN O
protein NN NN O
( NN NN O
PLP NN NN O
) NN NN O
gene NN NN O
in NN NN O
a NN NN O
family NN NN O
with NN NN O
Pelizaeus-Merzbacher NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
. NN NN O

Uncoupling NN NN O
of NN NN O
hypomyelination NN NN B-SpecificDisease
and NN NN O
glial NN NN B-SpecificDisease
cell NN NN I-SpecificDisease
death NN NN I-SpecificDisease
by NN NN O
a NN NN O
mutation NN NN O
in NN NN O
the NN NN O
proteolipid NN NN O
protein NN NN O
gene NN NN O
. NN NN O

A NN NN O
pseudodeficiency NN NN O
allele NN NN O
common NN NN O
in NN NN O
non-Jewish NN NN O
Tay-Sachs NN NN B-Modifier
carriers NN NN O
: NN NN O
implications NN NN O
for NN NN O
carrier NN NN O
screening NN NN O
. NN NN O

Pelizaeus-Merzbacher NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
: NN NN O
detection NN NN O
of NN NN O
mutations NN NN O
Thr181----Pro NN NN O
and NN NN O
Leu223----Pro NN NN O
in NN NN O
the NN NN O
proteolipid NN NN O
protein NN NN O
gene NN NN O
, NN NN O
and NN NN O
prenatal NN NN O
diagnosis NN NN O
. NN NN O

von NN NN B-SpecificDisease
Willebrand NN NN I-SpecificDisease
disease NN NN I-SpecificDisease
type NN NN I-SpecificDisease
B NN NN I-SpecificDisease
: NN NN O
a NN NN O
missense NN NN O
mutation NN NN O
selectively NN NN O
abolishes NN NN O
ristocetin-induced NN NN O
von NN NN B-Modifier
Willebrand NN NN I-Modifier
factor NN NN O
binding NN NN O
to NN NN O
platelet NN NN O
glycoprotein NN NN O
Ib NN NN O
. NN NN O

Typical NN NN O
and NN NN O
partial NN NN O
cat NN NN B-SpecificDisease
eye NN NN I-SpecificDisease
syndrome NN NN I-SpecificDisease
: NN NN O
identification NN NN O
of NN NN O
the NN NN O
marker NN NN O
chromosome NN NN O
by NN NN O
FISH NN NN O
. NN NN O

[Genetic NN NN O
heterogeneity NN NN O
of NN NN O
G6PD NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
: NN NN O
mutant NN NN O
alleles NN NN O
of NN NN O
G6PD NN NN O
in NN NN O
the NN NN O
Shekii NN NN O
district NN NN O
of NN NN O
Azerbaijan] NN NN O

Craniofrontonasal NN NN B-SpecificDisease
dysplasia NN NN I-SpecificDisease
. NN NN O

The NN NN O
intron NN NN O
7 NN NN O
donor NN NN O
splice NN NN O
site NN NN O
transition NN NN O
: NN NN O
a NN NN O
second NN NN O
Tay-Sachs NN NN B-Modifier
disease NN NN I-Modifier
mutation NN NN O
in NN NN O
French NN NN O
Canada NN NN O
. NN NN O

Assignment NN NN O
of NN NN O
the NN NN O
aspartylglucosaminidase NN NN O
gene NN NN O
( NN NN O
AGA NN NN O
) NN NN O
to NN NN O
4q33----q35 NN NN O
based NN NN O
on NN NN O
decreased NN NN O
activity NN NN O
in NN NN O
a NN NN O
girl NN NN O
with NN NN O
a NN NN O
46,XX,del(4)(q33 NN NN O
) NN NN O
karyotype NN NN O
. NN NN O

Resolution NN NN O
of NN NN O
the NN NN O
two NN NN O
loci NN NN O
for NN NN O
autosomal NN NN O
dominant NN NN O
aniridia NN NN B-SpecificDisease
, NN NN O
AN1 NN NN O
and NN NN O
AN2 NN NN O
, NN NN O
to NN NN O
a NN NN O
single NN NN O
locus NN NN O
on NN NN O
chromosome NN NN O
11p13 NN NN O
. NN NN O

Fatal NN NN O
pyoderma NN NN B-SpecificDisease
gangrenosum NN NN I-SpecificDisease
in NN NN O
association NN NN O
with NN NN O
C7 NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
. NN NN O

Diverse NN NN O
point NN NN O
mutations NN NN O
result NN NN O
in NN NN O
glucose-6-phosphate NN NN O
dehydrogenase NN NN O
( NN NN O
G6PD NN NN O
) NN NN O
polymorphism NN NN O
in NN NN O
Taiwan NN NN O
. NN NN O

An NN NN O
error NN NN O
in NN NN O
dystrophin NN NN O
mRNA NN NN O
processing NN NN O
in NN NN O
golden NN NN B-SpecificDisease
retriever NN NN I-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
, NN NN O
an NN NN O
animal NN NN O
homologue NN NN O
of NN NN O
Duchenne NN NN B-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

Type NN NN B-SpecificDisease
I NN NN I-SpecificDisease
human NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
C2 NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
. NN NN O

A NN NN O
28-base NN NN O
pair NN NN O
gene NN NN O
deletion NN NN O
causes NN NN O
skipping NN NN O
of NN NN O
exon NN NN O
6 NN NN O
during NN NN O
RNA NN NN O
splicing NN NN O
. NN NN O

Molecular NN NN O
characterization NN NN O
of NN NN O
two NN NN O
galactosemia NN NN B-Modifier
mutations NN NN O
and NN NN O
one NN NN O
polymorphism NN NN O
: NN NN O
implications NN NN O
for NN NN O
structure-function NN NN O
analysis NN NN O
of NN NN O
human NN NN O
galactose-1-phosphate NN NN O
uridyltransferase NN NN O
. NN NN O

Linkage NN NN O
relationship NN NN O
of NN NN O
C2 NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
, NN NN O
HLA NN NN O
and NN NN O
glyoxalase NN NN O
I NN NN O
loci NN NN O
. NN NN O

Germline NN NN O
mutations NN NN O
in NN NN O
the NN NN O
Wilms NN NN B-Modifier
' NN NN I-Modifier
tumor NN NN I-Modifier
suppressor NN NN O
gene NN NN O
are NN NN O
associated NN NN O
with NN NN O
abnormal NN NN O
urogenital NN NN O
development NN NN O
in NN NN O
Denys-Drash NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Linkage NN NN O
analysis NN NN O
in NN NN O
X-linked NN NN B-SpecificDisease
adrenoleukodystrophy NN NN I-SpecificDisease
and NN NN O
application NN NN O
in NN NN O
post NN NN O
- NN NN O
and NN NN O
prenatal NN NN O
diagnosis NN NN O
. NN NN O

Two NN NN O
distinct NN NN O
mutations NN NN O
at NN NN O
a NN NN O
single NN NN O
BamHI NN NN O
site NN NN O
in NN NN O
phenylketonuria NN NN B-SpecificDisease
. NN NN O

A NN NN O
detailed NN NN O
multipoint NN NN O
map NN NN O
of NN NN O
human NN NN O
chromosome NN NN O
4 NN NN O
provides NN NN O
evidence NN NN O
for NN NN O
linkage NN NN O
heterogeneity NN NN O
and NN NN O
position-specific NN NN O
recombination NN NN O
rates NN NN O
. NN NN O

Carrier NN NN O
detection NN NN O
and NN NN O
prenatal NN NN O
diagnosis NN NN O
of NN NN O
Pelizaeus-Merzbacher NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
using NN NN O
a NN NN O
combination NN NN O
of NN NN O
anonymous NN NN O
DNA NN NN O
polymorphisms NN NN O
and NN NN O
the NN NN O
proteolipid NN NN O
protein NN NN O
( NN NN O
PLP NN NN O
) NN NN O
gene NN NN O
cDNA NN NN O
. NN NN O

Identification NN NN O
of NN NN O
deletion NN NN O
mutations NN NN O
and NN NN O
three NN NN O
new NN NN O
genes NN NN O
at NN NN O
the NN NN O
familial NN NN B-Modifier
polyposis NN NN I-Modifier
locus NN NN O
. NN NN O

Exclusion NN NN O
of NN NN O
linkage NN NN O
between NN NN O
familial NN NN B-SpecificDisease
Mediterranean NN NN I-SpecificDisease
fever NN NN I-SpecificDisease
and NN NN O
the NN NN O
human NN NN O
serum NN NN O
amyloid NN NN O
A NN NN O
( NN NN O
SAA NN NN O
) NN NN O
gene NN NN O
cluster NN NN O
. NN NN O

PRAD1 NN NN O
, NN NN O
a NN NN O
candidate NN NN O
BCL1 NN NN O
oncogene NN NN O
: NN NN O
mapping NN NN O
and NN NN O
expression NN NN O
in NN NN O
centrocytic NN NN B-DiseaseClass
lymphoma NN NN I-DiseaseClass
. NN NN O

Two NN NN O
new NN NN O
arylsulfatase NN NN O
A NN NN O
( NN NN O
ARSA NN NN O
) NN NN O
mutations NN NN O
in NN NN O
a NN NN O
juvenile NN NN O
metachromatic NN NN B-Modifier
leukodystrophy NN NN I-Modifier
( NN NN O
MLD NN NN B-Modifier
) NN NN O
patient NN NN O
. NN NN O

Analysis NN NN O
of NN NN O
X-chromosome NN NN O
inactivation NN NN O
and NN NN O
presumptive NN NN O
expression NN NN O
of NN NN O
the NN NN O
Wiskott-Aldrich NN NN B-Modifier
syndrome NN NN I-Modifier
( NN NN O
WAS NN NN B-Modifier
) NN NN O
gene NN NN O
in NN NN O
hematopoietic NN NN O
cell NN NN O
lineages NN NN O
of NN NN O
a NN NN O
thrombocytopenic NN NN O
carrier NN NN O
female NN NN O
of NN NN O
WAS NN NN B-SpecificDisease
. NN NN O

A NN NN O
new NN NN O
mutation NN NN O
in NN NN O
the NN NN O
proteolipid NN NN O
protein NN NN O
( NN NN O
PLP NN NN O
) NN NN O
gene NN NN O
in NN NN O
a NN NN O
German NN NN O
family NN NN O
with NN NN O
Pelizaeus-Merzbacher NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
. NN NN O

A NN NN O
3-base NN NN O
pair NN NN O
in-frame NN NN O
deletion NN NN O
of NN NN O
the NN NN O
phenylalanine NN NN O
hydroxylase NN NN O
gene NN NN O
results NN NN O
in NN NN O
a NN NN O
kinetic NN NN O
variant NN NN O
of NN NN O
phenylketonuria NN NN B-SpecificDisease
. NN NN O

Mutation NN NN O
of NN NN O
the NN NN O
KIT NN NN O
( NN NN O
mast/stem NN NN O
cell NN NN O
growth NN NN O
factor NN NN O
receptor NN NN O
) NN NN O
protooncogene NN NN O
in NN NN O
human NN NN O
piebaldism NN NN B-SpecificDisease
. NN NN O

Genetic NN NN O
analysis NN NN O
of NN NN O
a NN NN O
Japanese NN NN O
family NN NN O
with NN NN O
normotriglyceridemic NN NN B-SpecificDisease
abetalipoproteinemia NN NN I-SpecificDisease
indicates NN NN O
a NN NN O
lack NN NN O
of NN NN O
linkage NN NN O
to NN NN O
the NN NN O
apolipoprotein NN NN O
B NN NN O
gene NN NN O
. NN NN O

Localisation NN NN O
of NN NN O
the NN NN O
gene NN NN O
for NN NN O
Norrie NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
to NN NN O
between NN NN O
DXS7 NN NN O
and NN NN O
DXS426 NN NN O
on NN NN O
Xp NN NN O
. NN NN O

Aberrant NN NN O
splicing NN NN O
of NN NN O
phenylalanine NN NN O
hydroxylase NN NN O
mRNA NN NN O
: NN NN O
the NN NN O
major NN NN O
cause NN NN O
for NN NN O
phenylketonuria NN NN B-SpecificDisease
in NN NN O
parts NN NN O
of NN NN O
southern NN NN O
Europe NN NN O
. NN NN O

Gardner NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
in NN NN O
a NN NN O
boy NN NN O
with NN NN O
interstitial NN NN O
deletion NN NN O
of NN NN O
the NN NN O
long NN NN O
arm NN NN O
of NN NN O
chromosome NN NN O
5 NN NN O
. NN NN O

Huntington NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
and NN NN O
childhood-onset NN NN O
Tourette NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Sequence NN NN O
of NN NN O
DNA NN NN O
flanking NN NN O
the NN NN O
exons NN NN O
of NN NN O
the NN NN O
HEXA NN NN O
gene NN NN O
, NN NN O
and NN NN O
identification NN NN O
of NN NN O
mutations NN NN O
in NN NN O
Tay-Sachs NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
. NN NN O

Molecular NN NN O
characterization NN NN O
of NN NN O
two NN NN O
galactosemia NN NN B-Modifier
mutations NN NN O
: NN NN O
correlation NN NN O
of NN NN O
mutations NN NN O
with NN NN O
highly NN NN O
conserved NN NN O
domains NN NN O
in NN NN O
galactose-1-phosphate NN NN O
uridyl NN NN O
transferase NN NN O
. NN NN O

Hypoxanthine-guanine NN NN B-SpecificDisease
phosphoribosyltransferase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
: NN NN O
analysis NN NN O
of NN NN O
HPRT NN NN O
mutations NN NN O
by NN NN O
direct NN NN O
sequencing NN NN O
and NN NN O
allele-specific NN NN O
amplification NN NN O
. NN NN O

Molecular NN NN O
and NN NN O
metabolic NN NN O
basis NN NN O
for NN NN O
the NN NN O
metabolic NN NN B-DiseaseClass
disorder NN NN I-DiseaseClass
normotriglyceridemic NN NN B-SpecificDisease
abetalipoproteinemia NN NN I-SpecificDisease
. NN NN O

A NN NN O
single NN NN O
origin NN NN O
of NN NN O
phenylketonuria NN NN B-SpecificDisease
in NN NN O
Yemenite NN NN O
Jews NN NN O
. NN NN O

Linkage NN NN O
of NN NN O
aspartylglucosaminuria NN NN B-SpecificDisease
( NN NN O
AGU NN NN B-SpecificDisease
) NN NN O
to NN NN O
marker NN NN O
loci NN NN O
on NN NN O
the NN NN O
long NN NN O
arm NN NN O
of NN NN O
chromosome NN NN O
4 NN NN O
. NN NN O

Linkage NN NN O
relationships NN NN O
of NN NN O
the NN NN O
apolipoprotein NN NN O
C1 NN NN O
gene NN NN O
and NN NN O
a NN NN O
cytochrome NN NN O
P450 NN NN O
gene NN NN O
( NN NN O
CYP2A NN NN O
) NN NN O
to NN NN O
myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

Genetic NN NN O
linkage NN NN O
map NN NN O
of NN NN O
six NN NN O
polymorphic NN NN O
DNA NN NN O
markers NN NN O
around NN NN O
the NN NN O
gene NN NN O
for NN NN O
familial NN NN B-SpecificDisease
adenomatous NN NN I-SpecificDisease
polyposis NN NN I-SpecificDisease
on NN NN O
chromosome NN NN O
5 NN NN O
. NN NN O

Serum NN NN O
amyloid NN NN O
A NN NN O
and NN NN O
P NN NN O
protein NN NN O
genes NN NN O
in NN NN O
familial NN NN B-SpecificDisease
Mediterranean NN NN I-SpecificDisease
fever NN NN I-SpecificDisease
. NN NN O

Some NN NN O
Mexican NN NN O
glucose-6-phosphate NN NN O
dehydrogenase NN NN O
variants NN NN O
revisited NN NN O
. NN NN O

Hereditary NN NN O
deficiency NN NN B-SpecificDisease
of NN NN I-SpecificDisease
C5 NN NN I-SpecificDisease
in NN NN O
association NN NN O
with NN NN O
discoid NN NN B-SpecificDisease
lupus NN NN I-SpecificDisease
erythematosus NN NN I-SpecificDisease
. NN NN O

Founder NN NN O
effect NN NN O
of NN NN O
a NN NN O
prevalent NN NN O
phenylketonuria NN NN B-Modifier
mutation NN NN O
in NN NN O
the NN NN O
Oriental NN NN O
population NN NN O
. NN NN O

Glucose/galactose NN NN B-SpecificDisease
malabsorption NN NN I-SpecificDisease
caused NN NN O
by NN NN O
a NN NN O
defect NN NN O
in NN NN O
the NN NN O
Na+/glucose NN NN O
cotransporter NN NN O
. NN NN O

A NN NN O
de NN NN O
novo NN NN O
unbalanced NN NN O
reciprocal NN NN O
translocation NN NN O
identified NN NN O
as NN NN O
paternal NN NN O
in NN NN O
origin NN NN O
in NN NN O
the NN NN O
Prader-Willi NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Localisation NN NN O
of NN NN O
the NN NN O
myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
locus NN NN O
to NN NN O
19q13.2-19q13.3 NN NN O
and NN NN O
its NN NN O
relationship NN NN O
to NN NN O
twelve NN NN O
polymorphic NN NN O
loci NN NN O
on NN NN O
19q NN NN O
. NN NN O

Localization NN NN O
of NN NN O
histidase NN NN O
to NN NN O
human NN NN O
chromosome NN NN O
region NN NN O
12q22----q24.1 NN NN O
and NN NN O
mouse NN NN O
chromosome NN NN O
region NN NN O
10C2----D1 NN NN O
. NN NN O

Determination NN NN O
of NN NN O
the NN NN O
mutations NN NN O
responsible NN NN O
for NN NN O
the NN NN O
Lesch-Nyhan NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
in NN NN O
17 NN NN O
subjects NN NN O
. NN NN O

Linkage NN NN O
of NN NN O
DNA NN NN O
markers NN NN O
at NN NN O
Xq28 NN NN O
to NN NN O
adrenoleukodystrophy NN NN B-SpecificDisease
and NN NN O
adrenomyeloneuropathy NN NN B-SpecificDisease
present NN NN O
within NN NN O
the NN NN O
same NN NN O
family NN NN O
. NN NN O

Skewed NN NN O
X NN NN O
inactivation NN NN O
in NN NN O
a NN NN O
female NN NN O
MZ NN NN O
twin NN NN O
results NN NN O
in NN NN O
Duchenne NN NN B-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

Adrenoleukodystrophy NN NN B-SpecificDisease
and NN NN O
adrenomyeloneuropathy NN NN B-SpecificDisease
associated NN NN O
with NN NN O
partial NN NN O
adrenal NN NN B-DiseaseClass
insufficiency NN NN I-DiseaseClass
in NN NN O
three NN NN O
generations NN NN O
of NN NN O
a NN NN O
kindred NN NN O
. NN NN O

Regional NN NN O
localisation NN NN O
of NN NN O
the NN NN O
Friedreich NN NN B-Modifier
ataxia NN NN I-Modifier
locus NN NN O
to NN NN O
human NN NN O
chromosome NN NN O
9q13----q21.1 NN NN O
. NN NN O

Increased NN NN O
high-density NN NN O
lipoprotein NN NN O
levels NN NN O
caused NN NN O
by NN NN O
a NN NN O
common NN NN O
cholesteryl-ester NN NN O
transfer NN NN O
protein NN NN O
gene NN NN O
mutation NN NN O
. NN NN O

Further NN NN O
mapping NN NN O
of NN NN O
an NN NN O
ataxia-telangiectasia NN NN B-Modifier
locus NN NN O
to NN NN O
the NN NN O
chromosome NN NN O
11q23 NN NN O
region NN NN O
. NN NN O

Recurrent NN NN O
meningitis NN NN B-SpecificDisease
in NN NN O
a NN NN O
patient NN NN O
with NN NN O
congenital NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
C9 NN NN I-SpecificDisease
component NN NN I-SpecificDisease
of NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
. NN NN O

First NN NN O
case NN NN O
of NN NN O
C9 NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
in NN NN O
Europe NN NN O
. NN NN O

Detection NN NN O
of NN NN O
98% NN NN O
of NN NN O
DMD NN NN B-Modifier
/ NN NN O
BMD NN NN B-Modifier
gene NN NN O
deletions NN NN O
by NN NN O
polymerase NN NN O
chain NN NN O
reaction NN NN O
. NN NN O

Genetic NN NN O
heterogeneity NN NN O
at NN NN O
the NN NN O
glucose-6-phosphate NN NN O
dehydrogenase NN NN O
locus NN NN O
in NN NN O
southern NN NN O
Italy NN NN O
: NN NN O
a NN NN O
study NN NN O
on NN NN O
a NN NN O
population NN NN O
from NN NN O
the NN NN O
Matera NN NN O
district NN NN O
. NN NN O

Deficiency NN NN B-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
murine NN NN I-SpecificDisease
fifth NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
component NN NN I-SpecificDisease
( NN NN I-SpecificDisease
C5 NN NN I-SpecificDisease
) NN NN I-SpecificDisease
. NN NN O

A NN NN O
2-base NN NN O
pair NN NN O
gene NN NN O
deletion NN NN O
in NN NN O
a NN NN O
5'-exon NN NN O
. NN NN O

Molecular NN NN O
genetics NN NN O
of NN NN O
PKU NN NN B-SpecificDisease
in NN NN O
eastern NN NN O
Europe NN NN O
: NN NN O
a NN NN O
nonsense NN NN O
mutation NN NN O
associated NN NN O
with NN NN O
haplotype NN NN O
4 NN NN O
of NN NN O
the NN NN O
phenylalanine NN NN O
hydroxylase NN NN O
gene NN NN O
. NN NN O

The NN NN O
red-green NN NN O
visual NN NN O
pigment NN NN O
gene NN NN O
region NN NN O
in NN NN O
adrenoleukodystrophy NN NN B-SpecificDisease
. NN NN O

Paroxysmal NN NN B-SpecificDisease
nocturnal NN NN I-SpecificDisease
haemoglobinuria NN NN I-SpecificDisease
with NN NN O
coexisting NN NN O
deficiency NN NN B-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
ninth NN NN I-SpecificDisease
component NN NN I-SpecificDisease
of NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
: NN NN O
lack NN NN O
of NN NN O
massive NN NN O
haemolytic NN NN B-SpecificDisease
attack NN NN I-SpecificDisease
. NN NN O

Duplicational NN NN O
mutation NN NN O
at NN NN O
the NN NN O
Duchenne NN NN B-Modifier
muscular NN NN I-Modifier
dystrophy NN NN I-Modifier
locus NN NN O
: NN NN O
its NN NN O
frequency NN NN O
, NN NN O
distribution NN NN O
, NN NN O
origin NN NN O
, NN NN O
and NN NN O
phenotypegenotype NN NN O
correlation NN NN O
. NN NN O

Glucose NN NN O
6-phosphate NN NN O
dehydrogenase NN NN O
variants NN NN O
: NN NN O
Gd NN NN O
( NN NN O
+ NN NN O
) NN NN O
Alexandra NN NN O
associated NN NN O
with NN NN O
neonatal NN NN B-SpecificDisease
jaundice NN NN I-SpecificDisease
and NN NN O
Gd NN NN O
(-) NN NN O
Camperdown NN NN O
in NN NN O
a NN NN O
young NN NN O
man NN NN O
with NN NN O
lamellar NN NN B-SpecificDisease
cataracts NN NN I-SpecificDisease
. NN NN O

Statistical NN NN O
analysis NN NN O
of NN NN O
the NN NN O
two NN NN O
stage NN NN O
mutation NN NN O
model NN NN O
in NN NN O
von NN NN B-SpecificDisease
Hippel-Lindau NN NN I-SpecificDisease
disease NN NN I-SpecificDisease
, NN NN O
and NN NN O
in NN NN O
sporadic NN NN B-SpecificDisease
cerebellar NN NN I-SpecificDisease
haemangioblastoma NN NN I-SpecificDisease
and NN NN O
renal NN NN B-SpecificDisease
cell NN NN I-SpecificDisease
carcinoma NN NN I-SpecificDisease
. NN NN O

Screening NN NN O
for NN NN O
carriers NN NN O
of NN NN O
Tay-Sachs NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
among NN NN O
Ashkenazi NN NN O
Jews NN NN O
. NN NN O

A NN NN O
comparison NN NN O
of NN NN O
DNA-based NN NN O
and NN NN O
enzyme-based NN NN O
tests NN NN O
. NN NN O

Total NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
of NN NN I-SpecificDisease
plasma NN NN I-SpecificDisease
cholesteryl NN NN I-SpecificDisease
ester NN NN I-SpecificDisease
transfer NN NN I-SpecificDisease
protein NN NN I-SpecificDisease
in NN NN O
subjects NN NN O
homozygous NN NN O
and NN NN O
heterozygous NN NN O
for NN NN O
the NN NN O
intron NN NN O
14 NN NN O
splicing NN NN O
defect NN NN O
. NN NN O

Molecular NN NN O
genetics NN NN O
of NN NN O
the NN NN O
glucose-6-phosphate NN NN O
dehydrogenase NN NN O
( NN NN O
G6PD NN NN O
) NN NN O
Mediterranean NN NN O
variant NN NN O
and NN NN O
description NN NN O
of NN NN O
a NN NN O
new NN NN O
G6PD NN NN O
mutant NN NN O
, NN NN O
G6PD NN NN O
Andalus1361A NN NN O
. NN NN O

A NN NN O
normal NN NN O
male NN NN O
with NN NN O
an NN NN O
inherited NN NN O
deletion NN NN O
of NN NN O
one NN NN O
exon NN NN O
within NN NN O
the NN NN O
DMD NN NN B-Modifier
gene NN NN O
. NN NN O

Duchenne NN NN B-Modifier
muscular NN NN I-Modifier
dystrophy NN NN I-Modifier
gene NN NN O
expression NN NN O
in NN NN O
normal NN NN O
and NN NN O
diseased NN NN O
human NN NN O
muscle NN NN O
. NN NN O

Molecular NN NN O
and NN NN O
phenotypic NN NN O
analysis NN NN O
of NN NN O
patients NN NN O
with NN NN O
deletions NN NN O
within NN NN O
the NN NN O
deletion-rich NN NN O
region NN NN O
of NN NN O
the NN NN O
Duchenne NN NN B-Modifier
muscular NN NN I-Modifier
dystrophy NN NN I-Modifier
( NN NN O
DMD NN NN B-Modifier
) NN NN O
gene NN NN O
. NN NN O

Cloning NN NN O
of NN NN O
breakpoints NN NN O
of NN NN O
a NN NN O
chromosome NN NN O
translocation NN NN O
identifies NN NN O
the NN NN O
AN2 NN NN O
locus NN NN O
. NN NN O

Linkage NN NN O
analysis NN NN O
of NN NN O
the NN NN O
apolipoprotein NN NN O
C2 NN NN O
gene NN NN O
and NN NN O
myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
on NN NN O
human NN NN O
chromosome NN NN O
19 NN NN O
reveals NN NN O
linkage NN NN O
disequilibrium NN NN O
in NN NN O
a NN NN O
French-Canadian NN NN O
population NN NN O
. NN NN O

Phenylalanine NN NN O
hydroxylase NN NN O
gene NN NN O
haplotypes NN NN O
in NN NN O
Polynesians NN NN O
: NN NN O
evolutionary NN NN O
origins NN NN O
and NN NN O
absence NN NN O
of NN NN O
alleles NN NN O
associated NN NN O
with NN NN O
severe NN NN O
phenylketonuria NN NN B-SpecificDisease
. NN NN O

Preferential NN NN O
germline NN NN O
mutation NN NN O
of NN NN O
the NN NN O
paternal NN NN O
allele NN NN O
in NN NN O
retinoblastoma NN NN B-SpecificDisease
. NN NN O

Haplotype NN NN O
analysis NN NN O
of NN NN O
the NN NN O
phenylalanine NN NN O
hydroxylase NN NN O
gene NN NN O
in NN NN O
Turkish NN NN O
phenylketonuria NN NN B-Modifier
families NN NN O
. NN NN O

Huntington NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
: NN NN O
no NN NN O
evidence NN NN O
for NN NN O
locus NN NN O
heterogeneity NN NN O
. NN NN O

Haplotype NN NN O
and NN NN O
multipoint NN NN O
linkage NN NN O
analysis NN NN O
in NN NN O
Finnish NN NN O
choroideremia NN NN B-Modifier
families NN NN O
. NN NN O

Autosomal NN NN O
dominant NN NN O
aniridia NN NN B-SpecificDisease
linked NN NN O
to NN NN O
the NN NN O
chromosome NN NN O
11p13 NN NN O
markers NN NN O
catalase NN NN O
and NN NN O
D11S151 NN NN O
in NN NN O
a NN NN O
large NN NN O
Dutch NN NN O
family NN NN O
. NN NN O

Recombination NN NN O
events NN NN O
that NN NN O
locate NN NN O
myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
distal NN NN O
to NN NN O
APOC2 NN NN O
on NN NN O
19q NN NN O
. NN NN O

Mutations NN NN O
in NN NN O
the NN NN O
RB1 NN NN O
gene NN NN O
and NN NN O
their NN NN O
effects NN NN O
on NN NN O
transcription NN NN O
. NN NN O

Partial NN NN O
deletion NN NN O
8q NN NN O
without NN NN O
Langer-Giedion NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
: NN NN O
a NN NN O
recognisable NN NN O
syndrome NN NN O
. NN NN O

Myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
is NN NN O
closely NN NN O
linked NN NN O
to NN NN O
the NN NN O
gene NN NN O
for NN NN O
muscle-type NN NN O
creatine NN NN O
kinase NN NN O
( NN NN O
CKMM NN NN O
). NN NN O

Color NN NN B-DiseaseClass
vision NN NN I-DiseaseClass
defects NN NN I-DiseaseClass
in NN NN O
adrenomyeloneuropathy NN NN B-SpecificDisease
. NN NN O

Molecular NN NN O
analysis NN NN O
of NN NN O
a NN NN O
female NN NN O
Lesch-Nyhan NN NN B-Modifier
patient NN NN O
. NN NN O

Pelizaeus-Merzbacher NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
: NN NN O
an NN NN O
X-linked NN NN B-DiseaseClass
neurologic NN NN I-DiseaseClass
disorder NN NN I-DiseaseClass
of NN NN I-DiseaseClass
myelin NN NN I-DiseaseClass
metabolism NN NN I-DiseaseClass
with NN NN O
a NN NN O
novel NN NN O
mutation NN NN O
in NN NN O
the NN NN O
gene NN NN O
encoding NN NN O
proteolipid NN NN O
protein NN NN O
. NN NN O

Molecular NN NN O
basis NN NN O
of NN NN O
human NN NN O
von NN NN B-SpecificDisease
Willebrand NN NN I-SpecificDisease
disease NN NN I-SpecificDisease
: NN NN O
analysis NN NN O
of NN NN O
platelet NN NN O
von NN NN B-Modifier
Willebrand NN NN I-Modifier
factor NN NN O
mRNA NN NN O
. NN NN O

Familial NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
seventh NN NN I-SpecificDisease
component NN NN I-SpecificDisease
of NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
associated NN NN O
with NN NN O
recurrent NN NN O
meningococcal NN NN B-SpecificDisease
infections NN NN I-SpecificDisease
. NN NN O

Translocation NN NN O
t(5 NN NN O
; NN NN O

11)(q13.1 NN NN O
; NN NN O

p13 NN NN O
) NN NN O
associated NN NN O
with NN NN O
familial NN NN O
isolated NN NN B-SpecificDisease
aniridia NN NN I-SpecificDisease
. NN NN O

Homozygous NN NN B-SpecificDisease
hypobetalipoproteinemia NN NN I-SpecificDisease
: NN NN O
a NN NN O
disease NN NN O
distinct NN NN O
from NN NN O
abetalipoproproteinemia NN NN B-SpecificDisease
at NN NN O
the NN NN O
molecular NN NN O
level NN NN O
. NN NN O

Spontaneous NN NN O
reversion NN NN O
of NN NN O
novel NN NN O
Lesch-Nyhan NN NN B-Modifier
mutation NN NN O
by NN NN O
HPRT NN NN O
gene NN NN O
rearrangement NN NN O
. NN NN O

Complex NN NN B-SpecificDisease
glycerol NN NN I-SpecificDisease
kinase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
: NN NN O
molecular-genetic NN NN O
, NN NN O
cytogenetic NN NN O
, NN NN O
and NN NN O
clinical NN NN O
studies NN NN O
of NN NN O
five NN NN O
Japanese NN NN O
patients NN NN O
. NN NN O

Genetically NN NN O
determined NN NN O
low NN NN O
C4 NN NN O
: NN NN O
a NN NN O
predisposing NN NN O
factor NN NN O
to NN NN O
autoimmune NN NN B-SpecificDisease
chronic NN NN I-SpecificDisease
active NN NN I-SpecificDisease
hepatitis NN NN I-SpecificDisease
. NN NN O

An NN NN O
amino-acid NN NN O
substitution NN NN O
involved NN NN O
in NN NN O
phenylketonuria NN NN B-SpecificDisease
is NN NN O
in NN NN O
linkage NN NN O
disequilibrium NN NN O
with NN NN O
DNA NN NN O
haplotype NN NN O
2 NN NN O
. NN NN O

Choroideremia NN NN B-SpecificDisease
: NN NN O
close NN NN O
linkage NN NN O
to NN NN O
DXYS1 NN NN O
and NN NN O
DXYS12 NN NN O
demonstrated NN NN O
by NN NN O
segregation NN NN O
analysis NN NN O
and NN NN O
historical-genealogical NN NN O
evidence NN NN O
. NN NN O

Von NN NN B-SpecificDisease
Hippel-Lindau NN NN I-SpecificDisease
disease NN NN I-SpecificDisease
maps NN NN O
to NN NN O
the NN NN O
region NN NN O
of NN NN O
chromosome NN NN O
3 NN NN O
associated NN NN O
with NN NN O
renal NN NN B-SpecificDisease
cell NN NN I-SpecificDisease
carcinoma NN NN I-SpecificDisease
. NN NN O

Tightly NN NN O
linked NN NN O
flanking NN NN O
markers NN NN O
for NN NN O
the NN NN O
Lowe NN NN B-SpecificDisease
oculocerebrorenal NN NN I-SpecificDisease
syndrome NN NN I-SpecificDisease
, NN NN O
with NN NN O
application NN NN O
to NN NN O
carrier NN NN O
assessment NN NN O
. NN NN O

Identification NN NN O
of NN NN O
a NN NN O
single NN NN O
nucleotide NN NN O
change NN NN O
in NN NN O
the NN NN O
hypoxanthine-guanine NN NN O
phosphoribosyltransferase NN NN O
gene NN NN O
( NN NN O
HPRTYale NN NN O
) NN NN O
responsible NN NN O
for NN NN O
Lesch-Nyhan NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Two NN NN O
point NN NN O
mutations NN NN O
are NN NN O
responsible NN NN O
for NN NN O
G6PD NN NN O
polymorphism NN NN O
in NN NN O
Sardinia NN NN O
. NN NN O

Chronic NN NN B-SpecificDisease
nonspherocytic NN NN I-SpecificDisease
hemolytic NN NN I-SpecificDisease
anemia NN NN I-SpecificDisease
( NN NN O
CNSHA NN NN B-SpecificDisease
) NN NN O
and NN NN O
glucose NN NN B-SpecificDisease
6 NN NN I-SpecificDisease
phosphate NN NN I-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
( NN NN I-SpecificDisease
G6PD NN NN I-SpecificDisease
) NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
in NN NN O
a NN NN O
patient NN NN O
with NN NN O
familial NN NN B-SpecificDisease
amyloidotic NN NN I-SpecificDisease
polyneuropathy NN NN I-SpecificDisease
( NN NN O
FAP NN NN B-SpecificDisease
). NN NN O

Molecular NN NN O
study NN NN O
of NN NN O
a NN NN O
new NN NN O
variant NN NN O
( NN NN O
G6PD NN NN O
Clinic NN NN O
) NN NN O
with NN NN O
markedly NN NN O
acidic NN NN O
pH NN NN O
optimum NN NN O
. NN NN O

Molecular NN NN O
detection NN NN O
of NN NN O
chromosomal NN NN O
translocations NN NN O
that NN NN O
disrupt NN NN O
the NN NN O
putative NN NN O
retinoblastoma NN NN B-Modifier
susceptibility NN NN O
locus NN NN O
. NN NN O

Inherited NN NN O
C3 NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
with NN NN O
recurrent NN NN O
infections NN NN O
and NN NN O
glomerulonephritis NN NN B-SpecificDisease
. NN NN O

DNA NN NN O
restriction NN NN O
fragments NN NN O
associated NN NN O
with NN NN O
alpha NN NN O
1-antitrypsin NN NN O
indicate NN NN O
a NN NN O
single NN NN O
origin NN NN O
for NN NN O
deficiency NN NN O
allele NN NN O
PI NN NN O
Z NN NN O
. NN NN O

Segregation NN NN O
analysis NN NN O
of NN NN O
a NN NN O
marker NN NN O
localised NN NN O
Xp21.2-Xp21.3 NN NN O
in NN NN O
Duchenne NN NN B-CompositeMention
and NN NN I-CompositeMention
Becker NN NN I-CompositeMention
muscular NN NN I-CompositeMention
dystrophy NN NN I-CompositeMention
families NN NN O
. NN NN O

Isolation NN NN O
of NN NN O
molecular NN NN O
probes NN NN O
associated NN NN O
with NN NN O
the NN NN O
chromosome NN NN O
15 NN NN O
instability NN NN O
in NN NN O
the NN NN O
Prader-Willi NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Analysis NN NN O
of NN NN O
deletions NN NN O
in NN NN O
DNA NN NN O
from NN NN O
patients NN NN O
with NN NN O
Becker NN NN B-CompositeMention
and NN NN I-CompositeMention
Duchenne NN NN I-CompositeMention
muscular NN NN I-CompositeMention
dystrophy NN NN I-CompositeMention
. NN NN O

A NN NN O
potential NN NN O
animal NN NN O
model NN NN O
for NN NN O
Lesch-Nyhan NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
through NN NN O
introduction NN NN O
of NN NN O
HPRT NN NN O
mutations NN NN O
into NN NN O
mice NN NN O
. NN NN O

Re-evaluation NN NN O
of NN NN O
the NN NN O
sublocalization NN NN O
of NN NN O
esterase NN NN O
D NN NN O
and NN NN O
its NN NN O
relation NN NN O
to NN NN O
the NN NN O
retinoblastoma NN NN B-Modifier
locus NN NN O
by NN NN O
in NN NN O
situ NN NN O
hybridization NN NN O
. NN NN O

Hereditary NN NN B-SpecificDisease
C2 NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
associated NN NN O
with NN NN O
common NN NN O
variable NN NN O
immunodeficiency NN NN B-DiseaseClass
. NN NN O

Mild NN NN O
and NN NN O
severe NN NN O
muscular NN NN B-DiseaseClass
dystrophy NN NN I-DiseaseClass
associated NN NN O
with NN NN O
deletions NN NN O
in NN NN O
Xp21 NN NN O
of NN NN O
the NN NN O
human NN NN O
X NN NN O
chromosome NN NN O
. NN NN O

Patterns NN NN O
of NN NN O
exon NN NN O
deletions NN NN O
in NN NN O
Duchenne NN NN B-CompositeMention
and NN NN I-CompositeMention
Becker NN NN I-CompositeMention
muscular NN NN I-CompositeMention
dystrophy NN NN I-CompositeMention
. NN NN O

Hereditary NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
third NN NN I-SpecificDisease
component NN NN I-SpecificDisease
of NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
in NN NN O
a NN NN O
child NN NN O
with NN NN O
fever NN NN B-DiseaseClass
, NN NN O
skin NN NN B-DiseaseClass
rash NN NN I-DiseaseClass
, NN NN O
and NN NN O
arthralgias NN NN B-DiseaseClass
: NN NN O
response NN NN O
to NN NN O
transfusion NN NN O
of NN NN O
whole NN NN O
blood NN NN O
. NN NN O

Glucose-6-phosphate NN NN O
dehydrogenase NN NN O
variants NN NN O
and NN NN O
their NN NN O
frequency NN NN O
in NN NN O
Guangdong NN NN O
, NN NN O
China NN NN O
. NN NN O

Homozygous NN NN O
and NN NN O
heterozygous NN NN O
deletions NN NN O
of NN NN O
the NN NN O
von NN NN B-Modifier
Willebrand NN NN I-Modifier
factor NN NN O
gene NN NN O
in NN NN O
patients NN NN O
and NN NN O
carriers NN NN O
of NN NN O
severe NN NN O
von NN NN B-SpecificDisease
Willebrand NN NN I-SpecificDisease
disease NN NN I-SpecificDisease
. NN NN O

Sjogren-Larsson NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Impaired NN NN O
fatty NN NN O
alcohol NN NN O
oxidation NN NN O
in NN NN O
cultured NN NN O
fibroblasts NN NN O
due NN NN O
to NN NN O
deficient NN NN O
fatty NN NN O
alcohol:nicotinamide NN NN O
adenine NN NN O
dinucleotide NN NN O
oxidoreductase NN NN O
activity NN NN O
. NN NN O

Germinal NN NN B-DiseaseClass
mosaicism NN NN I-DiseaseClass
in NN NN O
Duchenne NN NN B-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

Nebulin NN NN O
seen NN NN O
in NN NN O
DMD NN NN B-Modifier
males NN NN O
including NN NN O
one NN NN O
patient NN NN O
with NN NN O
a NN NN O
large NN NN O
DNA NN NN O
deletion NN NN O
encompassing NN NN O
the NN NN O
DMD NN NN B-Modifier
gene NN NN O
. NN NN O

Expression NN NN O
of NN NN O
the NN NN O
murine NN NN O
Duchenne NN NN B-Modifier
muscular NN NN I-Modifier
dystrophy NN NN I-Modifier
gene NN NN O
in NN NN O
muscle NN NN O
and NN NN O
brain NN NN O
. NN NN O

Glucose NN NN B-SpecificDisease
6-phosphate NN NN I-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
and NN NN O
incidence NN NN O
of NN NN O
hematologic NN NN B-DiseaseClass
malignancy NN NN I-DiseaseClass
. NN NN O

Hepatoblastoma NN NN B-SpecificDisease
, NN NN O
pigmented NN NN B-DiseaseClass
ocular NN NN I-DiseaseClass
fundus NN NN I-DiseaseClass
lesions NN NN I-DiseaseClass
and NN NN O
jaw NN NN B-DiseaseClass
lesions NN NN I-DiseaseClass
in NN NN O
Gardner NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Identification NN NN O
of NN NN O
an NN NN O
altered NN NN O
splice NN NN O
site NN NN O
in NN NN O
Ashkenazi NN NN O
Tay-Sachs NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
. NN NN O

X-linked NN NN B-SpecificDisease
glucose-6-phosphate NN NN I-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
in NN NN O
Mus NN NN O
musculus NN NN O
. NN NN O

Diverse NN NN O
point NN NN O
mutations NN NN O
in NN NN O
the NN NN O
human NN NN O
glucose-6-phosphate NN NN O
dehydrogenase NN NN O
gene NN NN O
cause NN NN O
enzyme NN NN B-DiseaseClass
deficiency NN NN I-DiseaseClass
and NN NN O
mild NN NN O
or NN NN O
severe NN NN O
hemolytic NN NN B-SpecificDisease
anemia NN NN I-SpecificDisease
. NN NN O

Tight NN NN O
linkage NN NN O
between NN NN O
myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
and NN NN O
apolipoprotein NN NN O
E NN NN O
genes NN NN O
revealed NN NN O
with NN NN O
allele-specific NN NN O
oligonucleotides NN NN O
. NN NN O

Regional NN NN O
localization NN NN O
of NN NN O
polymorphic NN NN O
DNA NN NN O
loci NN NN O
on NN NN O
the NN NN O
proximal NN NN O
long NN NN O
arm NN NN O
of NN NN O
the NN NN O
X NN NN O
chromosome NN NN O
using NN NN O
deletions NN NN O
associated NN NN O
with NN NN O
choroideremia NN NN B-SpecificDisease
. NN NN O

Retroviral-mediated NN NN O
gene NN NN O
transfer NN NN O
of NN NN O
human NN NN O
phenylalanine NN NN O
hydroxylase NN NN O
into NN NN O
NIH NN NN O
3T3 NN NN O
and NN NN O
hepatoma NN NN B-Modifier
cells NN NN O
. NN NN O

Estimation NN NN O
of NN NN O
the NN NN O
male NN NN O
to NN NN O
female NN NN O
ratio NN NN O
of NN NN O
mutation NN NN O
rates NN NN O
from NN NN O
the NN NN O
segregation NN NN O
of NN NN O
X-chromosomal NN NN O
DNA NN NN O
haplotypes NN NN O
in NN NN O
Duchenne NN NN B-Modifier
muscular NN NN I-Modifier
dystrophy NN NN I-Modifier
families NN NN O
. NN NN O

Deletions NN NN O
of NN NN O
a NN NN O
DNA NN NN O
sequence NN NN O
in NN NN O
retinoblastomas NN NN B-SpecificDisease
and NN NN O
mesenchymal NN NN B-DiseaseClass
tumors NN NN I-DiseaseClass
: NN NN O
organization NN NN O
of NN NN O
the NN NN O
sequence NN NN O
and NN NN O
its NN NN O
encoded NN NN O
protein NN NN O
. NN NN O

Treatment NN NN O
of NN NN O
Duchenne NN NN B-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
with NN NN O
growth NN NN O
hormone NN NN O
inhibitors NN NN O
. NN NN O

Identification NN NN O
and NN NN O
localization NN NN O
of NN NN O
mutations NN NN O
at NN NN O
the NN NN O
Lesch-Nyhan NN NN B-Modifier
locus NN NN O
by NN NN O
ribonuclease NN NN O
A NN NN O
cleavage NN NN O
. NN NN O

Two NN NN O
new NN NN O
variants NN NN O
of NN NN O
glucose-6-phosphate NN NN O
dehydrogenase NN NN O
associated NN NN O
with NN NN O
hereditary NN NN B-SpecificDisease
non-spherocytic NN NN I-SpecificDisease
hemolytic NN NN I-SpecificDisease
anemia NN NN I-SpecificDisease
: NN NN O
G6PD NN NN O
Wayne NN NN O
and NN NN O
G6PD NN NN O
Huron NN NN O
. NN NN O

Sialophorin NN NN O
, NN NN O
a NN NN O
surface NN NN O
sialoglycoprotein NN NN O
defective NN NN O
in NN NN O
the NN NN O
Wiskott-Aldrich NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
, NN NN O
is NN NN O
involved NN NN O
in NN NN O
human NN NN O
T NN NN O
lymphocyte NN NN O
proliferation NN NN O
. NN NN O

Hypopigmentation NN NN B-DiseaseClass
in NN NN O
the NN NN O
Prader-Willi NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Phenotype NN NN O
heterogeneity NN NN O
among NN NN O
hemizygotes NN NN O
in NN NN O
a NN NN O
family NN NN O
biochemically NN NN O
screened NN NN O
for NN NN O
adrenoleukodystrophy NN NN B-SpecificDisease
. NN NN O

The NN NN O
mapping NN NN O
of NN NN O
a NN NN O
cDNA NN NN O
from NN NN O
the NN NN O
human NN NN O
X-linked NN NN B-Modifier
Duchenne NN NN I-Modifier
muscular NN NN I-Modifier
dystrophy NN NN I-Modifier
gene NN NN O
to NN NN O
the NN NN O
mouse NN NN O
X NN NN O
chromosome NN NN O
. NN NN O

Localization NN NN O
of NN NN O
the NN NN O
region NN NN O
homologous NN NN O
to NN NN O
the NN NN O
Duchenne NN NN B-Modifier
muscular NN NN I-Modifier
dystrophy NN NN I-Modifier
locus NN NN O
on NN NN O
the NN NN O
mouse NN NN O
X NN NN O
chromosome NN NN O
. NN NN O

GT NN NN O
to NN NN O
AT NN NN O
transition NN NN O
at NN NN O
a NN NN O
splice NN NN O
donor NN NN O
site NN NN O
causes NN NN O
skipping NN NN O
of NN NN O
the NN NN O
preceding NN NN O
exon NN NN O
in NN NN O
phenylketonuria NN NN B-SpecificDisease
. NN NN O

Conservation NN NN O
of NN NN O
the NN NN O
Duchenne NN NN B-Modifier
muscular NN NN I-Modifier
dystrophy NN NN I-Modifier
gene NN NN O
in NN NN O
mice NN NN O
and NN NN O
humans NN NN O
. NN NN O

Familial NN NN O
Prader-Willi NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
with NN NN O
apparently NN NN O
normal NN NN O
chromosomes NN NN O
. NN NN O

Nebulin NN NN O
and NN NN O
titin NN NN O
expression NN NN O
in NN NN O
Duchenne NN NN B-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
appears NN NN O
normal NN NN O
. NN NN O

Heterozygous NN NN B-SpecificDisease
C2 NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
associated NN NN O
with NN NN O
angioedema NN NN B-SpecificDisease
, NN NN O
myasthenia NN NN B-SpecificDisease
gravis NN NN I-SpecificDisease
, NN NN O
and NN NN O
systemic NN NN B-SpecificDisease
lupus NN NN I-SpecificDisease
erythematosus NN NN I-SpecificDisease
. NN NN O

Genetic NN NN O
analysis NN NN O
of NN NN O
an NN NN O
inherited NN NN O
deficiency NN NN B-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
third NN NN I-SpecificDisease
component NN NN I-SpecificDisease
of NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
in NN NN O
Brittany NN NN O
spaniel NN NN O
dogs NN NN O
. NN NN O

Gene NN NN O
transfer NN NN O
and NN NN O
expression NN NN O
of NN NN O
human NN NN O
phenylalanine NN NN O
hydroxylase NN NN O
. NN NN O

Regional NN NN O
mapping NN NN O
of NN NN O
the NN NN O
phenylalanine NN NN O
hydroxylase NN NN O
gene NN NN O
and NN NN O
the NN NN O
phenylketonuria NN NN B-Modifier
locus NN NN O
in NN NN O
the NN NN O
human NN NN O
genome NN NN O
. NN NN O

Heterogeneity NN NN O
of NN NN O
type NN NN B-SpecificDisease
I NN NN I-SpecificDisease
von NN NN I-SpecificDisease
Willebrand NN NN I-SpecificDisease
disease NN NN I-SpecificDisease
: NN NN O
evidence NN NN O
for NN NN O
a NN NN O
subgroup NN NN O
with NN NN O
an NN NN O
abnormal NN NN O
von NN NN B-Modifier
Willebrand NN NN I-Modifier
factor NN NN O
. NN NN O

Genetic NN NN O
analysis NN NN O
in NN NN O
families NN NN O
with NN NN O
van NN NN B-SpecificDisease
der NN NN I-SpecificDisease
Woude NN NN I-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Hereditary NN NN B-SpecificDisease
C7 NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
. NN NN O

Diagnosis NN NN O
and NN NN O
HLA NN NN O
studies NN NN O
in NN NN O
a NN NN O
French-Canadian NN NN O
family NN NN O
. NN NN O

Genetic NN NN O
defect NN NN B-SpecificDisease
in NN NN I-SpecificDisease
secretion NN NN I-SpecificDisease
of NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
C5 NN NN I-SpecificDisease
in NN NN O
mice NN NN O
. NN NN O

Recurrent NN NN O
meningococcal NN NN B-SpecificDisease
meningitis NN NN I-SpecificDisease
with NN NN O
absence NN NN B-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
sixth NN NN I-SpecificDisease
component NN NN I-SpecificDisease
of NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
: NN NN O
an NN NN O
evaluation NN NN O
of NN NN O
underlying NN NN O
immunologic NN NN O
mechanisms NN NN O
. NN NN O

Deficiency NN NN B-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
fifth NN NN I-SpecificDisease
component NN NN I-SpecificDisease
of NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
in NN NN O
human NN NN O
subjects NN NN O
. NN NN O

Clinical NN NN O
, NN NN O
genetic NN NN O
and NN NN O
immunologic NN NN O
studies NN NN O
in NN NN O
a NN NN O
large NN NN O
kindred NN NN O
. NN NN O

Incidence NN NN O
and NN NN O
characteristics NN NN O
of NN NN O
glucose-6-phosphate NN NN O
dehydrogenase NN NN O
variants NN NN O
in NN NN O
Japan NN NN O
. NN NN O

Utilization NN NN O
of NN NN O
purines NN NN O
by NN NN O
an NN NN O
HPRT NN NN O
variant NN NN O
in NN NN O
an NN NN O
intelligent NN NN O
, NN NN O
nonmutilative NN NN O
patient NN NN O
with NN NN O
features NN NN O
of NN NN O
the NN NN O
Lesch-Nyhan NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Localisation NN NN O
of NN NN O
the NN NN O
Becker NN NN B-Modifier
muscular NN NN I-Modifier
dystrophy NN NN I-Modifier
gene NN NN O
on NN NN O
the NN NN O
short NN NN O
arm NN NN O
of NN NN O
the NN NN O
X NN NN O
chromosome NN NN O
by NN NN O
linkage NN NN O
to NN NN O
cloned NN NN O
DNA NN NN O
sequences NN NN O
. NN NN O

Molecular NN NN O
evidence NN NN O
for NN NN O
new NN NN O
mutation NN NN O
at NN NN O
the NN NN O
hprt NN NN O
locus NN NN O
in NN NN O
Lesch-Nyhan NN NN B-Modifier
patients NN NN O
. NN NN O

Allelic NN NN O
exclusion NN NN O
of NN NN O
glucose-6-phosphate NN NN O
dehydrogenase NN NN O
in NN NN O
platelets NN NN O
and NN NN O
T NN NN O
lymphocytes NN NN O
from NN NN O
a NN NN O
Wiskott-Aldrich NN NN B-Modifier
syndrome NN NN I-Modifier
carrier NN NN O
. NN NN O

Complement NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
and NN NN O
nephritis NN NN B-SpecificDisease
. NN NN O

A NN NN O
report NN NN O
of NN NN O
a NN NN O
family NN NN O
. NN NN O

Heterogeneity NN NN O
of NN NN O
glucose-6-phosphate NN NN B-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
in NN NN O
Algeria NN NN O
. NN NN O

Study NN NN O
in NN NN O
Northern NN NN O
Algeria NN NN O
with NN NN O
description NN NN O
of NN NN O
five NN NN O
new NN NN O
variants NN NN O
. NN NN O

Glucose-6-phosphate NN NN B-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
inhibits NN NN O
in NN NN O
vitro NN NN O
growth NN NN O
of NN NN O
Plasmodium NN NN O
falciparum NN NN O
. NN NN O

Bone NN NN O
marrow NN NN O
transplant NN NN O
in NN NN O
adrenoleukodystrophy NN NN B-SpecificDisease
. NN NN O

[Gd NN NN O
- NN NN O
allele NN NN O
distribution NN NN O
patterns NN NN O
in NN NN O
Azerbaijan NN NN O
. NN NN O

III NN NN O
. NN NN O

The NN NN O
identification NN NN O
of NN NN O
mutant NN NN O
forms NN NN O
of NN NN O
glucose-6-phosphate NN NN O
dehydrogenase] NN NN O

Adrenoleukodystrophy NN NN B-SpecificDisease
: NN NN O
survey NN NN O
of NN NN O
303 NN NN O
cases NN NN O
: NN NN O
biochemistry NN NN O
, NN NN O
diagnosis NN NN O
, NN NN O
and NN NN O
therapy NN NN O
. NN NN O

Genetic NN NN O
polymorphism NN NN O
of NN NN O
G6PD NN NN O
in NN NN O
a NN NN O
Bulgarian NN NN O
population NN NN O
. NN NN O

Clinical NN NN O
use NN NN O
of NN NN O
DNA NN NN O
markers NN NN O
linked NN NN O
to NN NN O
the NN NN O
gene NN NN O
for NN NN O
Duchenne NN NN B-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

Family NN NN O
studies NN NN O
in NN NN O
Bechterew's NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
( NN NN O
ankylosing NN NN B-SpecificDisease
spondylitis NN NN I-SpecificDisease
) NN NN O
III NN NN O
. NN NN O

Genetics NN NN O
. NN NN O

Prader-Willi NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
and NN NN O
chromosome NN NN O

15 NN NN O
. NN NN O
A NN NN O
clinical NN NN O
discussion NN NN O
of NN NN O
20 NN NN O
cases NN NN O
. NN NN O

The NN NN O
Tay-Sachs NN NN B-Modifier
disease NN NN I-Modifier
gene NN NN O
in NN NN O
North NN NN O
American NN NN O
Jewish NN NN O
populations NN NN O
: NN NN O
geographic NN NN O
variations NN NN O
and NN NN O
origin NN NN O
. NN NN O

Human NN NN O
deficiency NN NN B-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
sixth NN NN I-SpecificDisease
component NN NN I-SpecificDisease
of NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
in NN NN O
a NN NN O
patient NN NN O
with NN NN O
meningococcal NN NN B-SpecificDisease
meningitis NN NN I-SpecificDisease
and NN NN O
no NN NN O
haemostasis NN NN B-DiseaseClass
abnormality NN NN I-DiseaseClass
. NN NN O

Absence NN NN B-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
seventh NN NN I-SpecificDisease
component NN NN I-SpecificDisease
of NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
in NN NN O
a NN NN O
patient NN NN O
with NN NN O
chronic NN NN B-SpecificDisease
meningococcemia NN NN I-SpecificDisease
presenting NN NN O
as NN NN O
vasculitis NN NN B-SpecificDisease
. NN NN O

Familial NN NN B-SpecificDisease
discoid NN NN I-SpecificDisease
lupus NN NN I-SpecificDisease
erythematosus NN NN I-SpecificDisease
associated NN NN O
with NN NN O
heterozygote NN NN O
C2 NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
. NN NN O

Severe-glucose-6-phosphate NN NN B-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
( NN NN I-SpecificDisease
G6PD NN NN I-SpecificDisease
) NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
associated NN NN O
with NN NN O
chronic NN NN O
hemolytic NN NN B-SpecificDisease
anemia NN NN I-SpecificDisease
, NN NN O
granulocyte NN NN B-DiseaseClass
dysfunction NN NN I-DiseaseClass
, NN NN O
and NN NN O
increased NN NN O
susceptibility NN NN O
to NN NN O
infections NN NN O
: NN NN O
description NN NN O
of NN NN O
a NN NN O
new NN NN O
molecular NN NN O
variant NN NN O
( NN NN O
G6PD NN NN O
Barcelona NN NN O
). NN NN O

Glucose-6-phosphate NN NN B-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
in NN NN O
Papua NN NN O
New NN NN O
Guinea NN NN O
. NN NN O

The NN NN O
description NN NN O
of NN NN O
13 NN NN O
new NN NN O
variants NN NN O
. NN NN O

Heterogeneity NN NN O
of NN NN O
" NN NN O
Mediterranean NN NN O
type NN NN O
" NN NN O
glucose-6-phosphate NN NN B-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
( NN NN I-SpecificDisease
G6PD NN NN I-SpecificDisease
) NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
in NN NN O
Spain NN NN O
and NN NN O
description NN NN O
of NN NN O
two NN NN O
new NN NN O
variants NN NN O
associated NN NN O
with NN NN O
favism NN NN B-SpecificDisease
. NN NN O

A NN NN O
new NN NN O
glucose-6-phosphate NN NN O
dehydrogenase NN NN O
variant NN NN O
( NN NN O
G6PD NN NN O
Nagano NN NN O
) NN NN O
associated NN NN O
with NN NN O
congenital NN NN B-SpecificDisease
hemolytic NN NN I-SpecificDisease
anemia NN NN I-SpecificDisease
. NN NN O

Heterozygous NN NN O
C2-deficiency NN NN B-SpecificDisease
and NN NN O
myasthenia NN NN B-SpecificDisease
gravis NN NN I-SpecificDisease
. NN NN O

Adrenoleukodystrophy NN NN B-SpecificDisease
: NN NN O
increased NN NN O
plasma NN NN O
content NN NN O
of NN NN O
saturated NN NN O
very NN NN O
long NN NN O
chain NN NN O
fatty NN NN O
acids NN NN O
. NN NN O

Abnormal NN NN O
high NN NN O
density NN NN O
lipoproteins NN NN O
in NN NN O
cerebrotendinous NN NN B-SpecificDisease
xanthomatosis NN NN I-SpecificDisease
. NN NN O

Genetics NN NN O
of NN NN O
cerebrotendinous NN NN B-SpecificDisease
xanthomatosis NN NN I-SpecificDisease
( NN NN O
CTX NN NN B-SpecificDisease
): NN NN O
an NN NN O
autosomal NN NN O
recessive NN NN O
trait NN NN O
with NN NN O
high NN NN O
gene NN NN O
frequency NN NN O
in NN NN O
Sephardim NN NN O
of NN NN O
Moroccan NN NN O
origin NN NN O
. NN NN O

New NN NN O
genetic NN NN O
variants NN NN O
of NN NN O
glucose NN NN O
6-phosphate NN NN O
dehydrogenase NN NN O
( NN NN O
G6PD NN NN O
) NN NN O
in NN NN O
Italy NN NN O
. NN NN O

Variants NN NN O
of NN NN O
erythrocyte NN NN O
glucose-6-phosphate NN NN O
dehydrogenase NN NN O
( NN NN O
G6PD NN NN O
) NN NN O
in NN NN O
Bulgarian NN NN O
populations NN NN O
. NN NN O

Nephropathy NN NN B-SpecificDisease
in NN NN O
the NN NN O
Wiskott-Aldrich NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Wiskott-Aldrich NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
: NN NN O
cellular NN NN B-DiseaseClass
impairments NN NN I-DiseaseClass
and NN NN O
their NN NN O
implication NN NN O
for NN NN O
carrier NN NN O
detection NN NN O
. NN NN O

A NN NN O
new NN NN O
CT NN NN O
pattern NN NN O
in NN NN O
adrenoleukodystrophy NN NN B-SpecificDisease
. NN NN O

Further NN NN O
evidence NN NN O
for NN NN O
heterogeneity NN NN O
of NN NN O
glucose-6-phosphate NN NN B-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
in NN NN O
Papua NN NN O
New NN NN O
Guinea NN NN O
. NN NN O

Increased NN NN O
incidence NN NN O
of NN NN O
cataracts NN NN B-SpecificDisease
in NN NN O
male NN NN O
subjects NN NN O
deficient NN NN B-SpecificDisease
in NN NN I-SpecificDisease
glucose-6-phosphate NN NN I-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
. NN NN O

Molecular NN NN O
basis NN NN O
of NN NN O
human NN NN O
mitochondrial NN NN O
very-long-chain NN NN B-SpecificDisease
acyl-CoA NN NN I-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
causing NN NN O
cardiomyopathy NN NN B-SpecificDisease
and NN NN O
sudden NN NN B-SpecificDisease
death NN NN I-SpecificDisease
in NN NN O
childhood NN NN O
. NN NN O

Aberrant NN NN O
subcellular NN NN O
localization NN NN O
of NN NN O
BRCA1 NN NN O
in NN NN O
breast NN NN B-SpecificDisease
cancer NN NN I-SpecificDisease
. NN NN O

Mapping NN NN O
of NN NN O
the NN NN O
mouse NN NN O
homologue NN NN O
of NN NN O
the NN NN O
Wilson NN NN B-Modifier
disease NN NN I-Modifier
gene NN NN O
to NN NN O
mouse NN NN O
chromosome NN NN O
8 NN NN O
. NN NN O

Germline NN NN O
mutations NN NN O
of NN NN O
the NN NN O
BRCA1 NN NN O
gene NN NN O
in NN NN O
breast NN NN B-Modifier
and NN NN I-Modifier
ovarian NN NN I-Modifier
cancer NN NN I-Modifier
families NN NN O
provide NN NN O
evidence NN NN O
for NN NN O
a NN NN O
genotype-phenotype NN NN O
correlation NN NN O
. NN NN O

Hereditary NN NN O
deficiency NN NN B-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
seventh NN NN I-SpecificDisease
component NN NN I-SpecificDisease
of NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
and NN NN O
recurrent NN NN O
meningococcal NN NN B-SpecificDisease
infection NN NN I-SpecificDisease
: NN NN O
investigations NN NN O
of NN NN O
an NN NN O
Irish NN NN O
family NN NN O
using NN NN O
a NN NN O
novel NN NN O
haemolytic NN NN O
screening NN NN O
assay NN NN O
for NN NN O
complement NN NN O
activity NN NN O
and NN NN O
C7 NN NN O
M/N NN NN O
allotyping NN NN O
. NN NN O

Molecular NN NN O
basis NN NN O
of NN NN O
subtotal NN NN B-SpecificDisease
complement NN NN I-SpecificDisease
C6 NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
. NN NN O

A NN NN O
carboxy-terminally NN NN O
truncated NN NN O
but NN NN O
functionally NN NN O
active NN NN O
C6 NN NN O
. NN NN O

Myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
: NN NN O
evidence NN NN O
for NN NN O
a NN NN O
possible NN NN O
dominant-negative NN NN O
RNA NN NN O
mutation NN NN O
. NN NN O

A NN NN O
strong NN NN O
candidate NN NN O
for NN NN O
the NN NN O
breast NN NN B-Modifier
and NN NN I-Modifier
ovarian NN NN I-Modifier
cancer NN NN I-Modifier
susceptibility NN NN O
gene NN NN O
BRCA1 NN NN O
. NN NN O

Molecular NN NN O
characterization NN NN O
of NN NN O
galactosemia NN NN B-Modifier
( NN NN O
type NN NN O
1 NN NN O
) NN NN O
mutations NN NN O
in NN NN O
Japanese NN NN O
. NN NN O

Three NN NN O
novel NN NN O
aniridia NN NN B-Modifier
mutations NN NN O
in NN NN O
the NN NN O
human NN NN O
PAX6 NN NN O
gene NN NN O
. NN NN O

The NN NN O
carrier NN NN O
frequency NN NN O
of NN NN O
the NN NN O
BRCA1 NN NN O
185delAG NN NN O
mutation NN NN O
is NN NN O
approximately NN NN O
1 NN NN O
percent NN NN O
in NN NN O
Ashkenazi NN NN O
Jewish NN NN O
individuals NN NN O
. NN NN O

Identification NN NN O
and NN NN O
localization NN NN O
of NN NN O
huntingtin NN NN O
in NN NN O
brain NN NN O
and NN NN O
human NN NN O
lymphoblastoid NN NN O
cell NN NN O
lines NN NN O
with NN NN O
anti-fusion NN NN O
protein NN NN O
antibodies NN NN O
. NN NN O

Marked NN NN O
phenotypic NN NN O
heterogeneity NN NN O
associated NN NN O
with NN NN O
expansion NN NN O
of NN NN O
a NN NN O
CAG NN NN O
repeat NN NN O
sequence NN NN O
at NN NN O
the NN NN O
spinocerebellar NN NN B-Modifier
ataxia NN NN I-Modifier
3/Machado-Joseph NN NN I-Modifier
disease NN NN I-Modifier
locus NN NN O
. NN NN O

Overexpression NN NN O
of NN NN O
DM20 NN NN O
messenger NN NN O
RNA NN NN O
in NN NN O
two NN NN O
brothers NN NN O
with NN NN O
Pelizaeus-Merzbacher NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
. NN NN O

The NN NN O
Wiskott-Aldrich NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
and NN NN O
X-linked NN NN B-SpecificDisease
congenital NN NN I-SpecificDisease
thrombocytopenia NN NN I-SpecificDisease
are NN NN O
caused NN NN O
by NN NN O
mutations NN NN O
of NN NN O
the NN NN O
same NN NN O
gene NN NN O
. NN NN O

Myotonia NN NN B-SpecificDisease
levior NN NN I-SpecificDisease
is NN NN O
a NN NN O
chloride NN NN B-DiseaseClass
channel NN NN I-DiseaseClass
disorder NN NN I-DiseaseClass
. NN NN O

Southern NN NN O
analysis NN NN O
reveals NN NN O
a NN NN O
large NN NN O
deletion NN NN O
at NN NN O
the NN NN O
hypoxanthine NN NN O
phosphoribosyltransferase NN NN O
locus NN NN O
in NN NN O
a NN NN O
patient NN NN O
with NN NN O
Lesch-Nyhan NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Characterisation NN NN O
of NN NN O
molecular NN NN O
defects NN NN O
in NN NN O
X-linked NN NN B-SpecificDisease
amelogenesis NN NN I-SpecificDisease
imperfecta NN NN I-SpecificDisease
( NN NN O
AIH1 NN NN O
). NN NN O

Frequency NN NN O
of NN NN O
exon NN NN O
15 NN NN O
missense NN NN O
mutation NN NN O
( NN NN O
442D:G NN NN O
) NN NN O
in NN NN O
cholesteryl NN NN O
ester NN NN O
transfer NN NN O
protein NN NN O
gene NN NN O
in NN NN O
hyperalphalipoproteinemic NN NN B-Modifier
Japanese NN NN O
subjects NN NN O
. NN NN O

Mucopolysaccharidosis NN NN B-SpecificDisease
type NN NN I-SpecificDisease
IVA NN NN I-SpecificDisease
: NN NN O
common NN NN O
double NN NN O
deletion NN NN O
in NN NN O
the NN NN O
N-acetylgalactosamine-6-sulfatase NN NN O
gene NN NN O
( NN NN O
GALNS NN NN O
). NN NN O

Detection NN NN O
of NN NN O
eight NN NN O
BRCA1 NN NN O
mutations NN NN O
in NN NN O
10 NN NN O
breast/ovarian NN NN B-Modifier
cancer NN NN I-Modifier
families NN NN O
, NN NN O
including NN NN O
1 NN NN O
family NN NN O
with NN NN O
male NN NN B-SpecificDisease
breast NN NN I-SpecificDisease
cancer NN NN I-SpecificDisease
. NN NN O

Natural NN NN O
selection NN NN O
of NN NN O
hemi NN NN O
- NN NN O
and NN NN O
heterozygotes NN NN O
for NN NN O
G6PD NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
in NN NN O
Africa NN NN O
by NN NN O
resistance NN NN O
to NN NN O
severe NN NN O
malaria NN NN B-SpecificDisease
. NN NN O

The NN NN O
alveolar NN NN B-Modifier
rhabdomyosarcoma NN NN I-Modifier
PAX3/FKHR NN NN O
fusion NN NN O
protein NN NN O
is NN NN O
a NN NN O
transcriptional NN NN O
activator NN NN O
. NN NN O

A NN NN O
p16INK4a-insensitive NN NN O
CDK4 NN NN O
mutant NN NN O
targeted NN NN O
by NN NN O
cytolytic NN NN O
T NN NN O
lymphocytes NN NN O
in NN NN O
a NN NN O
human NN NN O
melanoma NN NN B-SpecificDisease
. NN NN O

Rapid NN NN O
detection NN NN O
of NN NN O
BRCA1 NN NN O
mutations NN NN O
by NN NN O
the NN NN O
protein NN NN O
truncation NN NN O
test NN NN O
. NN NN O

Cloning NN NN O
of NN NN O
human NN NN O
very-long-chain NN NN O
acyl-coenzyme NN NN O
A NN NN O
dehydrogenase NN NN O
and NN NN O
molecular NN NN O
characterization NN NN O
of NN NN O
its NN NN O
deficiency NN NN O
in NN NN O
two NN NN O
patients NN NN O
. NN NN O

Brain NN NN B-DiseaseClass
disease NN NN I-DiseaseClass
and NN NN O
molecular NN NN O
analysis NN NN O
in NN NN O
myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

Mutations NN NN O
in NN NN O
the NN NN O
gene NN NN O
for NN NN O
X-linked NN NN B-SpecificDisease
adrenoleukodystrophy NN NN I-SpecificDisease
in NN NN O
patients NN NN O
with NN NN O
different NN NN O
clinical NN NN O
phenotypes NN NN O
. NN NN O

Duchenne NN NN B-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
and NN NN O
myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
in NN NN O
the NN NN O
same NN NN O
patient NN NN O
. NN NN O

Age NN NN O
at NN NN O
diagnosis NN NN O
as NN NN O
an NN NN O
indicator NN NN O
of NN NN O
eligibility NN NN O
for NN NN O
BRCA1 NN NN O
DNA NN NN O
testing NN NN O
in NN NN O
familial NN NN B-SpecificDisease
breast NN NN I-SpecificDisease
cancer NN NN I-SpecificDisease
. NN NN O

Linkage NN NN O
analysis NN NN O
of NN NN O
26 NN NN O
Canadian NN NN O
breast NN NN B-Modifier
and NN NN I-Modifier
breast-ovarian NN NN I-Modifier
cancer NN NN I-Modifier
families NN NN O
. NN NN O

Structural NN NN O
analysis NN NN O
of NN NN O
the NN NN O
5 NN NN O
' NN NN O
region NN NN O
of NN NN O
mouse NN NN O
and NN NN O
human NN NN O
Huntington NN NN B-Modifier
disease NN NN I-Modifier
genes NN NN O
reveals NN NN O
conservation NN NN O
of NN NN O
putative NN NN O
promoter NN NN O
region NN NN O
and NN NN O
di NN NN O
- NN NN O
and NN NN O
trinucleotide NN NN O
polymorphisms NN NN O
. NN NN O

The NN NN O
protein NN NN O
deficient NN NN O
in NN NN O
Lowe NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
is NN NN O
a NN NN O
phosphatidylinositol-4,5-bisphosphate NN NN O
5-phosphatase NN NN O
. NN NN O

New NN NN O
founder NN NN O
haplotypes NN NN O
at NN NN O
the NN NN O
myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
locus NN NN O
in NN NN O
southern NN NN O
Africa NN NN O
. NN NN O

Discordant NN NN O
clinical NN NN O
outcome NN NN O
in NN NN O
myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
relatives NN NN O
showing NN NN O
( NN NN O
CTG)n NN NN O
> NN NN O
700 NN NN O
repeats NN NN O
. NN NN O

Purification NN NN O
of NN NN O
human NN NN O
very-long-chain NN NN O
acyl-coenzyme NN NN O
A NN NN O
dehydrogenase NN NN O
and NN NN O
characterization NN NN O
of NN NN O
its NN NN O
deficiency NN NN O
in NN NN O
seven NN NN O
patients NN NN O
. NN NN O

Hereditary NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
fifth NN NN I-SpecificDisease
component NN NN I-SpecificDisease
of NN NN I-SpecificDisease
complement NN NN I-SpecificDisease
in NN NN O
man NN NN O
. NN NN O

II NN NN O
. NN NN O

Biological NN NN O
properties NN NN O
of NN NN O
C5-deficient NN NN B-Modifier
human NN NN O
serum NN NN O
. NN NN O

Human NN NN O
peroxisomal NN NN O
targeting NN NN O
signal-1 NN NN O
receptor NN NN O
restores NN NN O
peroxisomal NN NN O
protein NN NN O
import NN NN O
in NN NN O
cells NN NN O
from NN NN O
patients NN NN O
with NN NN O
fatal NN NN O
peroxisomal NN NN B-DiseaseClass
disorders NN NN I-DiseaseClass
. NN NN O

Spectrum NN NN O
of NN NN O
germline NN NN O
mutations NN NN O
in NN NN O
the NN NN O
RB1 NN NN O
gene NN NN O
: NN NN O
a NN NN O
study NN NN O
of NN NN O
232 NN NN O
patients NN NN O
with NN NN O
hereditary NN NN B-CompositeMention
and NN NN I-CompositeMention
non NN NN I-CompositeMention
hereditary NN NN I-CompositeMention
retinoblastoma NN NN I-CompositeMention
. NN NN O

Aniridia NN NN B-Modifier
- NN NN O
associated NN NN O
cytogenetic NN NN O
rearrangements NN NN O
suggest NN NN O
that NN NN O
a NN NN O
position NN NN O
effect NN NN O
may NN NN O
cause NN NN O
the NN NN O
mutant NN NN O
phenotype NN NN O
. NN NN O

Somatic NN NN O
mutations NN NN O
in NN NN O
the NN NN O
BRCA1 NN NN O
gene NN NN O
in NN NN O
sporadic NN NN B-SpecificDisease
ovarian NN NN I-SpecificDisease
tumours NN NN I-SpecificDisease
. NN NN O

Decreased NN NN O
expression NN NN O
of NN NN O
BRCA1 NN NN O
accelerates NN NN O
growth NN NN O
and NN NN O
is NN NN O
often NN NN O
present NN NN O
during NN NN O
sporadic NN NN B-Modifier
breast NN NN I-Modifier
cancer NN NN I-Modifier
progression NN NN O
. NN NN O

Additional NN NN O
case NN NN O
of NN NN O
female NN NN O
monozygotic NN NN O
twins NN NN O
discordant NN NN O
for NN NN O
the NN NN O
clinical NN NN O
manifestations NN NN O
of NN NN O
Duchenne NN NN B-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
due NN NN O
to NN NN O
opposite NN NN O
X-chromosome NN NN O
inactivation NN NN O
. NN NN O

X-linked NN NN B-SpecificDisease
adrenoleukodystrophy NN NN I-SpecificDisease
( NN NN O
ALD NN NN B-SpecificDisease
): NN NN O
a NN NN O
novel NN NN O
mutation NN NN O
of NN NN O
the NN NN O
ALD NN NN B-Modifier
gene NN NN O
in NN NN O
6 NN NN O
members NN NN O
of NN NN O
a NN NN O
family NN NN O
presenting NN NN O
with NN NN O
5 NN NN O
different NN NN O
phenotypes NN NN O
. NN NN O

Novel NN NN O
mutation NN NN O
at NN NN O
the NN NN O
initiation NN NN O
codon NN NN O
in NN NN O
the NN NN O
Norrie NN NN B-Modifier
disease NN NN I-Modifier
gene NN NN O
in NN NN O
two NN NN O
Japanese NN NN O
families NN NN O
. NN NN O

Anticipation NN NN O
resulting NN NN O
in NN NN O
elimination NN NN O
of NN NN O
the NN NN O
myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
gene NN NN O
: NN NN O
a NN NN O
follow NN NN O
up NN NN O
study NN NN O
of NN NN O
one NN NN O
extended NN NN O
family NN NN O
. NN NN O

The NN NN O
gene NN NN O
for NN NN O
spinal NN NN B-Modifier
cerebellar NN NN I-Modifier
ataxia NN NN I-Modifier
3 NN NN O
( NN NN O
SCA3 NN NN O
) NN NN O
is NN NN O
located NN NN O
in NN NN O
a NN NN O
region NN NN O
of NN NN O
approximately NN NN O
3 NN NN O
cM NN NN O
on NN NN O
chromosome NN NN O
14q24.3-q32.2 NN NN O
. NN NN O

An NN NN O
evaluation NN NN O
of NN NN O
genetic NN NN O
heterogeneity NN NN O
in NN NN O
145 NN NN O
breast-ovarian NN NN B-Modifier
cancer NN NN I-Modifier
families NN NN O
. NN NN O

Breast NN NN B-Modifier
Cancer NN NN I-Modifier
Linkage NN NN O
Consortium NN NN O
. NN NN O

Molecular NN NN O
basis NN NN O
of NN NN O
essential NN NN B-SpecificDisease
fructosuria NN NN I-SpecificDisease
: NN NN O
molecular NN NN O
cloning NN NN O
and NN NN O
mutational NN NN O
analysis NN NN O
of NN NN O
human NN NN O
ketohexokinase NN NN O

( NN NN O
fructokinase NN NN O
). NN NN O

Homozygous NN NN O
presence NN NN O
of NN NN O
the NN NN O
crossover NN NN O
( NN NN O
fusion NN NN O
gene NN NN O
) NN NN O
mutation NN NN O
identified NN NN O
in NN NN O
a NN NN O
type NN NN B-Modifier
II NN NN I-Modifier
Gaucher NN NN I-Modifier
disease NN NN I-Modifier
fetus NN NN O
: NN NN O
is NN NN O
this NN NN O
analogous NN NN O
to NN NN O
the NN NN O
Gaucher NN NN O
knock-out NN NN O
mouse NN NN O
model NN NN O
? NN NN O

Late NN NN O
infantile NN NN O
metachromatic NN NN B-SpecificDisease
leukodystrophy NN NN I-SpecificDisease
in NN NN O
Israel NN NN O
. NN NN O

A NN NN O
single NN NN O
amino NN NN O
acid NN NN O
substitution NN NN O
( NN NN O
G103D NN NN O
) NN NN O
in NN NN O
the NN NN O
type NN NN O
II NN NN O
collagen NN NN O
triple NN NN O
helix NN NN O
produces NN NN O
Kniest NN NN B-SpecificDisease
dysplasia NN NN I-SpecificDisease
. NN NN O

CAG NN NN O
expansions NN NN O
in NN NN O
a NN NN O
novel NN NN O
gene NN NN O
for NN NN O
Machado-Joseph NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
at NN NN O
chromosome NN NN O
14q32.1 NN NN O
. NN NN O

Mutations NN NN O
in NN NN O
the NN NN O
BRCA1 NN NN O
gene NN NN O
in NN NN O
families NN NN O
with NN NN O
early-onset NN NN O
breast NN NN B-CompositeMention
and NN NN I-CompositeMention
ovarian NN NN I-CompositeMention
cancer NN NN I-CompositeMention
. NN NN O

Confirmation NN NN O
of NN NN O
BRCA1 NN NN O
by NN NN O
analysis NN NN O
of NN NN O
germline NN NN O
mutations NN NN O
linked NN NN O
to NN NN O
breast NN NN B-CompositeMention
and NN NN I-CompositeMention
ovarian NN NN I-CompositeMention
cancer NN NN I-CompositeMention
in NN NN O
ten NN NN O
families NN NN O
. NN NN O

High NN NN O
resolution NN NN O
genetic NN NN O
analysis NN NN O
suggests NN NN O
one NN NN O
ancestral NN NN O
predisposing NN NN O
haplotype NN NN O
for NN NN O
the NN NN O
origin NN NN O
of NN NN O
the NN NN O
myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
mutation NN NN O
. NN NN O

Genetic NN NN O
instability NN NN O
in NN NN O
human NN NN O
ovarian NN NN B-Modifier
cancer NN NN I-Modifier
cell NN NN O
lines NN NN O
. NN NN O

BRCA1 NN NN O
mutations NN NN O
in NN NN O
primary NN NN O
breast NN NN B-CompositeMention
and NN NN I-CompositeMention
ovarian NN NN I-CompositeMention
carcinomas NN NN I-CompositeMention
. NN NN O

PAX6 NN NN O
gene NN NN O
dosage NN NN O
effect NN NN O
in NN NN O
a NN NN O
family NN NN O
with NN NN O
congenital NN NN B-SpecificDisease
cataracts NN NN I-SpecificDisease
, NN NN O
aniridia NN NN B-SpecificDisease
, NN NN O
anophthalmia NN NN B-SpecificDisease
and NN NN O
central NN NN B-DiseaseClass
nervous NN NN I-DiseaseClass
system NN NN I-DiseaseClass
defects NN NN I-DiseaseClass
. NN NN O

A NN NN O
physical NN NN O
map NN NN O
and NN NN O
candidate NN NN O
genes NN NN O
in NN NN O
the NN NN O
BRCA1 NN NN O
region NN NN O
on NN NN O
chromosome NN NN O
17q12-21 NN NN O
. NN NN O

The NN NN O
LEC NN NN O
rat NN NN O
has NN NN O
a NN NN O
deletion NN NN O
in NN NN O
the NN NN O
copper NN NN O
transporting NN NN O
ATPase NN NN O
gene NN NN O
homologous NN NN O
to NN NN O
the NN NN O
Wilson NN NN B-Modifier
disease NN NN I-Modifier
gene NN NN O
. NN NN O

Genomic NN NN O
organization NN NN O
of NN NN O
the NN NN O
adrenoleukodystrophy NN NN B-Modifier
gene NN NN O
. NN NN O

The NN NN O
murine NN NN O
homologues NN NN O
of NN NN O
the NN NN O
Huntington NN NN B-Modifier
disease NN NN I-Modifier
gene NN NN O
( NN NN O
Hdh NN NN O
) NN NN O
and NN NN O
the NN NN O
alpha-adducin NN NN O
gene NN NN O
( NN NN O
Add1 NN NN O
) NN NN O
map NN NN O
to NN NN O
mouse NN NN O
chromosome NN NN O
5 NN NN O
within NN NN O
a NN NN O
region NN NN O
of NN NN O
conserved NN NN O
synteny NN NN O
with NN NN O
human NN NN O
chromosome NN NN O
4p16.3 NN NN O
. NN NN O

Genetic NN NN O
cholesteryl NN NN B-SpecificDisease
ester NN NN I-SpecificDisease
transfer NN NN I-SpecificDisease
protein NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
caused NN NN O
by NN NN O
two NN NN O
prevalent NN NN O
mutations NN NN O
as NN NN O
a NN NN O
major NN NN O
determinant NN NN O
of NN NN O
increased NN NN O
levels NN NN O
of NN NN O
high NN NN O
density NN NN O
lipoprotein NN NN O
cholesterol NN NN O
. NN NN O

Treatment NN NN O
of NN NN O
cerebrotendinous NN NN B-SpecificDisease
xanthomatosis NN NN I-SpecificDisease
: NN NN O
effects NN NN O
of NN NN O
chenodeoxycholic NN NN O
acid NN NN O
, NN NN O
pravastatin NN NN O
, NN NN O
and NN NN O
combined NN NN O
use NN NN O
. NN NN O

Mutation NN NN O
spectrum NN NN O
in NN NN O
the NN NN O
CHM NN NN B-Modifier
gene NN NN O
of NN NN O
Danish NN NN O
and NN NN O
Swedish NN NN O
choroideremia NN NN B-Modifier
patients NN NN O
. NN NN O

Predominance NN NN O
of NN NN O
the NN NN O
adrenomyeloneuropathy NN NN B-Modifier
phenotype NN NN O
of NN NN O
X-linked NN NN B-SpecificDisease
adrenoleukodystrophy NN NN I-SpecificDisease
in NN NN O
The NN NN O
Netherlands NN NN O
: NN NN O
a NN NN O
survey NN NN O
of NN NN O
30 NN NN O
kindreds NN NN O
. NN NN O

Adrenoleukodystrophy NN NN B-Modifier
gene NN NN O
encodes NN NN O
an NN NN O
80 NN NN O
kDa NN NN O
membrane NN NN O
protein NN NN O
. NN NN O

Isolation NN NN O
of NN NN O
the NN NN O
gene NN NN O
for NN NN O
McLeod NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
that NN NN O
encodes NN NN O
a NN NN O
novel NN NN O
membrane NN NN O
transport NN NN O
protein NN NN O
. NN NN O

X-linked NN NN B-SpecificDisease
spastic NN NN I-SpecificDisease
paraplegia NN NN I-SpecificDisease
and NN NN O
Pelizaeus-Merzbacher NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
are NN NN O
allelic NN NN B-DiseaseClass
disorders NN NN I-DiseaseClass
at NN NN O
the NN NN O
proteolipid NN NN O
protein NN NN O
locus NN NN O
. NN NN O

Canavan NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
: NN NN O
mutations NN NN O
among NN NN O
Jewish NN NN O
and NN NN O
non-Jewish NN NN O
patients NN NN O
. NN NN O

Intelligence NN NN O
quotient NN NN O
profile NN NN O
in NN NN O
myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
, NN NN O
intergenerational NN NN O
deficit NN NN O
, NN NN O
and NN NN O
correlation NN NN O
with NN NN O
CTG NN NN O
amplification NN NN O
. NN NN O

Adenomatous NN NN B-SpecificDisease
polyposis NN NN I-SpecificDisease
coli NN NN I-SpecificDisease
and NN NN O
a NN NN O
cytogenetic NN NN O
deletion NN NN O
of NN NN O
chromosome NN NN O
5 NN NN O
resulting NN NN O
from NN NN O
a NN NN O
maternal NN NN O
intrachromosomal NN NN O
insertion NN NN O
. NN NN O

Familial NN NN B-SpecificDisease
male NN NN I-SpecificDisease
breast NN NN I-SpecificDisease
cancer NN NN I-SpecificDisease
is NN NN O
not NN NN O
linked NN NN O
to NN NN O
the NN NN O
BRCA1 NN NN O
locus NN NN O
on NN NN O
chromosome NN NN O
17q NN NN O
. NN NN O

The NN NN O
EWS NN NN O
gene NN NN O
, NN NN O
involved NN NN O
in NN NN O
Ewing NN NN B-DiseaseClass
family NN NN I-DiseaseClass
of NN NN I-DiseaseClass
tumors NN NN I-DiseaseClass
, NN NN O
malignant NN NN B-DiseaseClass
melanoma NN NN I-DiseaseClass
of NN NN I-DiseaseClass
soft NN NN I-DiseaseClass
parts NN NN I-DiseaseClass
and NN NN O
desmoplastic NN NN B-SpecificDisease
small NN NN I-SpecificDisease
round NN NN I-SpecificDisease
cell NN NN I-SpecificDisease
tumors NN NN I-SpecificDisease
, NN NN O
codes NN NN O
for NN NN O
an NN NN O
RNA NN NN O
binding NN NN O
protein NN NN O
with NN NN O
novel NN NN O
regulatory NN NN O
domains NN NN O
. NN NN O

Canavan NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
: NN NN O
genomic NN NN O
organization NN NN O
and NN NN O
localization NN NN O
of NN NN O
human NN NN O
ASPA NN NN O
to NN NN O
17p13-ter NN NN O
and NN NN O
conservation NN NN O
of NN NN O
the NN NN O
ASPA NN NN O
gene NN NN O
during NN NN O
evolution NN NN O
. NN NN O

Myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
: NN NN O
size NN NN O
- NN NN O
and NN NN O
sex-dependent NN NN O
dynamics NN NN O
of NN NN O
CTG NN NN O
meiotic NN NN O
instability NN NN O
, NN NN O
and NN NN O
somatic NN NN O
mosaicism NN NN O
. NN NN O

Illegitimate NN NN O
transcription NN NN O
of NN NN O
the NN NN O
phenylalanine NN NN O
hydroxylase NN NN O
gene NN NN O
in NN NN O
lymphocytes NN NN O
for NN NN O
identification NN NN O
of NN NN O
mutations NN NN O
in NN NN O
phenylketonuria NN NN B-SpecificDisease
. NN NN O

High NN NN O
residual NN NN O
arylsulfatase NN NN O
A NN NN O
( NN NN O
ARSA NN NN O
) NN NN O
activity NN NN O
in NN NN O
a NN NN O
patient NN NN O
with NN NN O
late-infantile NN NN B-SpecificDisease
metachromatic NN NN I-SpecificDisease
leukodystrophy NN NN I-SpecificDisease
. NN NN O

An NN NN O
arylsulfatase NN NN O
A NN NN O
( NN NN O
ARSA NN NN O
) NN NN O
missense NN NN O
mutation NN NN O
( NN NN O
T274M NN NN O
) NN NN O
causing NN NN O
late-infantile NN NN B-SpecificDisease
metachromatic NN NN I-SpecificDisease
leukodystrophy NN NN I-SpecificDisease
. NN NN O

Mutations NN NN O
in NN NN O
the NN NN O
PAX6 NN NN O
gene NN NN O
in NN NN O
patients NN NN O
with NN NN O
hereditary NN NN O
aniridia NN NN B-SpecificDisease
. NN NN O

Three NN NN O
novel NN NN O
mutations NN NN O
in NN NN O
five NN NN O
unrelated NN NN O
subjects NN NN O
with NN NN O
hereditary NN NN O
protein NN NN B-SpecificDisease
S NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
type NN NN I-SpecificDisease
I NN NN I-SpecificDisease
. NN NN O

Characteristics NN NN O
of NN NN O
intergenerational NN NN O
contractions NN NN O
of NN NN O
the NN NN O
CTG NN NN O
repeat NN NN O
in NN NN O
myotonic NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

Gonosomal NN NN O
mosaicism NN NN O
in NN NN O
myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
patients NN NN O
: NN NN O
involvement NN NN O
of NN NN O
mitotic NN NN O
events NN NN O
in NN NN O
( NN NN O
CTG)n NN NN O
repeat NN NN O
variation NN NN O
and NN NN O
selection NN NN O
against NN NN O
extreme NN NN O
expansion NN NN O
in NN NN O
sperm NN NN O
. NN NN O

Regionally NN NN O
clustered NN NN O
APC NN NN B-Modifier
mutations NN NN O
are NN NN O
associated NN NN O
with NN NN O
a NN NN O
severe NN NN O
phenotype NN NN O
and NN NN O
occur NN NN O
at NN NN O
a NN NN O
high NN NN O
frequency NN NN O
in NN NN O
new NN NN O
mutation NN NN O
cases NN NN O
of NN NN O
adenomatous NN NN B-SpecificDisease
polyposis NN NN I-SpecificDisease
coli NN NN I-SpecificDisease
. NN NN O

Mutations NN NN O
at NN NN O
the NN NN O
PAX6 NN NN O
locus NN NN O
are NN NN O
found NN NN O
in NN NN O
heterogeneous NN NN O
anterior NN NN B-DiseaseClass
segment NN NN I-DiseaseClass
malformations NN NN I-DiseaseClass
including NN NN O
Peters NN NN B-SpecificDisease
' NN NN I-SpecificDisease
anomaly NN NN I-SpecificDisease
. NN NN O

Huntington NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
without NN NN O
CAG NN NN O
expansion NN NN O
: NN NN O
phenocopies NN NN O
or NN NN O
errors NN NN O
in NN NN O
assignment NN NN O
? NN NN O

Frequent NN NN O
detection NN NN O
of NN NN O
codon NN NN O
877 NN NN O
mutation NN NN O
in NN NN O
the NN NN O
androgen NN NN O
receptor NN NN O
gene NN NN O
in NN NN O
advanced NN NN B-SpecificDisease
prostate NN NN I-SpecificDisease
cancers NN NN I-SpecificDisease
. NN NN O

The NN NN O
human NN NN O
gene NN NN O
for NN NN O
alkaptonuria NN NN B-SpecificDisease
( NN NN O
AKU NN NN B-SpecificDisease
) NN NN O
maps NN NN O
to NN NN O
chromosome NN NN O
3q NN NN O
. NN NN O

Structure NN NN O
of NN NN O
the NN NN O
human NN NN O
Na+/glucose NN NN O
cotransporter NN NN O
gene NN NN O
SGLT1 NN NN O
. NN NN O

Four NN NN O
novel NN NN O
PEPD NN NN O
alleles NN NN O
causing NN NN O
prolidase NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
. NN NN O

Recombinations NN NN O
in NN NN O
individuals NN NN O
homozygous NN NN O
by NN NN O
descent NN NN O
localize NN NN O
the NN NN O
Friedreich NN NN B-SpecificDisease
ataxia NN NN I-SpecificDisease
locus NN NN O
in NN NN O
a NN NN O
cloned NN NN O
450-kb NN NN O
interval NN NN O
. NN NN O

Investigation NN NN O
of NN NN O
thermoregulatory NN NN O
characteristics NN NN O
in NN NN O
patients NN NN O
with NN NN O
Prader-Willi NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Phenotypic NN NN O
variation NN NN O
including NN NN O
retinitis NN NN B-SpecificDisease
pigmentosa NN NN I-SpecificDisease
, NN NN O
pattern NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
, NN NN O
and NN NN O
fundus NN NN B-SpecificDisease
flavimaculatus NN NN I-SpecificDisease
in NN NN O
a NN NN O
single NN NN O
family NN NN O
with NN NN O
a NN NN O
deletion NN NN O
of NN NN O
codon NN NN O
153 NN NN O
or NN NN O
154 NN NN O
of NN NN O
the NN NN O
peripherin/RDS NN NN O
gene NN NN O
. NN NN O

Assignment NN NN O
of NN NN O
the NN NN O
human NN NN O
Na+/glucose NN NN O
cotransporter NN NN O
gene NN NN O
SGLT1 NN NN O
to NN NN O
chromosome NN NN O
22q13.1 NN NN O
. NN NN O

Restriction NN NN O
of NN NN O
ocular NN NN O
fundus NN NN O
lesions NN NN O
to NN NN O
a NN NN O
specific NN NN O
subgroup NN NN O
of NN NN O
APC NN NN B-Modifier
mutations NN NN O
in NN NN O
adenomatous NN NN B-Modifier
polyposis NN NN I-Modifier
coli NN NN I-Modifier
patients NN NN O
. NN NN O

The NN NN O
effects NN NN O
of NN NN O
dystrophin NN NN O
gene NN NN O
mutations NN NN O
on NN NN O
the NN NN O
ERG NN NN O
in NN NN O
mice NN NN O
and NN NN O
humans NN NN O
. NN NN O

Association NN NN O
of NN NN O
the NN NN O
APC NN NN B-Modifier
tumor NN NN I-Modifier
suppressor NN NN O
protein NN NN O
with NN NN O
catenins NN NN O
. NN NN O

Difference NN NN O
in NN NN O
methylation NN NN O
patterns NN NN O
within NN NN O
the NN NN O
D15S9 NN NN O
region NN NN O
of NN NN O
chromosome NN NN O
15q11-13 NN NN O
in NN NN O
first NN NN O
cousins NN NN O
with NN NN O
Angelman NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
and NN NN O
Prader-Willi NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
. NN NN O

Haplotype NN NN O
studies NN NN O
in NN NN O
Wilson NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
. NN NN O

Genetic NN NN O
analysis NN NN O
of NN NN O
the NN NN O
BRCA1 NN NN O
region NN NN O
in NN NN O
a NN NN O
large NN NN O
breast/ovarian NN NN O
family NN NN O
: NN NN O
refinement NN NN O
of NN NN O
the NN NN O
minimal NN NN O
region NN NN O
containing NN NN O
BRCA1 NN NN O
. NN NN O

Myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
kinase NN NN O
is NN NN O
a NN NN O
component NN NN O
of NN NN O
neuromuscular NN NN O
junctions NN NN O
. NN NN O

Markedly NN NN O
accelerated NN NN O
catabolism NN NN O
of NN NN O
apolipoprotein NN NN O
A-II NN NN O
( NN NN O
ApoA-II NN NN O
) NN NN O
and NN NN O
high NN NN O
density NN NN O
lipoproteins NN NN O
containing NN NN O
ApoA-II NN NN O
in NN NN O
classic NN NN O
lecithin NN NN O
: NN NN O
cholesterol NN NN B-SpecificDisease
acyltransferase NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
and NN NN O
fish-eye NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
. NN NN O

X NN NN B-SpecificDisease
linked NN NN I-SpecificDisease
recessive NN NN I-SpecificDisease
thrombocytopenia NN NN I-SpecificDisease
. NN NN O

Macular NN NN B-SpecificDisease
dystrophy NN NN I-SpecificDisease
associated NN NN O
with NN NN O
mutations NN NN O
at NN NN O
codon NN NN O
172 NN NN O
in NN NN O
the NN NN O
human NN NN O
retinal NN NN B-Modifier
degeneration NN NN I-Modifier
slow NN NN O
gene NN NN O
. NN NN O

Anonymous NN NN O
marker NN NN O
loci NN NN O
within NN NN O
400 NN NN O
kb NN NN O
of NN NN O
HLA-A NN NN O
generate NN NN O
haplotypes NN NN O
in NN NN O
linkage NN NN O
disequilibrium NN NN O
with NN NN O
the NN NN O
hemochromatosis NN NN B-Modifier
gene NN NN O
( NN NN O
HFE NN NN O
) NN NN O

Genomic NN NN O
structure NN NN O
of NN NN O
the NN NN O
EWS NN NN O
gene NN NN O
and NN NN O
its NN NN O
relationship NN NN O
to NN NN O
EWSR1 NN NN O
, NN NN O
a NN NN O
site NN NN O
of NN NN O
tumor NN NN B-Modifier
- NN NN O
associated NN NN O
chromosome NN NN O
translocation NN NN O
. NN NN O

Norrie NN NN B-Modifier
disease NN NN I-Modifier
gene NN NN O
: NN NN O
characterization NN NN O
of NN NN O
deletions NN NN O
and NN NN O
possible NN NN O
function NN NN O
. NN NN O

The NN NN O
normal NN NN O
Huntington NN NN B-Modifier
disease NN NN I-Modifier
( NN NN O
HD NN NN B-Modifier
) NN NN O
allele NN NN O
, NN NN O
or NN NN O
a NN NN O
closely NN NN O
linked NN NN O
gene NN NN O
, NN NN O
influences NN NN O
age NN NN O
at NN NN O
onset NN NN O
of NN NN O
HD NN NN B-SpecificDisease
. NN NN O

Further NN NN O
investigation NN NN O
of NN NN O
the NN NN O
HEXA NN NN O
gene NN NN O
intron NN NN O
9 NN NN O
donor NN NN O
splice NN NN O
site NN NN O
mutation NN NN O
frequently NN NN O
found NN NN O
in NN NN O
non-Jewish NN NN O
Tay-Sachs NN NN B-Modifier
disease NN NN I-Modifier
patients NN NN O
from NN NN O
the NN NN O
British NN NN O
Isles NN NN O
. NN NN O

Molecular NN NN O
mechanisms NN NN O
of NN NN O
oncogenic NN NN O
mutations NN NN O
in NN NN O
tumors NN NN B-DiseaseClass
from NN NN O
patients NN NN O
with NN NN O
bilateral NN NN B-CompositeMention
and NN NN I-CompositeMention
unilateral NN NN I-CompositeMention
retinoblastoma NN NN I-CompositeMention
. NN NN O

PAX6 NN NN O
mutations NN NN O
in NN NN O
aniridia NN NN B-SpecificDisease
. NN NN O

Detection NN NN O
of NN NN O
a NN NN O
novel NN NN O
arginine NN NN O
vasopressin NN NN O
defect NN NN O
by NN NN O
dideoxy NN NN O
fingerprinting NN NN O
. NN NN O

Germinal NN NN O
mosaicism NN NN O
in NN NN O
a NN NN O
Duchenne NN NN B-Modifier
muscular NN NN I-Modifier
dystrophy NN NN I-Modifier
family NN NN O
: NN NN O
implications NN NN O
for NN NN O
genetic NN NN O
counselling NN NN O
. NN NN O

Genetic NN NN O
mapping NN NN O
of NN NN O
the NN NN O
breast-ovarian NN NN B-DiseaseClass
cancer NN NN I-DiseaseClass
syndrome NN NN I-DiseaseClass
to NN NN O
a NN NN O
small NN NN O
interval NN NN O
on NN NN O
chromosome NN NN O
17q12-21 NN NN O
: NN NN O
exclusion NN NN O
of NN NN O
candidate NN NN O
genes NN NN O
EDH17B2 NN NN O
and NN NN O
RARA NN NN O
. NN NN O

A NN NN O
missense NN NN O
mutation NN NN O
in NN NN O
the NN NN O
cholesteryl NN NN O
ester NN NN O
transfer NN NN O
protein NN NN O
gene NN NN O
with NN NN O
possible NN NN O
dominant NN NN O
effects NN NN O
on NN NN O
plasma NN NN O
high NN NN O
density NN NN O
lipoproteins NN NN O
. NN NN O

Familial NN NN B-SpecificDisease
Mediterranean NN NN I-SpecificDisease
fever NN NN I-SpecificDisease
in NN NN O
the NN NN O
colchicine NN NN O
era NN NN O
: NN NN O
the NN NN O
fate NN NN O
of NN NN O
one NN NN O
family NN NN O
. NN NN O

Detection NN NN O
of NN NN O
a NN NN O
new NN NN O
submicroscopic NN NN O
Norrie NN NN B-Modifier
disease NN NN I-Modifier
deletion NN NN O
interval NN NN O
with NN NN O
a NN NN O
novel NN NN O
DNA NN NN O
probe NN NN O
isolated NN NN O
by NN NN O
differential NN NN O
Alu NN NN O
PCR NN NN O
fingerprint NN NN O
cloning NN NN O
. NN NN O

Putative NN NN O
X-linked NN NN B-Modifier
adrenoleukodystrophy NN NN I-Modifier
gene NN NN O
shares NN NN O
unexpected NN NN O
homology NN NN O
with NN NN O
ABC NN NN O
transporters NN NN O
. NN NN O

Targeted NN NN O
modification NN NN O
of NN NN O
the NN NN O
apolipoprotein NN NN O
B NN NN O
gene NN NN O
results NN NN O
in NN NN O
hypobetalipoproteinemia NN NN B-SpecificDisease
and NN NN O
developmental NN NN B-DiseaseClass
abnormalities NN NN I-DiseaseClass
in NN NN O
mice NN NN O
. NN NN O

A NN NN O
novel NN NN O
disease NN NN O
with NN NN O
deficiency NN NN B-SpecificDisease
of NN NN I-SpecificDisease
mitochondrial NN NN I-SpecificDisease
very-long-chain NN NN I-SpecificDisease
acyl-CoA NN NN I-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
. NN NN O

Molecular NN NN O
characterization NN NN O
of NN NN O
glucose-6-phosphate NN NN B-SpecificDisease
dehydrogenase NN NN I-SpecificDisease
( NN NN I-SpecificDisease
G6PD NN NN I-SpecificDisease
) NN NN I-SpecificDisease
deficiency NN NN I-SpecificDisease
in NN NN O
patients NN NN O
of NN NN O
Chinese NN NN O
descent NN NN O
and NN NN O
identification NN NN O
of NN NN O
new NN NN O
base NN NN O
substitutions NN NN O
in NN NN O
the NN NN O
human NN NN O
G6PD NN NN O
gene NN NN O
. NN NN O

Identification NN NN O
of NN NN O
mutations NN NN O
in NN NN O
Danish NN NN O
choroideremia NN NN B-Modifier
families NN NN O
. NN NN O

Structure NN NN O
and NN NN O
genomic NN NN O
sequence NN NN O
of NN NN O
the NN NN O
myotonic NN NN B-Modifier
dystrophy NN NN I-Modifier
( NN NN O
DM NN NN B-Modifier
kinase NN NN O
) NN NN O
gene NN NN O
. NN NN O

Autosomal NN NN O
recessive NN NN O
transmission NN NN O
of NN NN O
hemophilia NN NN B-SpecificDisease
A NN NN I-SpecificDisease
due NN NN O
to NN NN O
a NN NN O
von NN NN B-Modifier
Willebrand NN NN I-Modifier
factor NN NN O
mutation NN NN O
. NN NN O

Somatic NN NN O
von NN NN B-Modifier
Hippel-Lindau NN NN I-Modifier
mutation NN NN O
in NN NN O
clear NN NN O
cell NN NN O
papillary NN NN B-SpecificDisease
cystadenoma NN NN I-SpecificDisease
of NN NN I-SpecificDisease
the NN NN I-SpecificDisease
epididymis NN NN I-SpecificDisease
. NN NN O

Identification NN NN O
of NN NN O
WASP NN NN O
mutations NN NN O
in NN NN O
patients NN NN O
with NN NN O
Wiskott-Aldrich NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
and NN NN O
isolated NN NN B-SpecificDisease
thrombocytopenia NN NN I-SpecificDisease
reveals NN NN O
allelic NN NN O
heterogeneity NN NN O
at NN NN O
the NN NN O
WAS NN NN B-Modifier
locus NN NN O
. NN NN O

WASP NN NN O
gene NN NN O
mutations NN NN O
in NN NN O
Wiskott-Aldrich NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
and NN NN O
X-linked NN NN B-SpecificDisease
thrombocytopenia NN NN I-SpecificDisease
. NN NN O

Evidence NN NN O
for NN NN O
inter-generational NN NN O
instability NN NN O
in NN NN O
the NN NN O
CAG NN NN O
repeat NN NN O
in NN NN O
the NN NN O
MJD1 NN NN O
gene NN NN O
and NN NN O
for NN NN O
conserved NN NN O
haplotypes NN NN O
at NN NN O
flanking NN NN O
markers NN NN O
amongst NN NN O
Japanese NN NN O
and NN NN O
Caucasian NN NN O
subjects NN NN O
with NN NN O
Machado-Joseph NN NN B-SpecificDisease
disease NN NN I-SpecificDisease
. NN NN O

A NN NN O
4-megabase NN NN O
YAC NN NN O
contig NN NN O
that NN NN O
spans NN NN O
the NN NN O
Langer-Giedion NN NN B-Modifier
syndrome NN NN I-Modifier
region NN NN O
on NN NN O
human NN NN O
chromosome NN NN O
8q24.1 NN NN O
: NN NN O
use NN NN O
in NN NN O
refining NN NN O
the NN NN O
location NN NN O
of NN NN O
the NN NN O
trichorhinophalangeal NN NN B-SpecificDisease
syndrome NN NN I-SpecificDisease
and NN NN O
multiple NN NN O
exostoses NN NN O
genes NN NN O
( NN NN O
TRPS1 NN NN O
and NN NN O
EXT1 NN NN O
). NN NN O

BRCA1 NN NN O
mutations NN NN O
in NN NN O
a NN NN O
population-based NN NN O
sample NN NN O
of NN NN O
young NN NN O
women NN NN O
with NN NN O
breast NN NN B-SpecificDisease
cancer NN NN I-SpecificDisease
. NN NN O

Novel NN NN O
inherited NN NN O
mutations NN NN O
and NN NN O
variable NN NN O
expressivity NN NN O
of NN NN O
BRCA1 NN NN O
alleles NN NN O
, NN NN O
including NN NN O
the NN NN O
founder NN NN O
mutation NN NN O
185delAG NN NN O
in NN NN O
Ashkenazi NN NN O
Jewish NN NN O
families NN NN O
. NN NN O

A NN NN O
new NN NN O
glucose-6-phosphate NN NN O
dehydrogenase NN NN O
variant NN NN O
, NN NN O
G6PD NN NN O
Orissa NN NN O
( NN NN O
44 NN NN O
Ala-->Gly NN NN O
), NN NN O
is NN NN O
the NN NN O
major NN NN O
polymorphic NN NN O
variant NN NN O
in NN NN O
tribal NN NN O
populations NN NN O
in NN NN O
India NN NN O
. NN NN O

Evidence NN NN O
for NN NN O
linkage NN NN O
of NN NN O
bipolar NN NN B-SpecificDisease
disorder NN NN I-SpecificDisease
to NN NN O
chromosome NN NN O
18 NN NN O
with NN NN O
a NN NN O
parent-of-origin NN NN O
effect NN NN O
. NN NN O

A NN NN O
prevalent NN NN O
mutation NN NN O
for NN NN O
galactosemia NN NN B-SpecificDisease
among NN NN O
black NN NN O
Americans NN NN O
. NN NN O

A NN NN O
high NN NN O
incidence NN NN O
of NN NN O
BRCA1 NN NN O
mutations NN NN O
in NN NN O
20 NN NN O
breast-ovarian NN NN B-Modifier
cancer NN NN I-Modifier
families NN NN O
. NN NN O

Brca1 NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
results NN NN O
in NN NN O
early NN NN O
embryonic NN NN B-DiseaseClass
lethality NN NN I-DiseaseClass
characterized NN NN O
by NN NN O
neuroepithelial NN NN B-DiseaseClass
abnormalities NN NN I-DiseaseClass
. NN NN O

Identification NN NN O
of NN NN O
mutations NN NN O
in NN NN O
the NN NN O
ALD-gene NN NN O
of NN NN O
20 NN NN O
families NN NN O
with NN NN O
adrenoleukodystrophy NN NN B-SpecificDisease
/ NN NN O
adrenomyeloneuropathy NN NN B-SpecificDisease
. NN NN O

The NN NN O
murine NN NN O
homolog NN NN O
of NN NN O
the NN NN O
human NN NN O
breast NN NN B-Modifier
and NN NN I-Modifier
ovarian NN NN I-Modifier
cancer NN NN I-Modifier
susceptibility NN NN O
gene NN NN O
Brca1 NN NN O
maps NN NN O
to NN NN O
mouse NN NN O
chromosome NN NN O
11D NN NN O
. NN NN O

Atelosteogenesis NN NN B-SpecificDisease
type NN NN I-SpecificDisease
II NN NN I-SpecificDisease
is NN NN O
caused NN NN O
by NN NN O
mutations NN NN O
in NN NN O
the NN NN O
diastrophic NN NN B-Modifier
dysplasia NN NN I-Modifier
sulfate-transporter NN NN O
gene NN NN O
( NN NN O
DTDST NN NN O
): NN NN O
evidence NN NN O
for NN NN O
a NN NN O
phenotypic NN NN O
series NN NN O
involving NN NN O
three NN NN O
chondrodysplasias NN NN B-DiseaseClass
. NN NN O

Haplotype NN NN O
and NN NN O
phenotype NN NN O
analysis NN NN O
of NN NN O
six NN NN O
recurrent NN NN O
BRCA1 NN NN O
mutations NN NN O
in NN NN O
61 NN NN O
families NN NN O
: NN NN O
results NN NN O
of NN NN O
an NN NN O
international NN NN O
study NN NN O
. NN NN O

Isolation NN NN O
of NN NN O
the NN NN O
mouse NN NN O
homologue NN NN O
of NN NN O
BRCA1 NN NN O
and NN NN O
genetic NN NN O
mapping NN NN O
to NN NN O
mouse NN NN O
chromosome NN NN O
11 NN NN O
. NN NN O

Emerin NN NN B-SpecificDisease
deficiency NN NN I-SpecificDisease
at NN NN O
the NN NN O
nuclear NN NN O
membrane NN NN O
in NN NN O
patients NN NN O
with NN NN O
Emery-Dreifuss NN NN B-SpecificDisease
muscular NN NN I-SpecificDisease
dystrophy NN NN I-SpecificDisease
. NN NN O

Growth NN NN B-DiseaseClass
retardation NN NN I-DiseaseClass
and NN NN O
tumour NN NN B-Modifier
inhibition NN NN O
by NN NN O
BRCA1 NN NN O
. NN NN O

